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Studies toward the total synthesis of 7-deoxyzaragozic acid A (2.56) were
intended to build upon the completion of the synthesis of 6,7-dideoxysqualestatin
H5 (2.47) that featured the stereoselective intramolecular vinylogous aldol
reaction of the furoic ester 2.23a to give 2.26 or its trimethylsilyl ether derivative
2.30, which possess the requisite absolute stereochemistry at C(3)-C(5) of the
zaragozic acids.  The improvement of the synthesis of α-ketoester 2.25a from an
18% overall yield to 28% while also reducing the amount of chromatography
needed for the intermediates was accomplished.  Efforts toward the elaboration of
butenolide 2.30 revealed that oxygen nucleophiles were incompatible with the
system, however this issue was effectively addressed by the use of a silane
nucleophile, which was added in a Michael fashion to the butenolide 2.30 with the
correct stereochemistry.  While this was proof of concept for elaboration of the
vi
core system, it was unfortunate that the silane 2.71 could not be converted to the
desired oxygen functionality.  Additionally, efforts were made to incorporate
functionality at C-6 from the beginning of the synthesis in the form of a
brominated furoic acid derivative 2.90, however the Lewis acid mediated
cyclization of this species was low yielding with unknown stereochemical
outcome.
In addition to the studies toward the total synthesis of 7-deoxyzaragozic
acid A, the total synthesis of galtamycinone (3.2) was also investigated.  Although
the total synthesis could not be completed, methodologies have been developed
that were used to synthesize C-aryl glycosides 3.80 and 3.85 which established
these methods as a viable alternative to the O C glycoside rearrangement.
vii
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CHAPTER 1.  APPROACHES TOWARD THE SYNTHESIS OF
THE ZARAGOZIC ACIDS (SQUALESTATINS).
1.1 BIOLOGICAL ACTIVITY AND MECHANISM OF ACTION OF THE ZARAGOZIC
ACIDS
The zaragozic acids and squalestatins were discovered independently by
scientists at Merck and Glaxo respectively and were found to exhibit biological
activity in the inhibition of squalene synthase.1-8  After the structures of the
zaragozic acids and the squalestatins had been elucidated, it was determined that
they had the same core structure, and in fact that squalestatin S1 and zaragozic
acid A were the same compound, in light of the commonality of these structures,
they will be referred to only as the zaragozic acids from this point forward.
Squalene synthase is the enzyme that catalyzes the first committed step in
cholesterol biosynthesis, and the fact that the zaragozic acids were potent
inhibitors of this enzyme provided an opportunity to develop a new drug to
combat high cholesterol.  This could be done either by use of one of the naturally
2
occurring zaragozic acids or the development of a biologically active synthetic
analog.  Additionally, the structure of the squalestatins and zaragozic acids
represents a synthetic challenge.  All of the zaragozic acids contain a highly
oxygenated bicyclic core flanked by a C-1 alkyl side chain and a C-6 acyl side
























































































Naturally occurring: S1, H1, S2, H2, H5, H6, H7, H9, S3,
S4,S5,S8, T1, U1, U2, V2, W1, W2, X1, Y1, 6-deoxy H1, 
6-deoxy H5, 7-deoxy S1, 6,7-dideoxy H5
High cholesterol levels have been a known risk factor for atherosclerosis,
and therefore the discovery of drugs that lower blood cholesterol levels is an
4
important area of pharmaceutical research.  Squalene synthase is the enzyme that
acts in the first committed step in the cholesterol biosynthetic pathway.  Since the
zaragozic acids have been found to be the most potent inhibitors of squalene
synthase to date, this represents a promising site for the selective inhibition of
cholesterol biosynthesis.  The biological assay methods for the Glaxo and Merck
groups differ, resulting in different IC50 values for the same compound (zaragozic
acid A vs. squalestatin S1).  Despite the fact that the assay methods were not
consistent between the two groups, general trends were observed in the biological
activities of the various zaragozic acids.  From the available data, it seems that the
presence of the C-6 side chain as well as both the C-6 and C-7 hydroxyl groups
are crucial to the biological activity.  In fact, the IC50 becomes greater than 500




Compound IC50 (nM) Rat SQS
Zaragozic acid A (Merck) 0.5
Zaragozic acid B 0.2
Zaragozic acid C 0.4
Zaragozic acid D 6






Unfortunately, the toxicity associated with the zaragozic acids would
prevent their use as pharmaceutical drugs.  More specifically, one possible
consequence of blocking squalene synthase is that farnesylpyrophosphate (FPP)
(1.1) can accumulate since it cannot be processed through the cholesterol
6
pathway.  It has been shown that in rats that have been treated with zaragozic acid
A (1.54), FPP levels increase and HMG-CoA reductase is upregulated.  The
excessive levels of FPP appear to be rapidly catabolized in the liver to a variety of
farnesyl-derived dicarboxylic acids (FDDCAs) that are excreted in urine.  It has
been suggested that the toxic effects that have been associated with zaragozic acid
A (1.54) are a result of the acidosis caused by massive overproduction of
FDDCAs from an increased pool of FPP.  When dogs were given zaragozic acid
A (1.54) or zaragozic acid C (1.7), extreme toxicity was observed after one to two
weeks.  Additionally, little or no lowering of cholesterol was observed.  In
contrast, rhesus monkeys that had been dosed with zaragozic acid A showed
lowered cholesterol and much lower levels of FDDCAs.  The reasons for these
differences are not clear.10
The mechanism of squalene synthase in the synthesis of cholesterol begins
with the conversion of two molecules of FPP (1.1) to presqualene pyrophosphate
(1.3) via carbocation 1.2 accompanied by loss of inorganic phosphate.
Presqualene pyrophosphate (PSPP) (1.3) can then be converted to squalene (1.6)
by loss of the remaining inorganic phosphate to form cyclopropyl cation 1.4.
7
Rearrangement to tertiary carbocation 1.5 and reduction with NADPH then
produces squalene (1.6).  It is thought that the ability of the zaragozic acids to
inhibit squalene synthase is derived from the resemblance of the zaragozic acids


























Subsequent to the original publications containing structure elucidation
and biological activity, studies were done on the mechanism of biological action
of the zaragozic acids.11  Research done by Harwood has shown that inhibition of
mammalian squalene synthase is a result of mechanism-based irreversible
inactivation, where the zaragozic acids function as a mimic of PSPP (1.3).
Zaragozic acid A has been shown to bind competitively (with respect to FPP) to
squalene synthase and then react covalently with the enzyme, rendering the
enzyme inactive (suicide inhibition).
1.2.  TOTAL SYNTHESES OF THE ZARAGOZIC ACIDS
The first total syntheses of the zaragozic acids were published in 1994 by
Carreira (zaragozic acid C), Evans (zaragozic acid C), and Nicolaou (zaragozic
acid A), just two years after the first publications on structure elucidation
appeared.10,12-20  These syntheses were followed by the syntheses of Heathcock
(zaragozic acid A) in 1996, Hashimoto (zaragozic acid C) in 1998, Armstrong
(zaragozic acid C) in 1998, and finally by Tomooka, Halcomb (zaragozic acid A),
and Martin (6,7-dideoxysqualestatin H5) in 2000.21-28  The discussion of the total
10
syntheses as well as the synthetic approaches will focus on the construction of the
core structure.
1.2.1 Carreira's Synthesis of Zaragozic Acid C
The first synthesis of zaragozic acid C (1.7) was accomplished in 1994 by
Carreira, who assembled the bicyclo[3.2.1]octane core 1.19 from an acyclic
intermediate 1.18 that was derived from erythronolactone.  Additional
stereochemical centers were set using asymmetric dihydroxylation, although the
selectivity in the dihydroxylation was only modest, even under Sharpless
conditions.  A unique aspect of Carreira's synthesis was the fact that the C-4
stereocenter was not set prior to the assembly of the zaragozic acid core system.
The installation of the required alcohol and ester functionality at C-4 proved to be
a challenge in the synthesis, but after some experimentation conditions were
found that led to the formation of the correct stereochemistry at the C-4 center.
Once the correct stereochemistry was established, the C-4 center could be further
elaborated to the required ester and alcohol functionality.  In the final stages of
the Carreira synthesis, installation of the C-6 acyl side chain was problematic due
11
to a lack of regioselectivity in the acylation of the hydroxyl groups at C-6 and C-
7.  Fortunately, it was found that the C-7 hydroxyl could be selectively protected
with greater than 20:1 regioselectivity, and therefore the C-6 side chain was
installed regioselectivity.  This strategy was later used in several subsequent




















Carreira’s synthesis began with the condensation of D-erythronolactone
(1.8) with Me2NH to give the amide 1.9 that was alkylated with ethyl vinyl ether
to give 1.10 (Scheme 1.2).14,15  Addition of a Grignard acetylide to ketone 1.10
gave alcohol 1.12 as a mixture (20:1) of diastereomers in an 84% yield over two
steps.  The high diastereoselectivity in the addition was due to chelation between
the metal and the benzyloxy and carbonyl as shown in 1.11.  The synthesis of
acetylene 1.13 was then accomplished in three steps from 1.12.  At this point, the
12
C-1 side chain could be introduced into the system.  Unlike most of the other
syntheses of the zaragozic acids, Carreira introduced the C-1 side chain relatively
early in the synthesis.  In doing so, the opportunity to prepare any of the other
































i) Me2NH, MeOH, 97%; ii) (MeO)2CEt2, cat. TsOH, 90%;
iii) NaH, BnBr, THF, 96%; iv) (ethoxyvinyl)lithium, THF; 
v) TMSC CMgBr, THF, 84%; vi) O3, CH2Cl2/EtOH, 84%; 
vi) NaBH4, MeOH; vii) K2CO3, MeOH, 78%; 













Incorporation of the C-1 side chain 1.14 into ynone 1.13 proceeded in
excellent yield after extensive experimentation to identify suitable conditions
(Scheme 1.3).  Lithiation of acetylene 1.13 gave a mixture of desired product 1.15
and starting material.  Recovery of starting material rather than formation of
desired product 1.15 was thought to be due to proton transfer between acetylide
1.13 and aldehyde 1.14.  Transmetalation of the lithium acetylide 1.13 with
14
MgBr2 or CeCl3 was done in an attempt to improve the reaction, but this had little
effect on the outcome.  Effective coupling of the acetylide 1.13 and aldehyde 1.14
was finally accomplished using the lithium acetylide in the presence of LiBr,
according to the method of Brandsma,29 to give 1.15 in excellent yield.  Although
Brandsma has found the addition of LiBr to be beneficial in the addition of
lithium acetylides to enolizable ketones, there was no explanation offered as to
the reason that this improved the results of the addition.  Dess-Martin oxidation of
the resulting mixture of epimeric alcohols gave ynone 1.16.  Reduction of the
ynone to the required trans enone was not as straightforward as anticipated.  Use
of metal hydrides, dissolving metal reductions, or partial reduction with H2 in the
presence of Pd/C gave only poor yields of trans product and extensive
decomposition of the starting material.  The desired reduction to the trans enone
was eventually accomplished using chromium (II) acetate monohydrate dimer to





































i) BuLi, THF; ii) 1.14, LiBr, THF, 93%; iii) Dess-Martin, CH2Cl2, 93%; 










Once trans enone 1.17 had been made, the next step in the synthesis was
the diastereoselective dihydroxylation of the enone double bond.  Unfortunately,
initial experiments using OsO4 under catalytic conditions gave only a small
amount of desired tetraol 1.18 as a mixture (1.1:1) of diastereomers (Scheme 1.4).
16
The Sharpless asymmetric dihydroxylation of 1.17 gave tetraol 1.18 with an
improved diastereomeric ratio (1.7:1).  Treatment of this tetraol with HCl/MeOH
gave the [3.2.1]bicyclic core 1.19.  Silyl protection of the primary alcohols,































i) (DHQD)2PHAL, NMO, MeSO2NH2, acetone; 
ii) HCl/MeOH, 86%; iii) TBSCl, DMAP, Et3N, CH2Cl2, 74%; 
iv) PivCl, DMAP, ClCH2CH2Cl, 97%; 
v) H2, Pd(OH)2/C, Pd/CaCO3, EtOH, 99%;

















Ketone 1.20 was then subjected to a Peterson olefination to provide 1.21
followed by dihydroxylation of the olefin in an effort to set the stereochemistry at
C-4 (Scheme 1.5).  Unfortunately, attempts at implementing this strategy gave
18
exclusively 1.23 with the incorrect stereochemistry at C-4 rather than desired diol
1.22 with the correct stereochemistry at the C-4 center.  This result was surprising
in light of the fact that molecular models had suggested that the preferred attack
would be from the convex face due to the distortion of the six membered ring to a
half-chair conformation.  This distortion would block the concave face of the
exocyclic methylene.  Additionally, dihydroxylation of exocyclic olefins in

















































i) TMSLi, LiBr, THF/HMPA; ii) 18-cr-6, KHMDS, THF; 
iii) TBSOTf, 2,6-lutidine, <35%; iv) OsO4, NMO, t-BuOH/acetone
Since the dihydroxylation strategy to set the stereochemistry at C-4 was
not successful, another approach involving acetylenic addition to the ketone 1.20
was investigated (Scheme 1.6).  After some optimization of the conditions, it was
found that addition of lithium acetylide to 1.20 in the presence of Me3N gave a
mixture (6.1:1) of diastereomers epimeric at C-4 of acetylide 1.24.  After several
20
steps, trialdehyde 1.27 was obtained, and subsequent oxidation and esterification



















































i) TMSC CH, tBuLi, Et2O, Me3N; ii) AgNO3, 2,6-lutidine, 90%; 
iii) Dibal-H, CH2Cl2/toluene, 84%; iv) Ac2O, DMAP, CH2Cl2, 94%; 
v) H2, Pd/C, pyr.; vi) HF•pyr, THF/pyr., 64%; 
vii) Dess-Martin, CH2Cl2/pyr, 93%; viii) O3, CH2Cl2/MeOH; 
ix) NaClO2, NaH2PO4, β-isoamylene, THF/H2O; 
























All that remained to complete the synthesis of zaragozic acid C (1.7) was
the installation of the C-6 side chain and saponification of the esters at C-3, C-4,
and C-5.  Initially it was anticipated that the regioselective acylation of 1.28 at C-
6 could be accomplished to provide 1.30 with the completed C-6 side chain intact.
However, deprotection of both the C-6 and C-7 hydroxyl groups and coupling of
1.28 to 1.29 resulted in an unfavorable (1:3) ratio of C-6 to C-7 acylated
regioisomers.  In order to circumvent this problem, another coupling strategy was
developed that involved selective protection of the C-7 hydroxyl group.  Thus,
when 1.28 was allowed to react with Boc2O in the presence of 4-
pyrrolidinopyridine rather than the more commonly used DMAP, the C-7
hydroxyl was converted to the Boc ester with greater than 20:1 regioselectivity
(Scheme 1.7).  It was speculated that the high regioselectivity of the coupling of
1.28 to 1.29 was due to the bulkier character of the acylating agent that was
generated using 4-pyrrolidinopyridine.  This bulky acylating agent would be more
selective for the less sterically hindered secondary alcohol at C-7.  Coupling of
the C-6 side chain then proceeded smoothly to give 1.30.  Completion of the
synthesis of zaragozic acid C (1.7) was then accomplished by saponification of
23
the three esters.  In summary, the Carreira synthesis of zaragozic acid C (1.7) was












































i) Boc2O, 4-pyrrolidinopyridine, CH2Cl2, 82%; ii) 1.29, DCC, DMAP, 








1.2.2 Nicolaou's Synthesis of Zaragozic Acid A
Later in 1994, Nicolaou published the first total synthesis of zaragozic
acid A (1.54) as a relay synthesis through 1.51.  At the outset of the studies
24
toward the total synthesis, a sample of zaragozic acid A (1.54) was degraded to
1.51, this compound was in turn, used to reassemble 1.54.  This study was
followed by the total synthesis of 1.51 in order to complete the total synthesis of
zaragozic acid A (1.54).  Installation of the stereochemical centers of the
zaragozic acid core system in this synthesis relied on a double dihydroxylation
sequence involving a Sharpless enantioselective dihydroxylation followed by a
diastereoselective dihydroxylation.  The initial enantioselective dihydroxylation
required a considerable amount of experimentation before the enantioselectivity
was optimized to above 80% ee.  Fortunately, the diastereoselective
dihydroxylation that followed provided the desired tetraol as a single
diastereomer.  Analogous to the synthesis of zaragozic acid C (1.7) by Carreira,
the C-6 and C-7 hydroxyl groups were not differentially protected.
Unfortunately, Nicolaou was not able to overcome the regioselectivity issue
leaving a disappointing 3:2 ratio of regioisomers in the final synthesis of
zaragozic acid A (1.54).
The Nicolaou synthesis began with protection of 2-butyne-1,4-diol (1.31),
followed by conversion to vinyl stannane 1.32 for use in a Stille coupling
25
(Scheme 1.8).  Vinyl iodide 1.34 was prepared in three steps from allyl alcohol
1.33.  Stille coupling of vinyl iodide 1.34 and vinyl stannane 1.32 produced the












i, ii iii, iv, v
vi
i) NaH, PMBCl, n-Bu4NI, DMF, 94%; ii) Bu3SnH, Pd(PPh3)2Cl2, 
THF, 94%; iii) SEMCl, iPr2NEt, CH2Cl2, 98%; iv) O3, CH2Cl2/MeOH; 
v) methyl iodo(triphenylphosphoranylidene) acetate, PhH, 78%; 








The enantioselective dihydroxylation of 1.35 under Sharpless conditions
gave exclusive dihydroxylation at the C-5 – C-6 olefin to give 1.36 with 83% ee
26
in a 30% yield (Scheme 1.9).  While the yield was rather low, it was reported to
be reproducible even on large scale.  A considerable amount of experimentation
was done in order to improve the yield and enantioselectivity of the
dihydroxylation before it was established that the best results utilized either 2-
methoxyethoxymethyl (MEM) or 2-(trimethylsilyl)ethoxymethyl (SEM) ethers at
C-7, PMB protecting groups on the other alcohols, and a methyl ester at C-5.  The
dramatic effects of the protecting groups were attributed to the steric requirements
in the binding pocket of the AD catalyst.  It appeared that this binding pocket was
unable to accommodate larger protecting groups such as the TBS group that was
originally utilized.  However, the binding pocket was able to accommodate
smaller, linear protecting groups such as SEM or MEM.  The rationale for the
exclusive regioselectivity in the dihydroxylation was not as clear, but it was
speculated that the methyl ester was twisted out of conjugation with the diene
system.  Additionally, the two allylic hydroxymethyl substituents were
approximately orthogonal to the plane of the C-3 – C-4 olefin, which maximizes
the hyperconjugative stabilization.  In contrast, the C-5 – C-6 olefin only has one
electron withdrawing hydroxymethyl group.  These two features suggest that,
27
contrary to superficial inspection of the dienyl system, the C-5 – C-6 olefin is





















i)  t-BuOH/H2O, K3Fe(CN)6, K2CO3, (DHQD)2PHAL, 
K2OsO2(OH)4, MeSO2NH2, 30%; 
ii) 2-methoxypropene, PPTS, CH2Cl2, 88%; 













After satisfactory conditions for the enantioselective dihydroxylation had
been found, attention was turned to the diastereoselective dihydroxylation of the
C-3 – C-4 olefin.  Initially, the diastereoselective dihydroxylation was attempted
on 1.36 rather than on 1.37, but 1.36 was found resistant to dihydroxylation using
28
either standard conditions or Sharpless asymmetric dihydroxylation conditions.
Removal of the PMB protecting groups was anticipated to increase the reactivity
by generating a less sterically hindered allylic alcohol.  Additionally, it was
anticipated that PMB deprotection would give lactone 1.37, after spontaneous
lactonization.  Formation of lactol 1.37 had the advantage of providing steric
hindrance to attack at the re face of the olefin in the dihydroxylation.
Dihydroxylation of the C-3-C-4 olefin in 1.37 followed by base-catalyzed
translactonization in one-pot formed 1.38 as a mixture (10:1) of diastereomers.
Recrystallization of the mixture provided 1.38 as a single diastereomer in an 83%
yield.
Originally, it was anticipated that both C-8 and C-9 could be oxidized
simultaneously, unfortunately all attempts at doing so resulted in complex
reaction mixtures.  Consequently, a stepwise approach was necessary (Scheme
1.10).  To this end, the C-8 hydroxyl of 1.38 was protected while the stepwise
oxidation at C-9 was accomplished to provide 1.39.  The selective protection at C-
4 was then accomplished while obtaining the free alcohol at C-8 to give 1.40.
Stepwise oxidation and esterification at C-8 then yielded 1.41.  If the second
29
oxidation sequence was performed without C-4 being protected, it was sometimes
found that the reaction gave a very low yield of desired product, particularly with
large scale reactions.  These low yields were attributed to retro-aldol cleavage of
the C-3 – C-4 bond.  Aldehyde 1.42 was then obtained from 1.41 in four steps.
Though this sequence of stepwise oxidations grew to be somewhat cumbersome
with protection/deprotection sequences, the yields were generally high and









































i) TBDPSCl, imid., DMAP, DMF, 89%; ii) Dess-Martin, 
CH2Cl2, 89%; iii) NaClO2, NaH2PO4, Me2C=CHMe, 
t-BuOH/H2O; iv) DCBI, PhCH3, 96%; v) TBAF, AcOH, 
THF, 97%; vi) CH3N(TMS)COCF3; vii) PPTS, 
CH2Cl2/MeOH; viii) Dess-Martin, CH2Cl2, 97%; 
ix) NaClO2, NaH2PO4, 2-methyl-2-butene, t-BuOH/H2O; 
x) DCBI, PhCH3, 60%; xi) TFA, CH2Cl2, 88%; 
xii) CH3N(TMS)COCF3; xiii) PPTS, CH2Cl2/ MeOH; 




Coupling of the C-1 side chain with the core structure was accomplished
by lithiation of dithiane 1.43 and addition to aldehyde 1.42 to give the desired
alcohol as a mixture (1:1) of diastereomers of 1.44 (Scheme 1.11).  Unfortunately,
31
the undesired isomer could not be converted to the desired isomer 1.44, but the
two isomers were readily separable since the desired isomer could be selectively
desilylated under the reaction conditions.  After removal of the dithiane protecting
group from 1.44, treatment of 1.45 with HCl/MeOH did not produce the expected
zaragozic acid [3.2.1] core 1.47.  Instead, it was found that the PMB group had




















































i) BuLi, THF, 29% ; ii) Hg(ClO4)2, CaCO3, THF/H2O, 67%; 













In order to circumvent this problem, the PMB group was removed from
1.43 using DDQ, and the resulting secondary alcohol was protected with the more
acid stable di-tert-butylmethylsilyl (DTBMS) to give C-1 side chain 1.48
(Scheme 1.12).  Coupling of 1.48 with aldehyde 1.42 gave a separable mixture of
diastereomers, and the desired isomer 1.49 was carried on through the desilylation
and dithiane removal as before to give 1.50.  Treatment of 1.50 with HCl/MeOH
provided the zaragozic acid bicyclic core in 45% yield.  Finally, the C-4' hydroxyl
of the C-1 side chain was reprotected as the PMB ether, thereby completing the
synthesis of relay compound 1.51 that had been shown by Nicolaou to be a viable





































i) DDQ, CH2Cl2/H2O, 70%; ii) DTBMSOTf, 2,6-lutidine, DMAP, 87%; 
iii) 1.42, BuLi, THF, 40%; iv) 2% HCl/MeOH/CH2Cl2, 99%; 
v)Hg(ClO4)2, CaCO3, THF/H2O, 83%; vi) 1.8% HCl/MeOH, 45%; 
vii) 49% aq, HF/MeNO2, 30%; viii) LiOH•H2O, THF/H2O then DCBI, THF, 68%; 








Final elaborations in the synthesis of zaragozic acid A began with the
coupling of the C-6 side chain 1.52 with core structure 1.51 to give a
disappointing mixture (3:2) of C-6 and C-7 acylated product (Scheme 1.13).
Although both the yield and selectivity of the reaction were poor, it was possible
to separate the two isomers by chromatography, hydrolyze the C-7 acylation
product and recycle it.  Silyl protection of the C-7 hydroxyl followed by PMB
deprotection at C-4' gave 1.53.  Installation of the C-4' acetate, silyl deprotection,
and saponification of the esters gave zaragozic acid A (1.54) in 34 steps and an























i) 1.51,  EDC, DMAP, CH2Cl2, 47%; 
ii) TESOTf, pyr., CH2Cl2,  79%; iii) DDQ, CH2Cl2/H2O, 98%; 
iv) Ac2O, pyr., DMAP, CH2Cl2, 99%; v) TBAF, THF, 85%; 




After the completion of the synthesis of zaragozic acid A (1.54), Nicolaou
redesigned the preparation of aldehyde 1.42 to address some of the major
problems in the synthesis (Figure 1.3).  First, the lack of control in the
diastereoselectivity in the coupling of aldehyde 1.42 to C-1 side chain 1.48
rendered half of the material unusable.  This was unfortunate in light of the fact
that it was such advanced intermediate in the synthesis.  Secondly, the aldehyde
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1.42 was not stable to chromatography.  Thirdly, the C-3 benzyl ester was prone
to attack by dithiane 1.48.  The rationale behind the design of aldehyde 1.55 to
replace aldehyde 1.42 was the anticipation that the benzylidene acetal would have
an influence on the approach of the C-1 side chain 1.48 to the aldehyde.
Additionally, it was also thought that the benzylidene acetal of 1.55 would prove
to be more stable to chromatography than the tertiary TMS ether of 1.42.  Lastly,
the absence of the benzyl ester at C-3 would prevent attack of the dithiane anion



















The preparation of aldehyde 1.55 began with selective protection of triol
1.56, which was prepared analogously to 1.38, at C-8 followed by oxidation of the
remaining alcohol to benzyl ester 1.57 (Scheme 1.14).  The preparation of
aldehyde 1.55 was then accomplished in four steps from 1.57.  A model C-1 side
chain was then used to examine the effect of aldehyde 1.55 on the
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diastereoselectivity of the addition.  The diastereoselectivity of the addition of
methyl dithane to 1.55 was 3:1 favoring the desired alcohol, which was a
significant improvement over previous results.  Through a series of
manipulations, dithiane 1.58 was converted to the zaragozic acid [3.2.1] core
system 1.60 with the model C-1 side chain.  This route is not as convergent as the
previous route, because it necessitates the oxidation at C8 after the addition of the
side chain.  However, the benefit of the higher diastereoselectivity in the addition





















































xiii, xiv, xv, xvi
i) TBDPSCl, imid., DMAP, DMF, 89%; ii) Dess-Martin, CH2Cl2; 
iii) NaClO2, NaH2PO4, 2-methyl-2-butene, t-BuOH/H2O; 
iv) DCBI,  PhCH3, 93%; v) TMSCl, NaI, 66%; 
vi) TBAF, AcOH, THF, 97%; vii) PhCH(OMe)2, CSA, CH2Cl2, 85%; 
viii) Dess-Martin, CH2Cl2, 90%; ix) 2-methyl-1,3-dithiane, BuLi, THF, 47%; 
x) Zn(OTf)2, EtSH, CH2Cl2, 89%; xi) Hg(ClO4)2, CaCO3, THF/H2O, 81%; 
xii) 2% HCl/MeOH, 82%; xiii) PCC, Celite, 3Å mol. sieves, CH2Cl2, 65%; 
xiv) NaClO2, NaH2PO4, Me2C=CHMe, t-BuOH/H2O; 













1.2.3 Evans' Synthesis of Zaragozic Acid C
The second synthesis of zaragozic acid C (1.7) by Evans was also
published in 1994 subsequent to the Carreira synthesis.  The synthesis featured
both an Evans aldol as well as a Mukaiyama aldol reaction to set all of the
stereocenters in 1.7 with the exception of the one at C-5.  The required C-5
stereochemistry was established through a chelation controlled Grignard reaction.
Interestingly, Evans chose to assemble the five-membered ring portion of the
zaragozic acid core before the ketalization to close the six-membered ring.  The
syntheses by both Nicolaou and Carreira on the other hand assembled the entire
core structure in one step.  Evans, like Carreira, chose to introduce the C-1 side
chain at an early stage, a decision that prevented the synthesis of a variety of
zaragozic acids from a common, late stage intermediate.  One of the most
attractive features of this synthesis was the fact that Evans had the foresight to
differentiate the C-6 and C-7 hydroxyl groups at an early stage.  Differentiating
these hydroxyl groups enabled Evans to incorporate the C-6 side chain with
complete regioselectivity in contrast to the strategies of Carreira and Nicolaou.
This synthesis of zaragozic acid C (1.7) was efficient in terms of both the number
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of steps (22) and the overall yield (9.7%).  Unfortunately, since there has been no
full paper published, there is little insight as to the reasoning behind various steps
in the synthesis.
The synthesis began with the diastereoselective aldol reaction of the boron
enolate of 1.61 to give the desired adduct in excellent yield (Scheme 1.15).
Subsequent modifications of the adduct provided aldehyde 1.62 in three steps,
which was to be used in a Mukaiyama aldol reaction later in the synthesis.  The
synthesis of the coupling partner 1.64 commenced with protection of di-t-butyl
tartrate (1.63) and formation of the silyl enol ether.  Mukaiyama aldol coupling of
the two fragments 1.62 and 1.64 under Lewis acidic conditions gave the adduct








































i) Bu2BOTf, Et3N, PhCH=CHCHO, CH2Cl2, 96%; 
ii) TBSOTf, 2,6-lutidine, CH2Cl2; iii)LiBH4, MeOH, THF; 
iv) (COCl)2, DMSO, Et3N, CH2Cl2; 92%; 
v) cyclopentanone dimethyl ketal, TsOH, PhH, 85%; 






Once 1.62 and 1.64 had been coupled, oxidation at C-5 of 1.65 yielded
ketone 1.66 (Scheme 1.16).  Treatment of 1.66 with vinyl magnesium bromide
formed the desired olefin 1.68 with high diastereoselectivity (10:1) due to
chelation control between the ketone and benzyloxy functionality as shown in
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1.67.  Dihydroxylation of the C-1 olefin of 1.68 followed by oxidative cleavage of
the diol and oxidation produced lactone 1.69 in an 84% yield.  Triester 1.70 was










































i) Dess-Martin, CH2Cl2, 94%; ii) CH2=CHMgBr, CH2Cl2/THF, 76%; 
iii) OsO4, NMO, t-BuOH/THF, H2O; iv) Pb(OAc)4, PhH, ; 
v) TPAP, NMO, 4Å mol. sieves, CH2Cl2, 84%; vi) O3, NMO, CH2Cl2; 
vii) NaClO2, NaH2PO4, Me2C=CHMe, t-BuOH; 






























Coupling of lactone 1.70 with 1.71 gave a mixture of lactols, and
deprotection at C-4' and acetylation provided lactol 1.72 (Scheme 1.17).
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Treatment of 1.72 with TFA and esterification yielded triester 1.73.  It is worth
noting that the hydroxyl groups at C-6 and C-7 were differentiatially protected
zaragozic acid core system, thereby avoiding the regioselectivity issues that both



































i) t-BuLi, 73%; ii) DDQ, CH2Cl2/H2O; iii) Ac2O, DMAP, pyr/PhH, 90%; 





Completion of the synthesis of zaragozic acid C (1.7) was accomplished
by deprotection of 1.73 to yield 1.74 and installation of the C-6 side chain 1.75
(Scheme 1.18).  Finally, silyl deprotection and saponification of the three esters
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i) H2, 10% Pd/C, AcOH, MeOH; 96%; ii) 1.75, DCC, DMAP, CH2Cl2, 82%; 







1.2.4 Heathcock's Synthesis of Zaragozic Acid A
The second total synthesis of zaragozic acid A was completed by
Heathcock in 1996 and was published as a relay synthesis from compound 1.86.
In the first of two papers, the synthesis of 1.86 from zaragozic acid A (1.54) and
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the reconstitution of zaragozic acid A from relay compound 1.86 were detailed.
The second publication presented the synthesis of 1.86 from methyl-D-
pyranoside.  Heathcock's synthesis of zaragozic acid was significantly longer than
any of the other syntheses with forty-two steps (longest linear sequence) and an
overall yield of less than 1%.  The zaragozic acid core 1.79 was assembled prior
to the functionalization of either C-3 or C-4.  Elaboration of the C-5 center was
facile, however, installing the requisite alcohol and ester at C-4 proved to be
challenging.  Although Heathcock had not differentiated the C-6 and C-7
hydroxyl groups early in the synthesis he was able to address this issue by
selectively protecting C-7 using the incomplete C-1 side chain to give 1.87.  The
use of the incomplete C-1 side chain as a protecting group for C-7 was a creative
way to regioselectively incorporate the C-6 side chain.  This was a creative way to
approach the issue of regioselectively installing the C-6 side chain in the absence
of differential protection early in the synthesis.
Compound 1.76, which was made in five steps from methyl-α-D-
pyranoside was converted to 1.77 with the requisite diol at C-5 in three steps
(Scheme 1.19).  Lactone 1.78, which contained the completed five-membered ring
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encompassing C-1 through C-5 of the zaragozic acid core, was then obtained from
1.77 in four steps.  Allyl magnesium bromide was added after transmetalation to
the cerium reagent to form the bicyclic[3.2.1]core 1.79 in a 74% yield after
treatment with acid.  If the Grignard reagent was used in the addition rather than



















i, ii, iii iv, v, vi, vii
viii, ix
x, xi, xii
i) Me2(i-PrO)SiCH2MgCl, THF; ii) H2O2, MeOH, THF, NaHCO3;  
iii) TBDPSCl, imid., DMF, 92%; iv) TFA, Ac2O; v) NaOMe, MeOH; 
vi) acetone, H+; vii) PDC, sieves, CH2Cl2, 77%; viii)CH2=CHCH2CH2CeCl2, 
THF; ix) HCl, H2O, THF, 74%; x) DMSO, TFAA, Et3N, CH2Cl2, 94%; 

















One of the more difficult challenges in this synthesis was the elaboration
of C-4.  After considerable experimentation, it was found that after
transmetalation of vinyl magnesium bromide to the cerium reagent and addition to
1.80 provided the requisite functionality at C-4.  Treatment with TBAF provided
triol 1.81 as a 15:1 diastereomeric mixture (Scheme 1.20).  Diester 1.82 was then
obtained from triol 1.81 in 76% overall yield using a three step oxidation
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sequence.  Selective ozonolysis of the C-1 side chain was then performed in the
presence of the C-4 olefin to give 1.83.  Presumably, the selectivity in the reaction
of 1.82 was due to the steric congestion about the C-4 olefin, though there was no
comment on the this issue.  The C-4 olefin was then subjected to ozonolysis and
oxidation to the ester to give triester 1.84.  Aldehyde 1.85 was obtained in two
steps from 1.84 and then protected as the dimethyl acetal to provide 1.86, which
constituted the synthesis of the relay compound in the Heathcock synthesis of

















































i) CH2=CHMgBr, CeCl3, THF; ii) TBAF, THF, 88%; iii) Dess-Martin, CH2Cl2; 
iv) NaClO2, NaH2PO4, Me2C=CHMe, t-BuOH/H2O; 
v) N, N'-diisopropylisourea, CH2Cl2, 76%; vi) O3, CH2Cl2/MeOH, then NaBH4, 61%; 
vii) O3, CH2Cl2/MeOH; viii) TBSCl, imid., DMF; ix) NaClO2, NaH2PO4, Me2C=CHMe, 
t-BuOH/H2O; x) N, N'-diisopropylisourea, CH2Cl2, 41%; xi) TBAF, THF, 61%; 













vii, viii, ix, x
The synthesis of zaragozic acid A (1.54) from the relay compound began
with installing the C-6 side chain (Scheme 1.21).  Initially, attempts to couple
either the acid 1.52 or the corresponding acid chloride to diol 1.85 resulting
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primarily in the acylation at C-7 rather than at C-6.  In order to circumvent this
problem, a novel approach was taken whereby the cyclic acetal 1.86 was made
from 1.85, thereby internally protecting the C-7 hydroxyl.  Side chain 1.52 was
then incorporated exclusively at C-6 to provide 1.87.  Aldehyde 1.88 was then


































i) PPTS, PhH, 4Å, 99%; ii) 1.52 DCC, DMAP, CH2Cl2, 95%; 

















The conclusion of the total synthesis began with the incorporation of the
remainder of the C-1 side chain (Scheme 1.22).  This was accomplished by first
transmetallating stannane 1.89 to the cerium anion and addition to aldehyde 1.88
to form 1.90 after Dess-Martin oxidation of the C-3' alcohol.  Use of the
organocerium rather than the organolithium was found critical in the addition of
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1.89 to aldehyde 1.88 due to extensive enolization when the addition was
attempted with the organolithium species.  Additionally when the lithium anion
was used, the diastereomeric ratio was a disappointing 1:1.  Compound 1.91 was
then obtained with a fully functionalized C-1 side chain.  Removal of the
protecting group at C-7 and saponification of the three t-butyl esters gave















































i) BuLi, THF, then CeCl3, 87%; ii) Dess-Martin, pyr., CH2Cl2, 92%; 
iii) Tebbe reagent, THF, 77%; iv) DDQ, CH2Cl2, H2O, 91%; 
v) Ac2O, DMAP, Et3N, CH2Cl2, 100%; vi) HF•pyr, THF, 87%; 






1.2.5 Hashimoto's Synthesis of Zaragozic Acid C
The third synthesis of zaragozic acid C was completed by Hashimoto in
1997.  This synthesis utilized a tin triflate-mediated Mukaiyama aldol reaction
between 1.94 and 1.97 to set the chiral centers at C-4 and C-5.  Unfortunately,
after extensive optimization of this key reaction, the best conditions gave only a
1.6:1 diastereomeric ratio of desired to undesired C5 epimer.  After ketalization to
assemble the zaragozic acid core, Hashimoto's synthesis intersected the synthesis
of zaragozic acid C (1.7) published by Carreira
The two coupling partners 1.94 and 1.97 were prepared from D- and L-
tartaric acid to form aldehydes 1.93 and 1.96 respectively (Schemes 1.23 and
1.24).[Mukaiyama, 1982 #441]  Initial studies on the aldol addition of the silyl
ketene thioacetal 1.94 to α-ketoester 1.97 provided rather disappointing results as
the undesired C-5 epimer was formed preferentially from both the E- and Z-
ketene thioacetals. Alternative protecting groups were explored to see if the












i) NaClO2, NaH2PO4, Me2C=CHMe, t-BuOH/H2O; ii) (COCl)2, DMF, CH2Cl2;














i NaClO2, NaHPO4, Me2C=CHMe, t-BuOH/H2O; ii) (COCl)2, DMF, CH2Cl2; 
iii) MeONHMe•HCl, pyr., CH2Cl2; iv) ethyl vinyl ether, t-BuLi, THF; v) O3, CH2Cl2
steps i, ii, iii, iv, v
1.95 1.96 1.97
It was eventually found that protection of the C-1' hydroxyl with a strong
chelating group was optimal, therefore MEM was selected to provide silyl ketene
acetal 1.98 (Scheme 1.25).  The Mukaiyama aldol of 1.98 and 1.97 provided a
1.6:1 ratio of desired C-5 epimer 1.99 to undesired (5-epi) aldol adduct.  Although
this ratio was certainly not ideal, it was the only experiment where the desired C-5






























The correct diastereomer 1.99 was converted in eight steps to alcohol
1.100 (Scheme 1.26).  Alcohol 1.101 was then made in several steps from 1.100.
Selective deprotection of the MEM group was followed by the selective silyl











































i, ii iii, iv, v
vi, vii, viii
i) Hg(OCOCF3), MeOH, 82%; ii) H2, Pd/C, MeOH; iii) Dess-Martin, CH2Cl2; 
iv) NaClO2, NaH2PO4, Me2C=CHMe, t-BuOH/H2O; v) CH2N2, Et2O, 88%; 
vi) TMSCl, NaI, MeCN, 88%; vii) MeN(TMS)COCF3; viii)10% aq. HCl, Et2O, 79%.
1.99 1.100
1.101 1.102
Dess-Martin oxidation of alcohol 1.102 was followed by installation of the
C-1 side 1.103 chain via lithioacetylide addition to yield 1.104 (Scheme 1.27).
Cyclization of 1.104 to give the zaragozic acid [3.2.1] core 1.105 then proceeded
to give both the desired ketal as well as a small amount (7%) of an isomeric ketal
1.106.  The equilibration of 1.105 to 1.106 was attempted without success
indicating that the ketalization was under kinetic control.  The preferential
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formation of 1.105 over 1.106 was ascribed to the fact that the C-6 – C-7
pentylidene acetal was hydrolyzed much more easily than the C-3 – C-4
isopropylidene acetal as monitored by TLC analysis.  Triacetate 1.107, which
intersected Carreira's synthesis, was obtained in four steps from 1.105.  The
remainder of the synthesis was carried out in an identical fashion to Carreira to










































 i) Dess-Martin, CH2Cl2, 98%; ii) 1.103, BuLi, THF; 
iii) Dess-Martin, CH2Cl2, 79%; iv) H2, Pd/C, EtOAc; 
v) 90% aq. TFA, 68%; vi) 1N KOH, dioxane; 
vii) N, N'-diisopropyl-O-t-butylisourea, CH2Cl2, 40%; 
















vi, vii, viii, ix
1.2.6 Armstrong's synthesis of Zaragozic Acid C
Armstrong's synthesis of zaragozic acid C (1.7) was strikingly similar to
the Nicolaou approach to zaragozic acid A (1.54).  The key steps for both
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syntheses involved a Sharpless enantioselective dihydroxylation followed by a
diastereoselective dihydroxylation to set the stereocenters in the [3.2.1] core
system.  Armstrong's synthesis of the zaragozic acid was shorter than Nicolaou's
but the overall yields of the two syntheses were comparable at less than 1%.
The diene 1.111 was made in a similar manner to that in Nicolaou's
synthesis (Scheme 1.28).  Sharpless asymmetric double dihydroxylation was then
examined on diene 1.111 as well as other dienes with various protecting group
schemes.  After some experimentation Armstrong found, as Nicolaou found, the

















i) LiI, AcOH, 95%; ii) Cu(2-thiophenecarboxylate), NMP, 87%; 
iii) Dibal-H, CH2Cl2, 94%
1.108 1.109 1.110
1.111
To this end, treatment of diene 1.111 with Super AD-mix followed by
treatment of the resulting triol with OsO4 in the presence of NMO produced
tetraol 1.112 with 76% ee and >9:1 d.r., in about 47% overall yield (Scheme
1.29).  Unfortunately, the dihydroxylation procedure required several days, but it
was shortened by replacing the K2S2O8 with the more soluble sodium salt in
conjunction with higher loadings of osmium and ligand.  This modification did
succeed in shortening the reaction time, however, it was accompanied by a slight
decrease in the enantioselectivity to give a 68% ee. Although it was unnecessary
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to use the chiral ligand in the second dihydroxylation since the first
dihydroxylation introduced the asymmetry to the system, the reaction rates were
higher using the (DHQD)2–PHAL ligand compared to the use of achiral
quinuclidine.  This process compares favorably to Nicolaou's results of 83% ee,
100% de with only a 30% yield for the first, and 83% yield for the second
dihydroxylation.  Diacetonide 1.113 was then obtained through a sequence of
protecting group manipulations.  Successive recrystallizations provided 1.113 in


































i) AD-mix β, OsO4, K2S2O8, CH3SO2NH2, (DHQD)2PHAL, 
NMO, t-BuOH/H2O, 78%; ii) acetone, H2O, (DHQD)2PHAL, 
OsO4, NMO, 58%; iii) PivCl, pyr., DMAP, CH2Cl2, 77%; 
iv) CH2=CH(OMe)CH3, cat. p-TsOH, DMF, 77%; 
v) Dibal-H, CH2Cl2, 91%; vi) (COCl)2, DMSO, Et3N, CH2Cl2, 75%
1.111 1.112
1.113 1.114
The C-1 side chain 1.115 was attached via dithiane monosulfoxide anion
addition to the aldehyde 1.114 to give the desired adduct, albeit the diastereomeric
ratio at C-7 was disappointingly only 1:1 (Scheme 1.30).  It was necessary to use
1.115 rather than the corresponding dithiane because the latter could not be
cleanly metallated.  Difficulties in the metalation of 1,3 dithianes that have
oxygen functionality in the δ-position have been noted previously, but in these
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cases, the difficulty has been circumvented by use of a sodium base.  This
difficulty was interesting in light of the fact that Nicolaou was able to use a
dithiane anion in the installation of C-1 side chain 1.43 or 1.48 to 1.42 without
difficulty.  The adduct was then subjected to deoxygenation to return the dithiane





























i) BuLi, THF; ii) P2I4, NEt3, CH2Cl2, 59%; 
iii) TBAF, THF, 32%; iv) Ac2O, DMAP, pyr., 85%
Ketalization of 1.116 then proceeded smoothly to provide the [3.2.1]
zaragozic acid core (Scheme 1.31).  Once the ketalization was accomplished,
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protecting group manipulations followed to give tetraol 1.117.  All that remained
to complete a formal synthesis of zaragozic acid C (1.7) was the oxidation of the
core to the acid oxidation state at C-3, C-4, and C-5.  To this end, all three
hydroxyls were simultaneously oxidized followed by esterification to provide
1.28, which intersected with the synthesis of zaragozic acid C by Carreira, and
therefore constituted a formal total synthesis.  Armstrong completed the
remaining steps in the same manner as Carreira to complete a total synthesis of
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i) CH2Cl2/TFA/H2O, 90%; ii) BzCl, DMAP, pyr., 97%; iii) H2, Pd/C, 89%; 
iv) (COCl)2, DMSO, NEt3, CH2Cl2; v) NaClO2, NaH2PO4, t-BuOH/β-isoamylene;




An important side note to the ketalization was that when 1.118 was treated
with either 2% HCl/MeOH or TFA, the desired ketal 1.119 was formed along
with isomeric ketal 1.120 in nearly a 1:1 ratio (Scheme 1.32).  If the ketalization
was performed prior to the removal of the dithiane, the desired ketal 1.119 was
the only product of the reaction.  It was believed that depending on the substrate,
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the ketalization could proceed under either kinetic or thermodynamic control.  In
the case of 1.118, it was speculated that the reaction had proceeded under kinetic
control since resubmitting the ketal isomers 1.119 and 1.120 to the reaction
conditions did not result in their interconversion.  It was hypothesized that the
relative rate of hydrolysis of the two acetonides in 1.118 was responsible for the
ratio of 1.119 to 1.120.  More specifically, if the C-3 – C4 acetonide was removed
first, then formation of a six membered ring through closure of the C-4 hydroxyl
onto the C-1 carbonyl might lead to 1.120.  Conversely, initial hydrolysis of the
C-5 – C-6 acetonide might be followed by rapid cyclization of the C-5 hydroxyl
group onto the C-1 carbonyl, leading to a five membered ring that may remain
closed until hydrolysis of the other acetonide and subsequent closure of the
second ring.  In order to test this hypothesis, 1.121 was treated with TFA to
remove both acetonide protecting groups before the removal of the dithiane
protecting group.  Unexpectedly, treatment of 1.121 with TFA not only effected
the acetonide deprotection, but also the removal of the dithiane protecting group





































i) 2% HCl, MeOH, 45% 1.119, 47% 1.120; 











1.2.7 Tomooka's Synthesis of Zaragozic Acid A
In 2000 Tomooka published a synthesis of zaragozic acid A (1.54) that
utilized the acetal 1,2-Wittig rearrangement as the key step.  Tomooka's approach
was not only novel, but also competitive in terms of overall length with the other
syntheses of the zaragozic acids at 32 steps from L-arabinose.  In Tomooka's
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synthesis of zaragozic acid A (1.54) the assembly of the five membered ring in
the core was completed before the six membered ring was assembled.
Additionally, Tomooka, like many others, did not differentially protect C-6 and
C-7, so the endgame of the synthesis utilized Carreira's selective protection
strategy to install the C-6 side chain.
The synthesis began with L-arabinose (1.122) that was converted to 1.124
in seven steps (Scheme 1.33). Deprotonation of dialkyne 1.124 and 1,2-Wittig
rearrangement provided 1.125 with high diastereoselectivity (84% d.r.).
Fortunately, the two diastereomers were separable by chromatography, and the

















i) LiC≡CH, Et2O, 75%; ii) TBDPSC≡CCH(OH)C≡CTMS, montmorillonite K10, 
























Ozonolysis of the olefin provided the aldehyde that was then treated with
vinylmagnesium bromide to form allyl alcohol 1.127 with high
diastereoselectivity (>95%) that was due to chelation control through the C-4
hydroxyl.  The resulting diol was protected as an acetal and the vinyl group at C-3
was converted to a t-butyl ester by a sequential oxidation/esterification (Scheme
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1.34).  Subsequent semihydrogenation of the C-5 alkyne then provided 1.128,





















i, ii iii, iv, v, vi, vii
viii, ix, x
i) O3, MeOH; ii) CH2=CHMgBr, PhCH3, 49%; iii) cyclopentanone dimethyl acetal, 
pTsOH, PhH, 87%; iv) O3, MeOH; v) NaClO2, NaH2PO4, Me2C=CHMe, 
t-BuOH/H2O; vi) N, N'-diisopropyl-O-t-butylisourea, CH2Cl2, 73-84%; 
vii ) H2, Pd/C, MeOH, 88%; viii) O3, MeOH; ix) NaClO2, NaH2PO4, 










The TMS acetylene 1.129 was then deprotected and the alkyne subjected
to semihydrogenation to give 1.130 and the same oxidation sequence that had
been used to install the other two esters was performed again to provide triester
1.131 (Scheme 1.35).  The fact that the three esters at C-3, C-4, and C-5 were
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oxidized separately made the sequence rather cumbersome, although there was no
comment made on whether simultaneous oxidations were attempted in this
synthesis.  Benzoyl deprotection was then followed by a two-step oxidation






































i) TBAF, THF, 94%; ii) H2, Lindlar cat., MeOH, 93%; iii) O3, MeOH; 
iv) NaClO2, NaHPO4, t-BuOH/H2O; 
v) N, N'-diisopropyl-O-t-butylisourea, CH2Cl2; 73-84%; 
vi) aq. KOH, MeOH, 78%; vii) cat. TPAP, NMO, 4Å mol. sieves, CH2Cl2, 98%; 
viii) O2, Cu(OAc)2, 2, 2'-bipyridyl, DABCO, DMF, 72%.
1.129 1.130
1.131 1.132
The C-1 side chain was installed via addition of the organolithium reagent
derived from 1.135.  Oxidative cleavage of the PMB group and acetylation gave
1.134 (Scheme 1.36).  The [3.2.1] zaragozic acid core was assembled by
treatment of 1.134 with acid, esterification, and silyl deprotection to form diol
1.135.  The C-6 side chain 1.52 was then attached using Carreira's strategy to






































i) t-BuLi, hexane/Et2O, 96%; ii) DDQ, CH2Cl2, 96%; iii) Ac2O, DMAP, CH2Cl2, 95%; 
iv) TFA, CH2Cl2/H2O; v) N, N'-diisopropy-O-t-butylisourea, CH2Cl2; 
vi) TBAF, THF, 51%; vii) Boc2O,  4-pyrrolidinopyridine, CH2Cl2, 81%; 




















1.2.8 Halcomb's Formal Synthesis of Zaragozic Acid A
The next synthesis of zaragozic acid A (1.54) was actually presented as a
formal synthesis that intersects an early intermediate in the Nicolaou synthesis.
This approach is symmetry-based, beginning with furan diester 1.136 where the
critical desymmetrization step is a singlet oxygen furan oxidation of 1.139 to
produce a 5:1 mixture of epimers at the hemiacetal 1.140.  Halcomb, like many
others, utilized the Sharpless asymmetric dihydroxylation as a tool for the
introduction of the appropriate stereochemistry.  While the novel symmetry-based
approach that Halcomb had was a clever idea, the fact that Halcomb's synthesis is
19 steps and it intersects Nicolaou's total synthesis with 21 steps left to reach
zaragozic acid A (1.54) makes it less appealing.
The approach begins with furan dimethyl ester 1.136 that was converted to
dialdehyde 1.137 (Scheme 1.37).  Dialdehyde 1.137 was subjected to a Peterson
olefination to provide diene 1.138.  Sharpless asymmetric dihydroxylation of
1.138 gave the corresponding tetraol (>98% ee).  Treatment of furan 1.139 with
singlet oxygen provided olefin 1.140 as a mixture (5:1) of epimers at the acetal.
Dihydroxylation of 1.140 with stoichiometric osmium tetraoxide installed the two
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tertiary alcohol stereocenters to provide 1.141.  It was stated that 1.141 appeared
to be a mixture (5:1) of inseparable hemiacetal in solution; however, a single
isomer appeared to crystallize from solution.  Although the dihydroxylation of
1.140 did not utilize a Sharpless asymmetric dihydroxylation, this reaction
showed remarkable facial selectivity.  The origin of the facial selectivity was not
clear, however it was speculated that the chirality of the acetonide-protected
secondary alcohols were responsible for controlling the facial selectivity in the

































i) TMSCH2MgCl, Et2O; ii) AD-mix α, K3Fe(CN)6, K2CO3, t-BuOH/H2O, 59%; 
iii) CH3C(OMe)2CH3, p-TsOH, DMF, 69%; iv) Hünigs base, rose bengal, O2, 





Opening of lactone 1.141 was accomplished to give the oxime 1.142
(Scheme 1.38).  This oxime was used as a protecting group for the aldehyde
because of the fact that it could be installed under mildly basic conditions and was
expected to be resistant to acetal formation.  The carboxylic acid functionality of
1.142 was used in the discrimination of the two secondary alcohols in a selective
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lactonization to produce 1.143 upon treatment with acid.  Acetonide protection of




























i) HONH2•HCl, pyr., THF/MeOH, 94%; ii) PPTS, MeOH; 
iii) PPTS, CH3(OCH3)CH3, DMF, 68%; 



















Cleavage of the acetonide of 1.144 and subsequent protecting group
manipulations resulted in the isolation of oxime 1.146 in four steps (Scheme
1.39).  The final steps in the formal synthesis included ozonolysis to remove the
oxime, oxidation of the aldehyde and esterification to the benzyl ester to give
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1.147.  Compound 1.147 was an intermediate in the Nicolaou synthesis, and









































i) PPTS, MeOH, 81%; ii) SEMCl, 2,6-di-t-butylpyridine, CH2Cl2/PhH, 56%;
iii) PPTS, CH2=C(OCH3)CH3, CH2Cl2, 52%; iv) TBAF, AcOH, THF, 80%; 
v) O3, NaHCO3, CH2Cl2/MeOH, 69%; vi) NaClO2, NaH2PO4, Me2C=CHMe, 
t-BuOH/H2O; vii) DCBI, THF/PhCH3, 70%.
1.144 1.145
1.146 1.147
Although the total synthesis of any member of the zaragozic acid family is
an achievement, comparisons between the various synthetic approaches show a
select few to be outstanding among the group.  In particular, the most impressive
total synthesis of them all was that of Evans, which constituted an outstanding use
of stereocontrol.  Additionally, the overall yield of the synthesis was nearly 10%
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in only 22 steps.  Carreira's total synthesis was also worth mention not only
because it was the first total synthesis of any of the zaragozic acids, but because
of the problem solving abilities that were apparent in the installation of the C-4
center.  Furthermore, installation of the C-6 side chain proved to be challenging
with respect to regioselectivity.  Carreira also provided a strategy to
regioselectively install the C-6 side chain that was used by several other zaragozic
acid syntheses.  While Nicolaou's total synthesis was rather cumbersome, it did
provide a valuable springboard for the formal total synthesis by Halcomb as well
as the total synthesis of zaragozic acid C by Armstrong.  Armstrong's total
synthesis was quite similar to Nicolaou's approach, however, Armstrong was able
to produce a much shorter synthesis using the same strategy of using an
enantioselective dihydroxylation followed by a diastereoselective dihydroxylation
(23 steps compared to 34).  Halcomb's formal synthesis of zaragozic acid A was a
novel approach to the zaragozic acid core, however, in practice it was
disappointing that this synthesis intersected Nicolaou's synthesis at such an early
stage.  Also, in all there were 40 steps in this synthesis which made Halcomb's
synthesis one of the longest that has been published, second only to Heathcock's
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synthesis.  Tomooka's synthesis used a novel approach that was quite different
from any of the other total syntheses, and furthermore was accomplished with
high stereoselectivity.  The use of the acetal Wittig rearrangement with such high
stereocontrol was impressive.  Heathcock's synthesis was the longest total
synthesis at 42 steps overall and grew to be rather cumbersome, although his
approach to the regioselective installation of the C-6 side chain was novel, and
certainly managed to make the best of a challenging situation.
1.3 SYNTHETIC APPROACHES TO THE ZARAGOZIC ACID CORE
In addition to the total and formal syntheses of the zaragozic acids, there
have also been a number of synthetic approaches to the unique [3.2.1] bicyclic
core.  An exhaustive survey of all of these will not be attempted here due to the
fact that there are so many approaches that have been published; however, a few
of the most novel examples to the core have been selected for discussion.  Some
of the total syntheses of the zaragozic acids did not have any particular "key" step,
but rather approached the synthesis as a stepwise application of known chemistry.
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In this section, the strategies that appear were chosen based on the creativity of a
key step in the assembly of the zaragozic acid core.
1.3.1 Johnson's Approach
In an effort to prepare a semi-functionalized core that did not include the
C-1 side chain, Johnson made use of an enzyme in the key step to introduce
asymmetry to the system.30  Cycloheptene diol 1.148 (prepared from
cycloheptatriene) was converted to acetate 1.149 with complete selectivity using
Candida antartica lipase B (Scheme 1.40).  Acetate 1.149 was then converted to
ketone 1.150 in two steps.  Rubottom oxidation of the ketone gave the diol that
was reduced under Luche conditions to yield 1.151.  Ketone 1.154 was then
obtained from 1.151 in eight steps.  It was anticipated that nucleophilic attack of
1.154 would result in the correct stereochemistry, opposite to the two α-
substituents of the ketone.  Thus, the alkylation of 1.154 proceeded as expected to
give 1.155 with the correct configuration at C-5.  Ozonolysis of the olefin
provided 1.156, which was then cyclized to the zaragozic acid core 1.157 bearing
functionality at C-3, C-4, and C-5.  It is anticipated that 1.157 could be further
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functionalized at C-4 using a strategy similar to that of Carreira or Heathcock;
however, these operations were not conducted.  Additionally, further oxidations at
C-3 and C-5 would be necessary to complete the zaragozic acid [3.2.1] core.
Unfortunately, this approach made no mention of a strategy for the introduction of
the C-1 side chain to the system, however, if lactol 1.156 were oxidized to the































iv, v vi, vii, viii
ix, x, xi xii, xiii
xv
xvi
i) Candida antartica lipase B, isopropenyl acetate; ii) TBSCl, imid., DMF, 100%; 
iii) KCN, MeOH, then PDC, 98%; iv) TMSOTf, Et3N, CH2Cl2; v) mCPBA, pentane,
then NaBH4, CeCl3, MeOH, 59%; vi) CH3C(OCH3)2CH3, CSA, 100%; vii) H2SiF6, 
Et3N, CH3CN; viii) PDC, CH2Cl2, 78%; ix) TMSOTf, Et3N, CH2Cl2; x) mCPBA, 
pentane, then NaBH4, CeCl3, MeOH, 54%; xi) MOMCl, Hünig's base, CH2Cl2, 100%; 
xii) TBAF, THF; xiii) PCC, CH2Cl2; xiv) Bu3SnCH2OBn, BuLi, THF, 88%; xv) O3, 




















Another approach to the zaragozic acid core was reported by Paterson,
who utilized an epoxidation cyclization sequence to form the final desired
ketal.31,32  Unlike most of the other approaches to the zaragozic acids, Paterson
chose to install the C-1 side chain very early in the synthesis, which limits the
flexibility of the approach.  Moreover, the advanced intermediate 1.169 had the
incorrect stereochemistry at C-7, and there was no mention of correcting the C-7
stereochemistry.  Additionally, the core was not fully oxidized at C-3, C-4, and C-
5; however, these operations should be relatively straightforward.  Nevertheless,
the synthesis begins with the assembly of aldehyde 1.160 through a Negishi-type
coupling of vinyl iodide 1.159 and vinyl bromide 1.158 (Scheme 1.41).  Coupling
of the aldehyde with ketone 1.161 was accomplished via a boron mediated aldol
addition to give alcohol 1.162 with very high diastereoselectivity (>97%) after













i) BuLi, THF, ZnBr2, Pd(MeCN)2Cl2, DMF, 99%;
 ii) 1 M HCl/THF; iii) (c-C6H11)2BCl, Me2NEt, Et2O, 
then H2O2, MeOH, pH 7 buffer , 68%; iv) TESOTf, 
2,6-lutidine, CH2Cl2, 76%; v) LiBH4, THF, 73%; 




















Although two routes to the bicyclic [3.2.1] ketal from 1.163 were
examined, the route shown below proved far superior with respect to
diastereoselectivity.  Accordingly, aldehyde 1.163 and sulfone 1.164 were
coupled, and the resulting alcohol was subjected to a Swern oxidation to provide
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ketone 1.165 (Scheme 1.42).  Removal of the sulfone was followed by silyl
deprotection to give 1.166.  At this point, a Sharpless dihydroxylation was
performed exclusively at the C-3 – C-4 olefin to yield 1.167 with high
diastereoselectivity (>95%).  Presumably the regioselectivity for the C-3 – C-4
olefin is based on the fact that the dihydroxylation of trisubstituted olefins was
known to at a much higher rate than cis-disubstituted olefins.33  Initially, attempts
at dihydroxylation of 1.166 with enriched AD-mix-β led only to decomposition,
but eventually the dihydroxylation was accomplished using substantially more
ligand (25 mol%) to provide 1.167 in modest yield.  Epoxidation of the remaining
olefin was then accomplished producing 1.168 as a single isomer.  Treatment of
1.168 with acid then produced the desired [3.2.1] bicyclic ketal in an impressive
95% yield.  The C-5 alcohol was protected as the silyl ether to provide 1.169,
which was an advanced zaragozic acid intermediate.  It should be noted, however,















































i) BuLi, THF/Et2O; ii) (COCl)2, DMSO, Et3N, CH2Cl2, 95%;
 iii) Na(Hg), Na2HPO4, MeOH/THF, iv) HF•pyr., pyr./THF, 64%;
v) AD-mix β, [(DHQD)2PHAL, K2OsO4•2H2O], MeSO2NH2,
 t-BuOH/H2O, 54%; vi) VO(acac)2, t-BuOOH, 78%, 















One thing worth mention in Paterson's study was the pronounced effect of
the nature of the C-1 side chain on the outcome of the ketalization.  Specifically,
if ketal 1.170 or epoxide 1.168 with the actual zaragozic acid C-1 side chain were
subjected to treatment with CSA in CDCl3, the desired [3.2.1] bicyclic core 1.169
was isolated from the reaction (Scheme 1.43).  Alternatively, if ketal 1.171, with a
model C-1 side chain was treated with PPTS, the isomeric ketal 1.172 was
produced.  Additionally, treatment of epoxide 1.173 that includes a different
model side chain with PPTS gave desired ketal 1.174.  The specific interactions
that contribute to the differences in the products that were observed were not
speculated upon; however, it is clear that the nature of the specific C-1 side chain
is important to the outcome of the cyclization.  This was also observed in
Nicolaou's synthesis where a change in the C-4' protecting group made a






























































2) TBSCl, imid., DMAP
1) PPTS or CSA, CDCl3
2) TBSCl, imid., DMAP
92
1.3.3 Myles' Approach
A third approach to the zaragozic acid core, was accompanied by an
extensive study of the ketalization step that involved both computational as well
as experimental data.34,35  The ketalization was studied experimentally using
substrates without functionalization at C-6 or C-7.  To this end, ketone 1.175
homologated to provide acetal 1.176 (Scheme 1.44).  Alkylation of ketone 1.176
and treatment with acid gave 1.177.  Dihydroxylation of the C-4 olefin gave a
separable 1:2 mixture of isomers 1.178 and 1.179, although through recycling, the
mixture could be manipulated to provide predominantly either 1.178 or 1.179.
Swern oxidation of the alcohol and treatment with vinylmagnesium bromide gave
1.180 as a single diastereomer through chelation control between the ketone and
the adjacent C-4 alcohol.  Treatment of 1.180 with acid provided the desired
zaragozic acid ketal 1.181.  Conversion of the C-5, C-4, and C-3 substituents to
the necessary oxidation state was then accomplished stepwise to give the








































i) HO(CH2)2OH, TsOH, PhH; ii) PhCN, H2O2; iii) BnOK, THF, 35%;
 iv) (COCl)2, DMSO, Et3N, CH2Cl2; v) (CH2=CCH2O)
2-MgBrLi, 45%; 
vi) TFA, CH2Cl2, 93%; vii) OsO4, K3FeCN6, t-BuOH/H2O, 100%; 
viii) (COCl)2, DMSO, Et3N, CH2Cl2; ix) CH2=CHMgBr; x) TFA;
xi) IBX; NaClO2; t-butylisourea, 70%; xii) O3, PPh3; NaClO2;
t-butylisourea, 83%; xiii) H2, Pd/C; xiv) IBX; NaClO2; t-butylisourea, 50%.











An interesting side note to Myles' study of the ketal system was that when
ketal isomers 1.178 or 1.179 were treated with more forcing conditions (2% HCl
in methanol) for several days, equilibration takes place to form a third isomer
1.184 (Scheme 1.45).  This isomer was formed when the tertiary alcohol at C-4
rather than the tertiary alcohol at C-5 was incorporated into the ketal moiety.  The
composition of the equilibrium mixture under HCl catalysis suggests that 1.184 is
the lowest energy isomer of the three; however there appears to be a kinetic
barrier to the formation of this isomer.  These experimental findings correlate
nicely with the computational study by Myles on a similar system 1.185 that
showed ketal isomer 1.85 to be lowest in energy of all possible ketal isomers












































Another approach to the desired core system was developed by Nagaoka
who utilized a Grob fragmentation in the ketalization to form 1.194.36.  An
attractive feature of the synthesis included the differential protection of C-6 and
C-7 at an early stage, therefore allowing for acylation at C-6 without issues of
regioselectivity in the incorporation of the C-6 side chain.  Although the zaragozic
96
acid core did not include a C-1 side chain or specific mention of a plan to
incorporate a C-1 side chain, 1.195 does have a handle that could potentially be
utilized to build the side chain.  Additionally, if the C-1 side chain were
incorporated at a late stage, it would allow for the synthesis of a wide variety of
zaragozic acids from a common, late stage intermediate.
Adduct 1.189 was obtained after Diels-Alder cyclization of 1.188 (Scheme
1.46).  Selective epoxidation of the C-6 – C-7 olefin in the presence of a radical
inhibitor and dihydroxylation of the remaining olefin provided 1.190 as a single
isomer.  The regio- and stereoselectivity in the epoxidation and dihydroxylation
sequence was explained on the basis of electronic effects and the convex attack of
oxidants on the stereochemically rigid 7-oxabicyclo[2.2.1]heptadiene ring system
1.189.  Acid catalyzed lactonization of 1.190 gave the lactone triol that was
selectively silylated at C-4 to provide 1.191.  Protecting group manipulations
were then performed to give 1.192 in three steps.  The lactone and methyl esters
were then reduced and the newly formed hydroxyl groups were protected to
provide 1.193, which was elaborated in two additional steps to give 1.194.  Grob
fragmentation of 1.194 was then accomplished to yield zaragozic acid core 1.195.
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i) BnBr, NaH, Bu4NI, THF, 92%; ii) MeO2C≡CO2Me, PhMe, 83%; 
iii) mCPBA, 4, 4'-thiobis(2-t-butyl-5-methylphenol), DCE, 76%; 
iv) OsO4, NMO, MeCN/H2O, 98%; v) p-TsOH, MeOH/H2O, 95%; 
vi) TBSCl, Et3N, CH2Cl2, 94%; vii) H2, Pd/C, MeOH; 
viii) acetone, Me2C(OMe)2, CSA, 96%; ix) SEMCl, i-Pr2NEt, 
CH2Cl2, 84%; x) LiAlH4, THF, 63%; xi) BnBr, NaH, Bu4NI, THF, 90%; 
xii) TBAF, DMPU, 94%; xiii) MsCl, Et3N, I2, 5% NaHCO3, 43%; 
xiv) KHMDS, dioxane, thenNaBH4, MeOH, then I2, 5% NaHCO3 43%; 
















Rizzacasa has published a synthesis of the zaragozic acid core using the
Ireland ester enolate Claisen reaction to elaborate the C-5 center.37-40  The
synthesis began with D-mannose, which unfortunately had the wrong
stereochemistry at C-7.  This issue was addressed and the stereochemistry at C-7
corrected through a six-step sequence, however it made this synthetic approach
somewhat cumbersome.  Additionally, through this sequence, Rizzacasa had the
opportunity to differentially protect C-6 and C-7, but chose not to do so.  It is true
that several syntheses and synthetic approaches were forced to deal with the
problems associated with not differentially protecting the C-6 and C-7 hydroxyl
groups.  However, it was not clear why the two hydroxyl groups were protected
identically.  The fact that there was no functionality at C-4 reduced the appeal of
the approach.
The allyl ester 1.200 necessary for the Ireland ester enolate Claisen was
synthesized from diacetonide mannose 1.197 (Scheme 1.47). Acid 1.199 was
obtained from 1.197 in four steps.  Conversion to the acid chloride and treatment
























i) NaH, BnBr, DMF, 85%; ii) conc. HCl, aq. MeOH; iii) NaIO4; 
iv) AgNO3, KOH, 82%; v) (COCl)2, DMF, PhH; 
vi) CH2=CHCH2OH, DMAP, CH2Cl2
1.197 1.198
1.199 1.200
Allyl ester 1.200 underwent an Ireland-Claisen rearrangement to form
methyl ester 1.201 as the major product (5.7:1 d.r.) though there was no comment
on the selectivity (Scheme 1.48).  Fortunately, the mixture can be recrystallized to
provide pure 1.201.  Reduction of the ester and MOM protection of the resulting
alcohol provided 1.202, which was dihydroxylated to give a mixture (1:1) of
diastereomers that could later be epimerized to favor the desired configuration.
Attempts at stereoselective dihydroxylation using the Sharpless dihydroxylation
gave only low selectivity.  Inversion at C-7 was than accomplished in six steps
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beginning with 1.203.  Debenzylation and chlorination of the resulting lactol
followed by reductive elimination to yield glycal 1.204. Subsequent
stereoselective epoxidation and opening of the epoxide with allyl alcohol
provided 1.205 after benzyl protection of the C-7 hydroxyl.  It seems as if it may
have been wise to differentiate the C-6 and C-7 hydroxyl groups when the
opportunity presented itself, however, they were protected identically after
opening of the epoxide.  Removal of the allyl group from 1.205 gave lactol 1.206




















































i) LDA, TMSCl, THF/HMPA, 74%; ii) LiAlH4; iii) MOMCl, i-Pr2NEt, CH2Cl2, 99%; 
iv) OsO4, K3FeCN6, K2CO3, t-BuOH; v) (MeO)2CMe2, PPTS, acetone, 96%; 
vi) Li/NH3, THF; vii) HMPT, CCl4/THF; viii) Li/NH3, THF, 68%; ix) NaH, BnBr, 
THF/DMF, 92%; x) DMDO, CH2Cl2; xi) CH2=CHOH, 95%; xii) BnBr, THF, 
DMF, 90%; xiii) (PPh3)3RhCl, DABCO, EtOH; xiv) Hg(OAc)2, THF, H2O;






Incorporation of the C-1 side chain was then accomplished by by
alkylating lactone 1.207 with the anion of 1.208.  Lactone 1.207 was then
converted to lactol 1.209 (Scheme 1.49).  Treatment of 1.209 with acid gave the
zaragozic acid [3.2.1] core 1.210 with a 3:1 epimeric ratio at C-3.  Rizzacasa
commented on this ratio being a result of the reluctance of the undesired
acetonide epimer to cyclize.  Oxidation of the C-3 hydroxyl to the methyl ester
gave 1.211 as a single isomer, apparently resulting from epimerization at C-3
during the oxidation sequence.  Similar oxidation at C-5 and elaboration at C-4































i) t-BuLi, Et2O/hexane, 48%; ii) 10% HCl, MeOH, 67%; 
iii) Dess-Martin, pyr./CH2Cl2; iv) NaClO2, NaH2PO4,














1.3.6 1,3-Dipolar Cycloaddition Approaches
Four different research groups approached the synthesis of the zaragozic
acid core using the 1,3-dipolar cycloaddition of an oxonium ylide to assemble the
dioxabicyclo[3.2.1] core system.41-47  They have all been assembled into one
section in order to provide a clear picture of the progress in the development of
this approach toward the synthesis of the zaragozic acid core.
Koyama published the first approach that utilized a 1,3-dipolar in 1994.  A
general survey of diazoketones and dipolarophiles revealed that the most
promising results for the synthesis of the zaragozic acid core came from the
coupling of diazoketoesters such as 1.212 and 1.215 with various dipolarophiles
to provide products such as 1.214 or 1.217 (Scheme 1.50).  Although Koyama did
show that this general strategy was certainly viable for the zaragozic acid core











































Hodgson also adopted a 1,3-dipolar cycloaddition strategy whereby
diazoketoester 1.218 was treated with methyl glyoxylate to give a single
cycloadduct 1.220 in modest yield (Scheme 1.51).  Treatment of the ketone with
TMS lithium acetylide gave 1.221, which after several steps provided olefin
1.222.  Finally, treatment with acid to effect the desired rearrangement formed
1.223 as the dioxabicyclo[3.2.1] ring system.  Unfortunately, the C-4 center of
1.223 had the wrong stereochemistry because of the propensity for endo
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selectivity in the cycloaddition, which was due to the secondary overlap between
























ii iii, iv, v, vi
vii
i) methyl glyoxylate, Rh2(OAc)4, PhMe, 60%; ii) TMSC≡CLi, 
THF, 80%; iii) K2CO3, DMF/H2O, 98%; iv) H2, Pd/C, 100%; 







Further studies of the dipolar cycloaddition by Hodgson sought to disrupt
the secondary overlap in 1.219 by altering substitution, therefore decreasing the
propensity for endo selectivity (Scheme 1.52).  To this end, diazoketoester 1.224
which was prepared in seven steps from γ-valerolactone, was treated with methyl
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glyoxylate to give, after removal of the silyl protecting group, cycloadduct 1.225.
Treatment of 1.225 with TFA produced 1.226 with correct stereochemistry at C-4
in a 33:64 ratio of 1.225 to 1.226.  It should be noted that if HCl/MeOH or
CSA/MeOH were used as the acid, 1.227 was also formed as a minor product



























i)methyl glyoxylate, Rh2(OAc)4, PhMe, 65%; ii) TBAF, THF, 74%.
1.224 1.225
1.226 1.227
Hashimoto also utilized the intermolecular 1,3-dipolar cycloaddition in a
synthesis of the zaragozic acid core.  The diazoesters 1.231 and 1.232 were
prepared from ester 1.228 as a mixture (1.5:1) of epimers that were readily

























1.231: R1 = CO2Me, R
2 = OTMS
1.232: R1 = OTMS, R2 = CO2Me
vi, vii
i) 10% aq. HCl/THF, 78%; ii) TBDPSCl, pyr., DMAP, CH2Cl2, 96%; 
iii) MOMO(CH2)2CO2H, EDCI, DMAP, CH2Cl2, 89%; iv) H2, Pd(OH)2/C, 
MeOH, 85%; v) Dess-Martin, CH2Cl2, 94%; vi) N2CHCO2Et, LiHMDS, 
THF; vii) HMDS, imid., THF, 40% (1.231), 26% (1.232)
1.228 1.229
1.230
Diazoketoester 1.231 was then used in the 1,3-dipolar cycloaddition with
dione 1.233 to form adduct 1.234 as a single diastereomer (Scheme 1.55).  The
stereochemical outcome of the cycloaddition was explained as a consequence of
the dipolarophile 1.233, which was presumed to proceed exclusively from the β-
face of the carbonyl ylide in order to avoid non-bonding interaction with the C-4
pseudoaxial TMS group.  Further elaboration of the core included deprotection of
the C-4 alcohol and stepwise oxidation and esterification at C-3 to give the
desired functionalized [3.2.1] core 1.235.  Hashimoto commented on the intention
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to complete the synthesis of the fully functionalized zaragozic acid core through























ii, iii, iv, v
i) Rh(OAc)4, PhH, 47%; ii) TBAF, AcOH, THF; iii) Dess-Martin, CH2Cl2;




Zercher also contributed to the evolution of the 1,3-dipolar cycloaddition
strategy, although his approach utilized an intramolecular rather than the
previously examined intermolecular approach.  Reaction of methyl acetoacetate
(1.236), with mixture of meso- and dl- 1,5-hexadiene-3,4-diol produced 1.237
(Scheme 1.56).  Subsequent conversion of 1.237 to the β-ketoester and
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diazotization was performed to give 1.238.  Conversion to the zaragozic acid core
was then accomplished via 1,3-dipolar cycloaddition to provide 1.239 as the
major product with the incorrect stereochemistry at both C-3 and C-4.  The fact
that 1.239 was produced with the incorrect stereochemistry at both the C-3 and C-
4 centers made this approach much less appealing, but since the 1,3-dipolar




















i ii, iii, iv
v
i) meso and dl-1,5-hexadien-3,4-diol, p-TsOH; ii) KOH, MeOH; 
iii) carbonyldiimidazole, then Mg(O2CCH2CO2CH3)2; 




The last approach to the zaragozic acid core system that will be discussed
by Wardrop utilized a directed C-H insertion as the key step in the assembly of
the zaragozic acid core system.44  The required diaoketone 1.245 was synthesized
in eight steps from 3,5-O-benzylidene xylitol (1.240) (Scheme 1.57).
Diazoketone 1.245 was then prepared and subjected to the cyclization conditions
to provide the desired [3.2.1] system 1.246.  Formation of the C-6/C-7 trans diol
1.247 was then accomplished in two steps from 1.246 where the C-6 and C-7
hydroxyl groups had been differentiated.  Although there was no mention of a
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specific plan to fully functionalize C-4 to produce the zaragozic acid core, there













































i) NaH, BnBr, TBAI, DMF; ii) EtSH, p-TsOH, CHCl3, 40%; iii) MeC(OMe)3,
p-TsOH, 4Å mol. sieves, CH2Cl2 then Na2CO3; iv) TMSCN, SnCl2, 
4Å mol. sieves, CH2Cl2 then K2CO3; v) NaOH, H2O2, EtOH, 73%; 
vi) DMF, DMA,MeOH, 73%; vii) LiOH, THF, H2O; viii) Et3N, then 
t-BuOCOCl, CH2Cl2, then CH2N2, 88%; ix) Rh2(OAc)4, CH2Cl2, 48%; 






Since the ketalization to form the zaragozic acid [3.2.1] core is a key step
in the synthesis of all members of the zaragozic acid family, it seemed worthwhile
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to carefully examine this particular step.  More specifically, examples of the
ketalization that provide some insight as to how substituents might influence the
outcome of the ketalization were selected in an effort to draw some general
conclusions about the reaction.  In order to gain insight about the important
factors in the ketalization, examples were selected where different results were
obtained depending on the substitution and/or reaction conditions that were used.
For example, in Nicolaou's synthesis of zaragozic acid A (1.54), 1.45 was
subjected to treatment with 2% HCl in methanol to give only undesired ketal 1.47
(Scheme 1.58).  The formation of analogous methyl ketals was also observed in
the work of Hodgson (Scheme 1.53) and Martin (Schemes 2.9 and 2.11).
Surprisingly, when 1.50 was subjected to acidic conditions, the exclusive product
of the reaction was the desired [3.2.1] bicyclic core 1.248.  Since the only
difference between the two cyclization substrates 1.45 and 1.50 was the C-4'
protecting group, this suggested that the specific nature of the C-1 substituent was
















































In addition to the observations by Nicolaou presented above, there was
also a short study by Nicolaou with 1.249 to determine the sequence of events in
the cascade reaction to form desired ketal 1.250.  To this end, 1.249 was treated
with 2% HCl/MeOH at room temperature for 12 h to yield the methyl glycoside
1.250 (Scheme 1.59).  After seven additional hours at 68 ºC, the reaction mixture
contained two major components, acetonide 1.251 and desired [3.2.1] bicyclic
ketal 1.252.  When acetonide 1.251 was resubjected to the reaction conditions,
desired ketal 1.252 was obtained.   This experiment suggested that ketal 1.252
was the thermodynamically most stable ketal for this system.  Unfortunately these
117
results cannot be applied as a general rule since when methyl ketal 1.47 was































12 h, 25 ºC
7 h, 68 ºC
9 h, 68 ºC
2% HCl/MeOH
14 h, 68 ºC
Similarly, Armstrong's work demonstrated that the nature of the product
depended on the C-1 side chain that was used in the precursor (Scheme 1.60).
When the cyclization was performed in the presence of a methyl group 1.118
rather than the zaragozic acid C-1 side chain, a mixture of the desired ketal 1.119
and undesired ketal 1.120 was obtained in approximately equal amounts.  In
contrast, if the ketone in 1.118 were protected as the dithiane 1.121, the
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cyclization provided 1.19 as the exclusive product of the reaction.  In agreement
with this finding, when the actual zaragozic acid C-1 side chain was used with
dithiane 1.116, the cyclization resulted in the isolation of desired [3.2.1] bicyclic
ketal 1.253 in excellent yield.  These findings also support the theory that the
nature of the C-1 side chain substituent is crucial to the outcome of the cyclization













































































Paterson also found that the ketalization of a series of substrates varied
depending upon the nature of the substituent at C-1.  If 1.171 was used with a
simple alkyl group at C-1, treatment with acid provided only undesired ketal
1.172 (Scheme 1.61).  Alternatively, when 1.173 was subjected to treatment with
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acid, desired ketal 1.174 was the only product isolated from the reaction.  Making
a direct comparison between the cyclizations of 1.171 and 1.173 may be difficult
in light of the fact that the nature of the substrate is different.  However, the acid-
catalyzed cyclizations of 1.168 and 1.170 using the actual zaragozic acid C-1 side
chain confirms the theory that the nature of the C-1 substituent determined the
outcome of the cyclization, since only the zaragozic acid [3.2.1] bicyclic core
































2) TBSCl, imid., DMAP
1) PPTS or CSA, CDCl3






























Hodgson conducted a model study that gave provided some insight as to
the importance of the nature of the acid (Scheme 1.62).  To this end, treatment of
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1.225 with camphorsulfonic acid or HCl in methanol provided starting material
1.225 along with desired ketal 1.226 and ketal 1.227 as a minor product.
Nicolaou (Scheme 1.57) and Martin (Schemes 2.9 and 2.11) have observed the
formation of analogous methyl ketals in the acid-catalyzed ketalization reaction to
form the zaragozic acid [3.2.1] bicyclic core.  Treatment of 1.225 with triflic acid
produced the desired ketal 1.226, but only in small amounts.  Conversely, desired
ketal 1.226 could be obtained as the major product by treatment of 1.225 with
Evans' conditions using trifluoroacetic acid.  When ketal 1.225 was subjected to
the same conditions, the same ratio (33:64) of 1.225 to 1.226 was obtained, which
































While it was anticipated that there would be some generalizations that
could be made about the acid-catalyzed ketalization, it was found that the reaction
is highly dependent upon the specific substrate.  Evidence thus far indicates that
there are at least two factors that are important to the outcome of the ketalization:
first, the nature of the C-1 substituent is crucial, though there does not seem to be
any pattern that could serve as a predictive indicator.  Second, the nature of the
acid catalyst and solvent are important to the outcome of the reaction, although
there are no predictive patterns with this component with the possible exception
that the formation of an undesired methyl acetal is a possible side product with the
use of HCl in methanol.
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CHAPTER 2.  EFFORTS TOWARD THE TOTAL SYNTHESIS
OF 7-DEOXYZARAGOZIC ACID A
2.1 PREVIOUS WORK IN THE MARTIN GROUP
In addition to the approaches to the zaragozic acids that have already been
discussed in Chapter 1, the Martin group also embarked on studies toward the
synthesis of this group of natural products. The strategy in the Martin group has
utilized a vinylogous aldol reaction as the key step in the synthesis.  The aldol
reaction has been used in other syntheses of the zaragozic acids.  More
specifically, Evans employed both an Evans aldol reaction using a chiral
oxazolidinone and a Mukaiyama aldol reaction.  Additionally, Hashimoto used a
Lewis acid mediated Mukaiyama aldol reaction as a key step.
The vinylogous aldol reaction has not been employed in the synthesis of
any of the members of the zaragozic acid family, although this reaction has been
employed extensively in the context of both methodological studies, as well as
total syntheses.48,49  In a generic sense, the vinylogous Mukaiyama aldol consists
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of the reaction of silyloxyfuran 2.2 and carbonyl 2.1 to provide butenolide 2.3
(Scheme 2.1).  Butenolide 2.3 could then be further elaborated to the five-














2.1.1 First Generation Approach
In the first approach to the zaragozic acids 2.4, Dr. Phil Kym targeted the
bicyclic lactone 2.5 as a potentially versatile gateway since it contains the
requisite absolute chirality at C-3 – C-5 of the zaragozic acid core 2.4 (Scheme
2.2).  Bicyclic lactone 2.5 also has appropriate functional handles for introducing
the remaining substituents and side chains of all the zaragozic acids.  This
compact intermediate might be rapidly assembled via reduction and cyclization of
2.6, which would in turn be assembled using an intermolecular vinylogous
Mukaiyama aldol reaction of furan 2.7 with dioxosuccinate 2.8.  Although this
retrosynthetic analysis constitutes a racemic approach, it was envisaged that the
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methods utlized here could later be applied to an enantioselective synthesis of any







































In accordance with the above retrosynthetic analysis, the requisite furan
2.10 was prepared by metallation and carbomethoxylation of the known furan 2.9
(Scheme 2.3).50  The second building block, dimethyl dioxosuccinate (2.8) was
prepared in one step by the acid catalyzed dehydration of dihydroxytartrate
according to the method of Beak.51
Scheme 2.3
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The stage was then set to examine the feasibility and the stereoselectivity
of the key vinylogous Mukaiyama aldol reaction between 2.10 and 2.8.  A series
of initial attempts to catalyze this reaction with a variety of Lewis acids, including
SnCl4, BF3•OEt2, Me2AlCl, TiCl4, and AlCl3 were unsuccessful.  However, the
desired vinylogous aldol addition could be induced using excess HF•pyridine to
provide an inseparable mixture (ca 2.3:1) of the diastereomeric adducts 2.11 and
2.12 in 91% yield (Scheme 2.4).  At this stage it was not possible to assign the
relative stereochemistry of the two adducts, but subsequent experiments revealed
that the major isomer was the desired 2.11 (vide infra).  Unfortunately, adducts
2.11 and 2.12 were extremely labile toward retro-aldolization under both acidic
and basic conditions.  The hydroxyl group at C-4 presumably serves as the trigger
where the suceptibility of butenolide 2.11/2.12 toward the retro-aldolization was
attributed to the stablization of the resulting anion at C-5.  This stabilization of the
C-5 anion was derived from the conjugation with the α,β-unsaturated lactone and
from the electron withdrawing methyl ester at C-5.  It was anticipated that
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reduction of the double bond of the butenolide moiety in 2.11/2.12 would hinder
the retro-aldolization process by removing the conjugation of the α,β-unsaturated
lactone.  It was found to be the case that the mixture of saturated lactones, which
were prepared by catalytic hydrogenation of 2.11/2.12, were stable and amenable
to further manipulation.
The stereoselectivity of the reduction of the carbonyl group at C-3 of
2.11/2.12 was then examined using a variety of hydride reducing agents, but
reduction with LiBH4 was the most selective, giving an inseparable mixture of
2.13 and 2.14 as the only identifiable products (Scheme 2.4).  Fortunately,
crystals of lactone 2.15 separated from the mixture of 2.13 and 2.14, and the
structure of this substance was unequivocally established by X-ray analysis
(Figure 2.1).  It was then found that treating the mixture of 2.13 and 2.14 with
camphorsulfonic acid in 2,2-dimethoxypropane in an attempt to form the
acetonide, unexpectedly gave a mixture (ca. 2.2:1) of 2.15 together with the
corresponding lactone derived from 2.13.  Pure 2.15 was isolated in 26% overall













































































The X-ray structure of 2.15 revealed that the vinylogous aldol reaction had
indeed proceeded predominantly in the desired stereochemical sense, but the
hydride reduction of the carbonyl group at C-3 proceeded with apparent chelation
control to give the incorrect relative stereochemistry (Figure 2.1).  Because it
seemed likely that it would be possible to correct this stereochemical error later in
the synthesis, the feasibility of converting 2.15 into the 2,8-
dioxabicyclo[3.2.1]octane system 2.18 characteristic of the zaragozic acids was
explored (Scheme 2.4).  Thus, selective reduction at C-1 of the less substituted
lactone ring of 2.15 using Dibal-H proceeded smoothly to give a mixture of
hemiacetals 2.16.  Subjecting this mixture to refluxing methanolic HCl gave a
mixture of methyl acetals 2.17 rather than the desired oxabicyclic core 2.18,
presumably because the ester group at C-3 would be axial in such a product.  It
was thus apparent that an alternate strategy that provided an intermediate with the
correct configuration at all centers was needed.
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Figure 2.1
2.1.2 Second Generation Approach
Inasmuch as the bimolecular vinylogous aldol reaction of 2.10 and 2.8
proceeded with only modest selectivity, it was anticipated that an intramolecular
variant of this process might be more stereoselective since the stereochemistry at
C-3 could be set early in the synthesis.  Hence, a different entry to the zaragozic
acids was developed by Dr. Satoru Naito in which an intermediate such as 2.19,
which has the requisite stereochemistry at C(3)-C(5), might be formed by the
cyclization of a furoic ester related to 2.20 (Scheme 3). Preparation of 2.20 by
esterification of substituted furoic acids with the appropriate alcohols was
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envisioned as being straightforward.  The activating group Z on the furan ring





























At the outset of these studies, it was not clear what the optimal nature of
the activating group Z on the furan ring would be, so the series of furoic acids
2.23a-c was prepared from 5-bromofuroic acid according to literature
procedures.52,53  Several routes to the α-ketoester generally represented by 2.25a-c
were developed.  In the first, dimethyl tartrate (2.21) was protected as the
monotetrahydropyranyl (THP) derivative (Scheme 2.6).  In practice, it was best to
use excess dimethyl tartrate in this reaction (relative to dihydropyran) to minimize
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formation of the bis-THP ether and to facilitate chromatographic purification.
Selective reduction of the protected tartrate was achieved with the highest
selectivity using BH3•SMe2 in the presence of catalytic NaBH4 to give an
inseparable mixture (4:1) of the 1,2- and 1,3 diols.54-56  Saito has explained this
selectivity in terms of the favored formation of a five-membered borane over the
corresponding six-membered ring.  Once this coordination complex had formed,
the polarization of the ester C-O bond was enhanced, therefore facilitating the
hydride delivery to the carbonyl.  After silyl protection of the primary alcohol, the
desired regioisomer 2.22 could be isolated in 50% yield.  Esterification of 2.22
with the furoic acids 2.23a-c gave the desired esters 2.24a-c in high yields.
Deprotection of the secondary alcohol using Me2AlCl followed by Dess-Martin




















1) DHP, PPTS, CH2Cl2
2) BH3•SMe2, NaBH4, THF







2.23a: Z = PhS
2.23b: Z = MeO






The intramolecular vinylogous aldol reactions of 2.25a-c were then
examined using various Lewis acids to induce the reaction (Scheme 2.7, Table
2.1).  When 2.25a was employed as the starting material, Lewis acids such as
BF3•OEt2, ZnCl2, Sc(OTf)3, and TMSI did not induce the desired cyclization, but
rather resulted in recovery of 2.25a or isolation of unidentified products.  On the
other hand, TiCl4 and SnCl4 effected the cyclization, although all four possible
diastereomers 2.26 – 2.29 in approximately equal amounts were obtained using
SnCl4.  Fortunately, TiCl4 induced the cyclization of 2.25a to give 2.26 with the
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highest selectivity, though the ratio of products was found to be highly dependent
on the number of equivalents of TiCl4 that were used.  Poorer selectivities and
lower yields were observed with fewer than three equivalents of TiCl4, and use of
more than three equivalents had little effect upon the results of the reaction.
That the number of equivalents and the nature of the Lewis acid had an
effect upon the course of the reaction was expected.  It was also expected that the
nature of leaving group Z might have an effect upon the yield and/or rate of the
reaction, but it was somewhat surprising that the nature of Z also had such a
pronounced influence on the stereochemical outcome of the reaction (Table 2.1).
For example, a methoxy group on the furan (i.e. 2.25b) led to preferential
formation of 2.28 and 2.29 in roughly equal amounts using TiCl4, but significant
amounts of 2.27 were isolated when TMSI was employed to catalyze the reaction.
The presence of a phenoxy group (i.e. 2.25c) on the furan led to the formation of
2.28 as the major product when TiCl4 was used as the catalyst, whereas other acid
catalysts gave mixtures of products.  It was clear that Z must be an electron
donating group as evidenced by the fact that when Z = H or Br there was no
cyclization.  Additionally, since both 2.25b and 2.25c contained oxygen
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functionality, perhaps it is necessary that the Z contain a softer center, namely
2.25a that utilized a sulfur rather than oxygen.  That the Lewis acids employed in
this study tend to be rather oxophilic may contribute to the stereoselectivity of
2.25a-c.  A rationale that would account for the effect of the various Lewis acids










































2.23a TiCl4 (1.0) rt, 3 h 6:2:1:0 2.26 (11)
TiCl4 (2.5) 0 °C→rt,
1.5 h
14:1:1:0 2.26 (33)
TiCl4 (3.0) 0 °C→rt,
1.5 h
>20:1:2:0 2.26 (42)
TiCl4 (5.0) 0 °C→rt, 2
h
>20: 2:1:0 2.26 (43)
SnCl4 (2.0) rt, 4 h 1:2:1:1
2.23b TiCl4 (3.0) -78→0 °C,
2 h
0:0:2:1 2.28 (56), 2.29
(30)
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SnCl4 (1.0) -78 °C→rt,
3 h
trace:1:4:5
BF3•OEt2 (1.0) rt, 3 h 0:1:0:3.4 2.27 (19), 2.29
(40)
TMS–I (1.2) 0 °C→rt, 1
h
0:3:0:1 2.27 (39), 2.29
(12)
2.23c TiCl4 (3.0) -78→0 °C,
2 h
1:1:>20:1 2.28 (65)
SnCl4 (2.0) -78 °C→rt,
2 h
2:1:5:6
BF3.OEt2 (1.0) rt, 12 h 0:1:trace:3 2.27 (12), 2.29
(32)
aThe reactants were combined in dichloromethane at the
lower temperature and then stirred at the final temperature for
the time indicated.  bRatio determined by 1H NMR of crude
reaction mixture.
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In order to facilitate structure determination of adducts 2.26 – 2.29 as well
as to increase their stability, they were all converted to their corresponding TMS
ethers 2.30 – 2.34 (Figure 2.2).  The structures of 2.30 – 2.34 were first tentatively
assigned based upon the observed nOes, however it was not possible to assign the
stereochemistry at C-4 based upon NMR alone.  Consequently, the structures of





































As noted previously, the spirocyclic adducts 2.26 – 2.29 could be isolated
in pure form, but they were somewhat unstable and prone to retroaldolization,
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especially in the presence of base.  For example, if either pure 2.26 or 2.28 were
heated in pyridine at 50 ºC, a mixture containing all four diastereomers 2.26 –
2.29 was obtained in a ratio of 5:10:5:1 that reflects their corresponding relative
stabilities.  When either 2.26 or 2.28 were resubjected to the cyclization
conditions, no isomerization was observed, and hence it was assumed that the
reactions were conducted under kinetically controlled conditions.
Careful analysis of the reaction mixtures obtained from the cyclization of
2.25a revealed that sulfide 2.34 was formed in nearly 20% yield.  Presumably
2.34 resulted from 1,4-addition of thiophenoxide anion that was released during
the course of the reaction of 2.25a to give 2.26 (Scheme 2.8).  In order to
circumvent this problem and therefore increase the yield of 2.26, various
thiophiles [Hg(II) and Cu(II) salts] were added in hopes of trapping the
thiophenoxide prior to reaction with 2.26.  Ultimately, all efforts to reduce the
amount of 2.34 formed during the reaction or workup were unsuccessful, and so a
modified protocol was adopted that accomplished the conversion of 2.34 to 2.30.
Upon the completion of the cyclization of 2.25a in the presence of TiCl4, the
crude product mixture was treated sequentially with TMSCl and imidazole then
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mCPBA and finally Et3N in the presence of TMSCl to give 2.30 in 54% overall
yield.  Catalytic hydrogenation of butenolide 2.34 then gave 2.35, which was









































1) TMSCl, imid., CH2Cl2
2) mCPBA, NaHCO3, CH2Cl2









In preliminary work directed toward the introduction of the C-1 aliphatic
side chain, additions of various aliphatic Grignard, organolithium, and cerium
reagents were examined.  However, starting material was recovered as the major
identifiable material from these reactions.  On some occasions low yields of the
cyclic hemiacetals arising from addition to the desired lactone carbonyl group
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were obtained, where the regioselectivity of the addition was expected to arise
from the higher steric accessibility of the desired carbonyl.  Dianions of
phenylsulfones are known to react cleanly with lactones,62-66 and it was found that
addition of methyl phenylsulfone to 2.35 resulted in formation of the desired
adduct (Scheme 2.9).  Reductive sulfonylation then furnished lactol 2.36 in good




























1) PhSO2CH3, BuLi, THF, 67%







In light of the positive results, efforts were directed toward the preparation
of the sulfone of the requisite C-1 side chain as shown in Scheme 2.10.
Accordingly, addition of 2-propenylmagnesium bromide 2.40 to aldehyde 2.39
gave alcohol 2.41.69  The optical purity of 2.41 (>95% ee) was established by
degradation (NaIO4, RuO2.xH2O) to the corresponding carboxylic acid derivative
of 2.39 and NMR analysis of its methyl (S)-(+)-mandelate derivative.  Mesylation
of 2.41 followed by reaction of the intermediate mesylate with NaBr gave the
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allyl bromide 2.42.  Initial attempts to convert 2.42 into 2.43 by alkylation of the
lithiated monoanion of methyl phenyl sulfone gave significant quantities of
dialkylated material.  The potassium salts of sulfones were known to undergo
selective monoalkylation,70 and reaction of 2.42 with the potassium salt of methyl












 1) MsCl, Et3N, CH2Cl2






The spirocycle 2.35 was then coupled with the C-1 side chain sulfone 2.43
to give 2.44 as a mixture of hemiacetals and the corresponding ring opened ketone
after reductive desulfonylation with aluminum amalgam.  This mixture was
treated with methanolic sulfuric acid to give a separable mixture of the desired
[3.2.1] bicycle 2.45 and acetals 2.46.  Oxidation of the C-3 primary alcohol of
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2.45 with TPAP in the presence of water afforded the acid.71  Subsequent
saponification of the two methyl esters gave 6,7-dideoxysqualestatin H5 (2.47),



























2) Al(Hg), HMPA, 
H2O, THF
0.1M H2SO4


























In the ketalization reactions of both 2.44 and 2.36 not only was the desired
bicyclooctane[3.2.1] zaragozic acid core obtained, but the methyl acetal was also
recovered from the reactions as the major product.  Hodgson had also observed
similar results in the ketalization of 1.225 as discussed in Section 1.4.41-43  As
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mentioned previously, there do not seem to be any predictive trends in the
ketalization reaction, however, both Hodgson and Martin performed the
ketalization on substrates where the core was not fully oxidized at C-3.  The fact
that Hodsgon later performed the ketalization with an alternative acid catalyst
(TFA/CH2Cl2/H2O) to obtain the zaragozic acid core system as the only product
indicates that using these alternative reaction conditions, may have proven to be
more effective.  That being said, the total synthesis of 6,7-dideoxysqualestatin H5
was completed nevertheless.
2.2 IMPROVEMENTS TO THE SYNTHESIS OF THE -KETOESTER
Although the desired α-ketoester 2.25a could be made from dimethyl-D-
tartrate (2.21), there were drawbacks that made further investigations into
improving the route worthwhile.  Namely, the initial THP protection of dimethyl
tartrate (2.21) resulted in an equilibrium mixture of starting material, mono-, and
diprotected tartrate, thereby requiring careful chromatography to isolate the
desired product.  Additionally, the borane reduction of 2.48 was only modestly
selective and the two regioisomers 2.49 and 2.50 were not separable until after the
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protection of the primary alcohol had been accomplished to provide 2.22.  There
were various attemps to improve the selectivity of the borane reduction were as
shown in Table 2.2, but this short study established THF was the best solvent for
this reaction.  With this in mind, alternative routes were investigated that would


















Solvent Ratio 1,2 : 1,3 Diola
THF 2-3 : 1
CH2Cl2 - : -
Ether 1 : 1.1
MeOBut - : -b
THF/dioxane (1:1) 1.5 : 1
THF/MeOBut (1:1) - : -
Toluene 1.1 : 1
a) Ratio determined from the TBDPS protected ether
b)THP cleavage was found to be the predominant reaction
A new route to the α-ketoester that avoided these selectivity issues was
thus developed that started with D-erythronolactone (2.51).  Previous work from
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Scharf had shown that the position α to the carbonyl of 2.51 can be selectively
benzylated by formation of the stannylidene acetal and subsequent treatment with
BnBr.73  The observed regioselectivity in this reaction was suggested to be due to
the fact the higher basicity of the α-hydroxyl group causes the oxygen to be two-
fold coordinated to the tin moiety while the more nucleophilic β-hydroxyl group
is three-fold coordinated to the tin, and therefore masked from electrophilic
attack.  While Scharf's method was appealing for the regioselective protection of
erythronolactone (2.51), the use of a benzyl protecting group raised some
concerns about the deprotection later in the synthesis.  The presence of a
thiophenyl group would likely result in catalyst poisoning when attempting to
remove a benzyl protecting group by hydrogenation.  However, the p-
methoxybenzyl (PMB) protecting group could be used because it could be
removed using dichlorodicyanobenzoquinone (DDQ), which would not be
affected by the presence of the thiophenyl moiety.
To this end, D-erythronolactone (2.51) was prepared from D-isoascorbic
acid according to literature procedure (Scheme 2.13).74  Selective protection of
2.51 was then accomplished according to the method of Scharf using dibutyltin
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oxide in refluxing toluene to form the stannylidene acetal 2.52.  The crude
stannylidene acetal was then treated with p-methoxybenzyl chloride in the
presence of CsF and KI.  The role of the CsF, according to Ohno, was primarily
used to activate the alkyl halide through interaction of the cesium cation with the
halogen.75  It was also speculated that the activation of Sn-O bonds might be
caused by the formation of a pentacoordinate complex as demonstrated by the
need for nearly two equivalents of CsF.  The crude reaction mixture contained a
mixture (6:1) of regioisomers, but recrystallization of the mixture provided 2.53
as a single isomer.  Alternatively, if erythronolactone (2.51) was simply treated
with NaH and p-methoxybenzyl chloride, a mixture (1:1) of regioisomers was
obtained.  The remaining hydroxyl was protected a TBDPS ether, and
methanolysis of the lactone occurred with concomitant silyl migration of the
TBDPS to the primary alcohol to give 2.54.  Although silyl migrations are more
commonly observed with the TBS protecting group, there are examples of the 1,2-
silyl migration of the TBDPS group in polyols.  The driving force was said to be
the preference of the bulky TBDPS group for the primary position, which is
favored by 8 – 9 kJ/mol compared to the secondary positions.76
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Coupling of 2.54 with furoic acid 2.25a using DCC gave ester 2.55 in high
yield.  Deprotection of ester 2.55 was accomplished using DDQ in a mixture of
CH2Cl2 and water.  Earlier work in the Martin group demonstrated that
chromatography of 2.55 resulted in small amounts of acyl migration.  The the p-
methoxybenzaldehyde that was produced in the reaction thus had to be removed
using an alternative purification method.  Hence, the reaction mixture was
concentrated and stirred vigorously with aqueous sodium bisulfite until TLC
showed complete removal of the aldehyde.  The intermediate alcohol was






















































2) TMSCl, imid., CH2Cl2
3) mCPBA, NaHCO3, CH2Cl2
4) TMSCl, Et3N, EtOAc
2.3056%
Although the erythronolactone route to α-ketoester 2.25a was one step
longer than the tartrate route, the overall yield was improved from 18 to 28%.
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Moreover, ease of purification of the intermediates made this route a more
favorable option.  Additionally, the cost effectiveness of the route highly favored
the erythronolactone route that used D-isoascorbic acid ($0.05/g) as the starting
material, while the tartrate route utilized dimethyl-D-tartrate ($4.06/g).
Cyclization of α-ketoester 2.25a to give 2.30 was then carried out in the four step
procedure described in Section 2.12 to give spirobislatone 2.30 (Scheme 2.13).
2.3 EFFORTS TOWARD THE SYNTHESIS OF THE 7-DEOXYZARAGOZIC ACID A
CORE
At this point, it was anticipated that the C-6 – C-7 olefin of butenolide
2.30 could be elaborated to allow access to the more highly functionalized
zaragozic acids, including 7-deoxyzaragozic acid A (2.56) (Scheme 2.14).  It was
anticipated that 2.56 could be made from bislactone 2.57, which in turn would be
accessible from the reductive opening of epoxide 2.58 using samarium diiodide as
described by Molander.77  Epoxide 2.58 could be synthesized from butenolide
2.30 via epoxidation of the C-6 –C-7 olefin.  It was expected that the oxygen
nucleophile would approach from the back face of 2.30 to give the desired
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stereochemistry due to the steric congestion that hinders approach from the front
face.  The relative stereochemistry of sulfide 2.34 was shown by nOe studies to be
a result of approach of thiophenoxide from the back face.  This supports the
hypothesis that the oxygen nucleophile would approach butenolide 2.30 from the




































Accordingly, efforts to effect the epoxidation of 2.30 commenced;
however this transformation proved to be significantly more troublesome than
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anticipated.  When 2.30 was allowed to react with basic hydrogen peroxide, only
starting material was recovered at low temperatures.  Only unidentified material
was isolated when the reaction was performed at higher temperatures.  This was
surprising in light of the fact that basic hydrogen peroxide has been used to
epoxidize α,β-unsaturated carbonyl groups such as 2.59 to yield 2.60 (Scheme
2.15).  This epoxidation strategy proved to be effective in the presence of other
isolated olefins in 2.59 due to the high nucleophilicity of the peroxide anion


















Alternatively, t-BuOOH in the presence of 1,8-diazabicyclo[5.4.0]undec-
7-ene (DBU) was said to be highly effective in the epoxidation of electron poor
olefins, and α,β-unsaturated-δ-lactones in particular in the epoxidation of lactone
2.61 to provide epoxide 2.62 (Scheme 2.16).79.  However, when 2.30 was treated
with t-BuOOH in the presence of DBU, 1H NMR spectra indicated the enone was
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still intact while the TMS and TBDPS groups had been cleaved, additionally, a
change in the shift of the proton at C-3 may indicate that retroaldolization
processes had occurred.  Attempts to perform the epoxidation using t-
BuOOH/DBU at lower temperatures to avoid the cleavage of the silyl protecting
groups resulted in recovery of starting material.  Numerous attempts to improve
the reaction by altering the solvent and the reaction temperature, but these











Hypochlorite in the presence of pyridine has also been used to oxidize
α,β-unsaturated-δ-lactones (Scheme 2.17).80,81  Unfortunately, treatment of
butenolide 2.30 with hypochlorite in the presence of pyridine resulted in recovery
of unidentified materials, although 1H NMR spectra showed that the tertiary TMS
group as well as the TBDPS group had been cleaved.  Given the fact that harsher
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conditions led to the decomposition of butenolide 2.30, milder reaction conditions









Both dimethyldioxirane and trifluoromethylmethyldioxirane are mild
reagents that effect the epoxidation of olefins under neutral conditions.82-85
Trifluoromethylmethyldioxirane is a more reactive reagent and because it can be
generated in situ, it is more attractive option for the epoxidation of 2.30.  Yang
had shown that trifluoromethylmethyldioxirane was capable of epoxidizing
enones, though there were no examples of the epoxidation of butenolides.  When
butenolide 2.30 was exposed to trifluoromethylmethyldioxirane, starting material
and a small amount of another compound were recovered from the reaction.  The
1H NMR spectra of this material revealed that the enone was still intact.
Additionally, changes in the shifts of the C-3 protons were observed, and although
the exact nature of the product was not determined, this may indicate that
retroaldolization had taken place once the tertiary TMS group had been cleaved.
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Since trifluoromethylmethyldioxirane was not a suitable reagent to effect
the desired epoxidation, the lower reactivity of dimethyldioxirane (DMDO) might
avoid the formation of unwanted side-products.  Accordingly, DMDO was
prepared according to literature procedure and used immediately after preparation.
Unfortunately, reaction of DMDO with butenolide 2.30 gave only recovered
starting material.
In addition to the aforementioned attempts at epoxidation, there was also
work toward the dihydroxylation of 2.30 to provide 2.65 (Scheme 2.18).  Since
most methods of dihydroxylation would produce the cis diol, a selective
deoxygenation would have been necessary to produce the required substitution for
7-deoxyzaragozic acid A (2.56).  Furthermore, a deoxygenation/reoxygenation
sequence would have been necessary to obtain the trans relationship present in
zaragozic acid A (1.54).  Attempted dihydroxylation of 2.30 with potassium
permanganate resulted in the recovery of unidentified material.  This was not
terribly surprising since the butenolide 2.30 had thus far been rather sensitive to
mild reaction conditions and permanganate is not a particularly mild reagent for
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the dihydroxylation of olefins.  The use of stoichiometric osmium tetraoxide in




















In light of the results thus far in the studies toward the functionalization of
2.30 by epoxidation or dihydroxylation, it seemed prudent to consider likely
reasons lack of success.  One of the more likely problems was the fact that the
TMS protecting group on the tertiary alcohol was prone to cleavage, and the
unprotected alcohol could serve as a trigger for retroaldolization.  Previous work
in the Martin group had already shown that in the case of butenolides 2.11/2.12,
the hydroxyl group δ to the butenolide carbonyl served as a trigger for
retroaldolization (Scheme 2.4).  Once the butenolide had been hydrogenated to
provide bislactones 2.12/2.13, the system was significantly more amenable to
handling and manipulation.  Unfortunately, the hydrogenation of butenolide 2.30
was not possible when attempting to epoxidize at C-6 – C-7.
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Another likely issue with butenolide 2.30 was the fact that in addition to
the butnolide, there were also two addiitonal elecrophilic sites that could react
with oxygen nucleophiles (Figure 2.2).  One way to address this point would be to
utilize a softer nucleophile that could later be converted to the desired oxygen
functionality.  It was anticipated that a softer nucleophile would be more likely to
add in a 1,4-fashion to the butenolide moiety, while the harder oxygen













In an effort to address the issue of TMS cleavage, it was anticipated that
both of the silyl protecting groups could be removed and replaced with a p-
methoxyphenyl (PMP) acetal.  This protecting group could later be removed
under relatively mild conditions using DDQ in a CH2Cl2/H2O mixture.  In order
to effect the deprotection of both silyl groups, 2.30 was first treated with TBAF.
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Unfortunately, extensive decomposition of starting material was observed, even
when acetic acid was added to buffer the system.  With this in mind, alternative
deprotection strategies were explored using HF.  Treatment of 2.30 with aqueous
HF effected the desired deprotection to yield 2.66 as shown by TLC analysis.
Attempts to purify and characterize diol 2.66 resulted in decomposition of the
material, so diol 2.66 was routinely carried on without purification.  Thus, 2.30
was treated with HF and removal of the reaction solvent and treatment with
dimethoxypropane in the presence of catalytic acid resulted in the recovery of



















It was thought that the decomposition of 2.66 under the conditions for
acetal formation (p-anisaldehyde/p-TsOH, p-methoxybenzaldehyde dimethyl
acetal/p-TsOH, acetone/p-TsOH, or benzaldehyde/p-TsOH)  may have been the
result the presence of catalytic acid.  Therefore neutral conditions for the
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reprotection of the diol were investigated.  Fortunately, Oikawa had shown that
treatment of diols with PMBOMe in the presence of DDQ and molecular sieves
produces the p-methoxyphenyl (PMP) acetal.86  To this end, butenolide 2.30 was
treated with HF to provide diol 2.66, which was treated with p-methoxybenzyl
methyl ether (PMBOMe) in the presence of DDQ to yield desired acetal 2.67,
albeit in low yield (<10%).  Although the desired deprotection/reprotection
scheme had been somewhat successful, it was anticipated that the yield could be
improved.  The deprotection protocol was altered slightly to enable the use of
conditions that were nearly neutral using HF•pyridine instead of HF to give diol
2.66 (Scheme 2.20).  Once the reaction was complete, it was found that an
aqueous workup was not possible since the deprotected diol was rather soluble in
the water layer.  Hence, solid sodium bicarbonate was added to the reaction until
all of the acid had been quenched as shown by the lack of CO2 evolution.  The
resulting suspension was filtered to remove any solid, and crude 2.66 was
reprotected using PMBOMe in the presence of DDQ to yield the desired acetal
2.67 in 44% yield as a single diastereomer.  The structure of 2.67 was verified by























With acetal 2.67 in hand, it was possible to reinvestigate the epoxidation
of the C-6 – C-7 olefin.  However, reaction of 2.67 with t-BuOOH in the presence
of DBU as described previously again led to extensive decomposition of 2.67.
Likewise, treatment of 2.67 with basic hydrogen peroxide gave many unidentified
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products from the reaction.  Acetal 2.67 was then treated with freshly prepared
DMDO, which gave diol 2.66 as the major product resulting from cleavage of the
acetal.
At this point it seemed as if the hard/soft interaction that had caused some
concern earlier might be worth investigation.  Fleming has done extensive work in
developing dimethylphenylsilane as a hydroxyl group surrogate that can be
unmasked to reveal the desired oxygen functionality.87-93  The 1,4-addition of silyl
groups to α,β-unsaturated ketones was accomplished using a cuprate that can be
made from the corresponding silyllithium species.  However, exposure of
butenolide 2.67 to these conditions resulted in recovery of starting material.
Fleming has also reported that the use of silyl zincates was superior to the cuprate
because side products such as 2.70 have been isolated when the cuprate was used
(Scheme 2.21).  These products are a result of the reaction of intermediate enolate





















Although an oligomerization product analogous to 2.70 was never isolated
from the reaction of the silyl cuprate with 2.67, it seemed worthwhile to
investigate use silyl zincate.  Treatment of acetal 2.67 with Me2PhSiZnMe2Li,
gave the desired silane 2.71 as a single diastereomer (Scheme 2.22).  The
stereochemistry of 2.71 was verified by X-ray crystallography (Figure 2.4).  The
stereoselectivity in the reaction of 2.67 was thought to be due to the steric




























With silane 2.71 in hand, a more direct route to the PMP acetal was
developed that avoided the cumbersome deprotection/reprotection sequence used
previously (Scheme 2.20).  Accordingly, the PMP acetal 2.72 was prepared from
erythronolactone 2.51 in modest yield according to a procedure developed Dr.
Phil Kym (Scheme 2.23).  Formation of acetal 2.72 followed by regioselective
opening with TiCl4 in the presence of NaCNBH3 provided 2.73 in good yield.
Opening of the acetal with the desired regioselectivity was accomplished more
consistently with TMSCl in the presence of NaCNBH3 to yield 2.73.
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Methodological studies by Samuelsson of the opening of the PMP acetal on
carbohydrates with NaBH3CN in the presence of TMSCl yielded one regioisomer
while opening of the PMP acetal in the presence of TFA produced the other
isomer.  It was suggested that the regioselectivity in their system was derived
from the fact that the silane is a more sterically demanding electrophile than the
proton derived from TFA.  While this steric argument may be the basis of
selectivity in Samuelsson's work, application of this hypothesis to the opening of
2.72 does not seem reasonable.  There were no experiments performed using
NaBH3CN in the presence of TFA or with NaBH3CN alone gain further insight
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into the source of regioselectivity in the opening of acetal 2.72.  Protection of the
remaining alcohol and methanolysis of the lactone under basic conditions
















CH3CN, 4Å mol. sieves










Since spontaneous migration of the PMB in 2.74 from the secondary to the
primary position was not possible under the conditions of the methanolysis, a two
step method to move the PMB protecting group was developed (Scheme 2.24).
Thus, reaction of 2.74 with DDQ formed an acetal that was opened
regioselectively with trifluoroacetic acid and sodium cyanoborohydride to yield
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2.75.  Coupling of the alcohol 2.75 with furoic acid 2.25a provided 2.76 in high
yield.  Unfortunately, it was not possible to effect complete removal of the
TBDPS group under various conditions (TBAF, HF/MeCN, and HF•pyr)
complete deprotection to give 2.77.  Additionally, attempts to purify 2.77 by flash
chromatography led to a significant amount of acyl migration to provide 2.78.
Since suitable conditions for the deprotection of 2.76 could not be found, efforts















































3) TMSCl, imid., CH2Cl2
4) mCPBA, NaHCO3, CH2Cl2
5) NEt3, TMSCl, EtOAc
6) DDQ, 4Å mol. sieves, CH2Cl2
Despite the fact that the alternative route to acetal 2.67 was not successful,
efforts to oxidize the C-6 – C-7 olefin were continued.  With the hydroxy
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surrogate in place in 2.71, it was anticipated that zaragozic acid A (1.54) could be
a possible target if α-hydroxylation of the lactone 2.71 was accomplished. The
first candidate that was explored for the installation of the additional oxygen was
Davis reagent.95  Since this reagent is not commercially available, it was prepared
according to literature procedure.  Formation of the enolate of lactone 2.67 and
addition of Davis reagent gave recovered starting material along with small
amounts of 2.80 derived from the imine impurities in the Davis reagent.  In the
absence of imine addition, only starting material was isolated (Scheme 2.25).
Since no desired product 2.79 was formed, enolate formation was verified by
treating 2.67 with LDA in THF followed by quenching with D2O.  The 1H NMR
showed 68% deuteration of 2.67, which verified that the enolate was being
formed, but not forming desired product 2.79 when exposed to the Davis
oxaziridine.  Purification of the Davis oxaziridine and treatment of 2.67 with


















































Another option to effect α-oxidation of a carbonyl group is MoOPH, a
reagent that was developed by Vedejs and utilizes a molybdenum peroxide as the
active oxidation species.96,97  Reaction of MoOPH with the enolate of lactone 2.67
afforded only recovered starting material.  A third tactic to effect oxidation of
lactone 2.67 was the utilization of LDA/molecular oxygen as reported by
Wasserman.98  Unfortunately, use of this method resulted in complex reaction
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mixtures.  A two step oxidation procedure was explored in which the silyl enol
ether is formed and treated with mCPBA and acid to give the desired α-hydroxy
carbonyl compound.99  Various attempts to form the silyl enol ether using
TMSCl/LDA, TBSCl/LDA, TMSOTf/NEt3, TIPSOTf/NEt3, or TBSOTf/NEt3
were unsuccessful and therefore the Rubottom oxidation could not be used.
Experiments using the crude silyl enol ether in the second step of the Rubottom
oxidation were also unsuccessful.
After close inspection of the X-ray crystallographic depiction of 2.67, it
was thought that the difficulties in the oxidizing C-7 might have been due to steric
hindrance provided by the dimethylphenylsilyl group (Figure 2.5).  This insight
led to attempts to unmask the C-6 hydroxy surrogate to give bislactone 2.81.  It




Conversion of the dimethylphenylsilyl group is most commonly
accomplished in a two-step operation involving protodesilylation of the
phenyldimethylsilane and rearrangement sequence with peracid.  Fleming has
demonstrated that both steps can be completed in a one-pot procedure using any
of four methods. 100  The first one-pot procedure involves use of mercury which is
electrophile to effect the aromatic desilylation, in the presence of the peracid.
Treatment of 2.71 under these conditions resulted in the recovery of starting
material even after prolonged reaction times or higher temperatures (Scheme
2.26).  Another option to effect the oxidation was the using catalytic mercury in
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the presence of catalytic palladium acetate to avoid use of stoichiometric
quantities of mercury.  Unfortunately, use of palladium acetate caused the

























The remaining two options for the oxidation of the silane involve either
the use of bromine or bromine generated in situ to effect the aromatic desilylation.
The best results were found with the in situ generation of bromine from KBr.  The
reaction of 2.72 with bromine (generated from the reaction of KBr and peracid)
accomplished the required aromatic desilylation, however the subsequent
rearrangement in the presence of peracid would not proceed, therefore resulting in
low yields of silanol 2.73.  Attempts to push the reaction using higher
temperatures or longer reaction times did not result in either higher yields of the
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silanol or any indication of the desired hydroxyl.  The majority of the material


























Since the one-pot procedures were not successful, two-pot operations that
utilize fluoride as the electrophile to accomplish the protodesilylation were
examined.91  Unfortunately, this method for protodesilylation generally requires
the use of rather harsh reagents such as tetrafluoroboric acid-diethyl etherate or
boron triflouoride-acetic acid, both of which gave complete decomposition of the
starting material to a black tar.  At the time that this research was being
conducted, Fleming had reported failure in attempts to prepare aryl-silyl reagents
by the Gilman cleavage of disilanes with lithium.  Included in this report were
several examples including o-methoxyphenyl, p-methoxyphenyl, tolyl, and 5-
methylfuryl silanes.  Given these results, the preparation of the o- or p-
methoxyphenyl derivatives was not attempted, despite the fact that it was
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anticipated that these derivatives might be more ammenable to oxidation than the
phenyldimethylsilane.  Recently, Corey has reported the preparation of the o-
methoxyphenyldimethylsilane group as a hydroxy surrogate.[Lee, 2001 #446]
Corey was able to prepare this derivative from lithiation of o-
methoxyphenyldimethylsilyl chloride rather than the Gilman cleavage of the
disilane.  The advantage of Corey's hydroxy surrogate, is that it can be cleaved
under more mild conditions than its dimethylphenylsilyl counterpart.  The use of
the o-methoxyphenyldimethylsilyl group to give a compound analogous to 2.71
may have allowed the cleavage of the surrogate under mild conditions to yield
2.72.
Since oxidation of silane 2.71 was unsuccessful, it was thought that
perhaps addition of the C-1 side chain and conversion to the zaragozic acid core
might allow the oxidation at C-6 and/or C-7.  In such compounds, the C-6 and C-
7 centers should be more sterically accessible once the rearrangement to the
zaragozic acid core was accomplished.  Synthesis of the C-1 side chain was then
examined with the idea that the completed side chain would be incorporated into
180
2.71 analogously to the incorporation of C-1 side chain 2.43 into 2.35 using a
sulfone anion addition to the C-1 center (Scheme 2.11).
The completed sulfone side chain 2.74 may be synthesized from 2.75 after
both the olefin and sulfide had been subjected to treatment with ozone (Scheme
2.28).  Olefin 2.75 may be made from the addition of vinyl bromide 2.76 to
known aldehyde 2.77 as the key step.69  Since the desired diastereomer of the
addition of 2.76 and 2.77 was the Cram product, it was anticipated that this might
be the major product of the reaction.  In the event that the Cram product was not
produced selectively, there have been several tactics that have been developed in
which chiral ligands of various types are used to promote selectivity in the
alkylations of aldehydes (vide infra).  While there are examples of the
enantioselective addition of simple vinyl anions to aldehydes in the presence of
chiral ligands, most notably by Oppolzer,101,102 the addition of more elaborate
vinyl anions to aldehydes is not well known.103  Finally, the desired bromide was
envisioned to come from the reaction of thioanisole (2.78) with 2,3-
dibromopropene (2.79).  This synthesis would constitute a very short and efficient




















The preparation of the C-1 side chain began with the alkylation of
thioanisole (2.78) with 2,3-dibromopropene (2.79) to give bromide 2.76 (Scheme
2.29).  This alkylation provided, only 6% yield of the desired product 2.76 as a
mixture of the desired bromide and recovered thioanisole.  Extensive
experimentation with different solvents and temperatures led to no improvement
in the outcome of the reaction.  Additonally, transmetallation of the lithium anion











In light of these results, experiments were performed to ascertain the
extent to which the anion of thioanisole was being produced.  This was
accomplished by quenching the anion with TMSCl to give sulfide 2.80 (Scheme
2.30).104  When 2.78 was treated with n-BuLi in Et2O, 2.80  was obtained in only
64% (as determined by 1H NMR).  If either DABCO or TMEDA were added to
the reaction, the yield of 2.80 improved dramatically to 92% (Table 2.3).105  When
either DABCO or TMEDA were added to the reaction of the anion of thioanisole
(2.78) with 2,3-dibromopropene (2.79), no product isolated from the reaction
(Scheme 2.29).  In fact, upon addition of dibromopropene (2.79) to a solution of
thioanisole (2.78), n-BuLi, and DABCO or TMEDA, the reaction mixture












In light of these negative results, another route to the side chain was
explored that began with 3-buyne-1-ol rather than dibromobutene.  Sulfide 2.76
was generated from butyn-1-ol by treating the alkyne with tetra-n-
butylammonium bromide to yield the vinyl bromide as described by Ley (Scheme
2.31).106  The vinyl bromide was then treated with diphenyl disulfide in the
presence of tributylphosphine and pyridine to give the desired bromide 2.76.
Although the process was not high yielding, it was facile to perform these
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reactions on a large scale since both the intermediate vinyl bromide and sulfide




2) Bu3P, (PhS)2, pyr.
BrPhS
2.762.81 29%
Treatment of the known aldehyde 2.77 with the lithium anion of 2.76 gave
a mixture (1:1) of both diastereomers of 2.82 in poor to modest yields, even after
transmetallation of 2.76 to the zinc anion (Scheme 2.32).69  Molander has reported
the diastereoselective addition of organoytterbium reagents to carbonyl substrates.
This tactic was reported to favor formation of the Cram product due to the
imposing steric bulk of lanthanide complexes.107  Therefore, transmetallation of
the lithium anion of 2.76 was accomplished using ytterbium triflate.  Addition of
the required aldehyde 2.77 to a solution of the anion produced the desired alcohol
2.82, albeit in low yield with no diastereoselectivity as determined by the












Oppolzer has developed a strategy for the enantioselective addition of
substituted vinylzinc species to aldehydes in the presence of N-methylephedrine
with good overall selectivity (73 - 98% ee).  Thus, the lithium anion of 2.76 was
transmetallated to the zinc anion followed by addition of lithiated N-
methylephedrine and aldehyde 2.77.101,102  Unfortunately, under these conditions,
only 2.77 and reduced 2.76 were recovered from the reaction (Scheme 2.32).
Seebach has also developed methods for the enantio- and
diastereoselective additions of dialkylzinc compounds to aldehydes in the
presence of titanium-TADDOLate complexes.108-114  Thus, tetraphenyl-TADDOL
was first treated with (iPrO)4Ti to form the titanate complex.  The lithium anion
of 2.76 was then treated with dimethyl zinc to effect the desired transmetallation
and the addition of the TADDOL titanate complex and aldehyde 2.77 gave a 19%
yield of alcohol 2.82 as a mixture (1:1) of diastereomers.  Use of the tetra(2-
naphthyl)-TADDOL which was reported to be more effective than the tetraphenyl
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TADDOL with aliphatic aldehydes in the addition of 2.76 to 2.77 gave 2.82 in
27% yield with no diastereoselectivity.
Kobayashi has developed a strategy that allows the enantio- and/or
diastereoselective addition of dialkylzinc compounds to aldehydes using a C2-
symmetric disulfonamide titanates as a chiral Lewis acid.115  Treatment of
cyclohexyldisulfonamide with (iPrO)4Ti to give the titanate, and addition to the
zinc anion of 2.76 was followed by addition of the aldehyde resulting in a low
yield of desired product 2.82 with no diastereoselectivity.
Although the diastereoselectivity of the addition of 2.76 to aldehyde 2.77
did not look very promising, work toward the completion of the side chain was
conducted with the hope that the diastereomers could eventually be separated.  To
this end, sulfide 2.82 was oxidized to the sulfone in the presence of the olefin
using phenylselenic acid, which was made from diphenyl diselenide and hydrogen
peroxide (Scheme 2.33).116  Subsequent protection of the alcohol gave 2.83 as a
mixture (1:1) of diastereomers.  Separation of the diastereomers by either column







OBn1) (PhSe)2, H2O2 
CH2Cl2, Et2O
2) NaHMDS, BnBr 
THF, DMF
2.82 2.8322%
Benzyl ether 2.83 was a crystalline solid, and selective recrystallization
could be used to separate the two diastereomers.  After two recrystallizations, a
mixture (14:1) of diastereomers was obtained, and the mother liquor composed of
a 1:2 ratio of diastereomers by 1H NMR.  Further recrystallizations of either the
1:2 mixture or the 14:1 mixture of diastereomers of 2.83 did not result in any
improvement of the diastereomeric ratio.  In an effort to establish the relative
stereochemistry of each diastereomer, a crystal isolated from the 14:1 mixture was
submitted for X-ray crystallographic analysis.  The crystal structure revealed that
the relative stereochemistry was the undesired anti diastereomer 2.84 (Figure 2.5,
Figure 2.6).  While the aforementioned routed to the C-1 side chain was indeed
short, it was unfortunately not diastereoselective.  Furthermore, the two
diastereomers were not easily separable, which made the synthesis of 2.84









Although the approach to the zaragozic acid A C-1 side chain was not
diastereoselective, the C-1 side chain described for the synthesis of 6,7-
dideoxysqualestatin H5 (2.47) was used to explore further manipulations of silane
2.71.  Addition of the side chain 2.43 to 2.71 was then attempted by addition of
2.71 to a solution of the dianion of 2.43 (Scheme 2.34).  Unfortunately, the
addition of the side chain 2.43 to lactone 2.71 was not successful, resulting in
recovery of starting material.  Although it is only speculation, the fact that side
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chain 2.43 did not add to lactone 2.71 was thought to be due to the steric bulk of
the silyl group.  In light of these results, it was concluded a route that necessitated
the functionalization of C-6 at a late stage in the synthesis was no longer a
































Although the oxidation of 2.71 at C-7 in the presence of the silyl group
was unsuccessful, it was thought that installation of a hydroxyl group at  C-7
might be more facile in the absence of a bulky group at C-6.  Initial attempts at
oxidation focused on anionic additions to bislactones 2.35 and 2.88 (Scheme
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2.35).  Treatment of the enolate of either 2.35 or 2.88 with Davis reagent resulted
in recovered starting material.  Attempts were also made with either the enolate of
2.35 or 2.88 using Davis reagent in the presence of either HMPA or crown ethers.
These reactions provided recovered starting material under mild reaction
conditions, while multiple unidentified products were recovered when the
reactions were performed under more forcing conditions.  Similarly, attempts at
making the silyl enol ether of 2.35 or 2.88 with TMSOTf/NEt3, TBSOTf/NEt3, or
TIPSOTf/NEt3 in an effort to use the Rubottom oxidation resulted in recovered
starting material. Finally, attempts were made to oxygenate both bislactones 2.35

















































Alternatively, an approach employing radical chemistry was considered as
shown in Scheme 2.36. To this end, both 2.30 and 2.67 were treated with
Mn(dpm)2 in the presence of phenylsilane and oxygen,
117-119 to give a 10% yield
of the desired product 2.90.  Unfortunately, alcohol 2.90 was contaminated with
an unidentified impurity.  The PMP acetal butenolide 2.67 gave only deprotected
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In addition to the aforementioned manganese catalyst, a cobalt-based
catalyst has been reported by Matsushita to convert α,β-unsaturated esters into α-
hydroxyesters.120  Accordingly, both silyl butenolide 2.30 and p-
methoxybenzylidene acetal 2.67 were exposed to Co(acac)2 or Co(tpp) in the
presence of either Et3SiH or PhSiH3 and oxygen (Scheme 2.37).  Unfortunately,
only starting material was recovered from the reaction.  Since all attempts to
elaborate install oxygen functionality failed on 2.30 and 2.67, it was hoped that
193
some functionality could be brought in with the furoic acid portion from the
beginning of the synthesis and further manipulated at a later time.  More
specifically, it was anticipated that the furoic acid portion could be incorporated











































Incorporation of the bromide into the furoic acid moiety began with the
synthesis of known bromofuroic acid 2.90,121-123.   Coupling of 2.90 with alcohol
2.54 gave ester 2.91 in 94% yield (Scheme 2.38).  Subsequent DDQ deprotection
of 2.91 and Dess-Martin oxidation gave the α-ketoester 2.92, which was then
treated with TiCl4 and TMSCl to give the cyclized product 2.93 with unknown
stereochemistry in ∼15% yield.  Unfortunately, butenolide 2.93 was an oil, so
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purification using column chromatography was necessary.  However,
chromatography was accompanied by decomposition of 2.93 on silica gel,
resulting in very low yields.  It was not possible to isolate clean material even
after repeated chromatography resulted in significant loss of material, rendering
this route unfavorable.  In light of all of the results thus far, it was concluded that










































In conclusion, studies toward the synthesis of 7-deoxyzaragozic acid A
(2.56) included the improvement of the synthesis of α-ketoester 2.25 from an
18% overall yield to 28% while also reducing the amount of chromatography
needed for the intermediates.  Efforts toward the elaboration of butenolide 2.30
revealed that oxygen nucleophiles were incompatible with the system, most often
resulting in the recovery of starting material or complex mixtures.  This issue was
effectively addressed by the use of a silane nucleophile, which was added in a
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Michael fashion to the butenolide 2.30 with the correct stereochemistry.  While
this was proof of concept for elaboration of the core system, it was unfortunate
that the silane 2.71 could not be converted to the desired oxygen functionality.
Additionally, efforts were made to incorporate functionality at C-6 from the
beginning of the synthesis in the form of a brominated furoic acid derivative 2.90,
however the Lewis acid mediated cyclization of this species was low yielding
with unknown stereochemical outcome.  Work toward the synthesis of the
zaragozic acid A C-1 side chain gave the desired alcohol 2.82; however, there was
no diastereoselectivity in the addition of 2.76 to 2.77.  The two diastereomers
were not separable which made this approach to the C-1 side chain impractical for
the synthesis of 7-deoxyzaragozic acid A.
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CHAPTER 3. TOWARD THE TOTAL SYNTHESIS OF
GALTAMYCINONE
3.1 BIOLOGICAL ACTIVITY OF THE ANGUCYCLINS
The angucycline group of natural products constitutes the largest family of
C-aryl glycoside antibiotics including examples such as galtamycinone (3.1) and
galtamycin (3.2) that are derived from a decaketide chain and formed via the
polyketide biosynthetic pathway (Figure 3.1).  These compounds are attractive
synthetic targets not only because of the antibiotic and antitumor activities but
also because of the synthetic challenge involved in the assembly of the linear
tetracyclic framework and the formidable challenge involved in attaching the

















The name angucycline is derived from the characteristic four-ring
aglycone carbon framework, which is assembled in an angular manner to give
compounds with the core structure 3.3.  Although both galtamycin and
galtamycinone do not posses the angular framework, they are still classified as
members of the angucyclin family since they are biosynthetically derived from an
angucycline framework such as that in aquayamycin (3.3)(Scheme 3.1).
Treatment of aquayamycinone with Ba(OH)2 resulted in the isolation of
galtamycinone through ring-expanded intermediates 3.4 and 3.5 to provide 3.6

























































3.2 SUZUKI'S TOTAL SYNTHESIS OF GALTAMYCINONE
Thus far, only one total synthesis of galtamycinone has been reported.125,126
The general synthetic strategy of Suzuki's approach involved an O→C-glycoside
rearrangement and a regioselective benzyne cycloaddition to assemble the
tetracyclic core.  The total synthesis commenced with the preparation of the
required benzyne precursor 3.13 from phenol 3.9 which was prepared in five steps
from resorcinol monobenzoate (3.7) (Scheme 3.2).127  A protection/deprotection
sequence then gave 3.10.  Glycoside 3.11 was attached via an O→C-glycoside
rearrangement to give 3.12 after methylation.  Suzuki has developed this O→C-
glycoside rearrangement method for the O-glycosidation of phenols, where the
reaction proceeds through the initial formation of an O-glycoside that rearranges,
in the presence of Lewis acids, to a C-glycoside.128-135  Finally, removal of the






















i) MOMCl, i-Pr2NEt/CH2Cl2, quant.; ii) 3 M aq. 
NaOH/MeOH, quant.;iii) DHP, PPTS, CH2Cl2, 95%; 
iv) BuLi, hexane, then I2, Et2O; v) PPTS, EtOH, 81%; 
vi) TBDPSCl, imid., DMF, 92%; vii) 3 M H2SO4, aq. dioxane, 98%; 
viii) Cp2HfCl2, AgClO4, CH2Cl2, 95%; 
ix) NaH, (MeO)2SO2, THF, DMF, 96%; 














The synthesis of the diene required for the cycloaddition began with
butenolide 3.16 that was made from acetylene 3.14 in two steps (Scheme 3.3).
Butenolide 3.16 was converted to silyl enol ether 3.17.  The benzyne
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cycloaddition was then performed with 3.17 and 3.13 to give 3.18
regioselectively.  The inductive polarization induced in the benzyne by the
methoxy group on 3.13 along with the electron donating silyl group on 3.17 were
suggested to be responsible for the high regioselectivity.136  Oxidation of the
hydroquinone provided chlorojuglone 3.19, which set the stage for the second






























i) HgCl2, H2O; ii) CO, Li2PdCl4, 96%; iii) TBSOTf, Et3N, CH2Cl2, 74%; 










The requisite diene precursor 3.25 was prepared in thirteen steps
beginning with diethyl oxalate (3.20).  Conversion of 3.20 to benzoic acid 3.22
was then accomplished in three steps (Scheme 3.3).  Benzyl protection of 3.22
was followed by formation of the oxazoline gave 3.23.  Desired anhydride 3.25
















i) EtOH, Na, acetone; ii) HOAc, H2O, 80%; iii) MgO, H2O, 42%; 
iv) BnBr, K2CO3, acetone; v) aq. NaOH, MeOH, 91%; vi) SOCl2; 
vii) H2NC(Me)2CH2OH, CH2Cl2; viii) SOCl2, 87%; 
ix) BuLi, THF, then MeI, 55%; x) BuLi, THF, ClCO2Me, 61%; 
xi) ClCO2Bn, aq. NaHCO3, CH2Cl2; xii) NaOH, MeOH; 
xiii) MeCOCl, acetone, 89%.














Regioselective cycloaddition of chlorojuglone 3.19 with anhydride 3.25
was accompanied by spontaneous decarboxylation to provide the desired
cycloadduct as a single regioisomer (Scheme 3.5).  Global deprotection then gave
galtamycinone (3.1).  The total synthesis of (3.1) was accomplished in 15 steps
(longest linear sequence) and 31 total steps with an overall yield of 6%.  The
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synthesis showcased the O→C-glycoside rearrangement that provided 3.12 in
high yield with excellent selectivity for the β-anomer.  Additionally, Suzuki
obtained excellent regioselectivity in the benzyne cycloaddition to assemble the
sugar-juglone moiety.  The second cycloaddition to assemble the tetracyclic core
was strikingly similar to the cycloaddition previously used by Tamura in the






















i) NaH, THF, 90%; ii) BBr3, CH2Cl2, 82%
3.253.19
3.1
3.3 SYNTHESES OF SS-228R
In addition to galtamycin (3.2) and galtamycinone (3.1) , SS-228R (3.33)
is another natural product that contains the same tetracyclic framework.  The
structure of 3.33 differs from both 3.1 and 3.2 inasmuch as there is no C-
glycoside present.  To date, there have been three total syntheses of SS-228R.
3.3.1 Tamura's Synthesis of SS-228R
The first total synthesis of 3.33 was reported by Tamura in 1985 and
utilized a base-catalyzed, regioselective cycloaddition of a homophthalic
207
anhydride as the key step.137  The required anhydride 3.28 was synthesized
analogously to 3.25 with the only difference between the two syntheses being the

















i) (MeO)2SO2, 30% NaOH, 78%; ii) SOCl2; 
iii) HOCH2C(CH3)NH2CH3, CH2Cl2; iv) SOCl2, 86%; 
v) BuLi, THF, MeI, 57%; vi) BuLi, THF, MeOC(O)OMe, 45%; 
vii) 4.5 N HCl, 71%; viii) CH3COCl, acetone, 81%.
3.22 3.26
3.27 3.28
Bromojuglone 3.31 was made in six steps from dimethoxynaphthalene
(3.29)(Scheme 3.7).  Treatment of anhydride 3.28 with NaH followed by addition
of bromojuglone 3.31 gave the desired cycloadduct 3.32 in good yield as a single
regioisomer.  Treatment of 3.32 with boron tribromide provided the monomethyl
SS-228R where the methyl group adjacent to the juglone had been cleaved, while
208
the other remained intact.  Treatment once more with boron tribromide in a
separate reaction under identical conditions provided SS-228R (3.33) in good
yield.  Tamura was also able to produce the other regioisomer in the
cycloaddition, using an alternative diene precursor, which made it possible to






















i) DMF, PhCH3, POCl3, 93%; ii) mCPBA, CH2Cl2; 
iii) KOH, MeOH/THF, 77%; iv) CAN, MeCN/H2O, 85%; 
v) Br2, CHCl3 vi) AcOH, EtOH, 80%; vii) NaH, THF, 87%; 







i, ii, iii iv, v, vi
OH
3.29 3.30
3.3.2 Cameron's Syntheses of SS-228R
The second total synthesis of SS-228R (3.33) by Cameron was also
published in 1985 and commenced with the addition of diene 3.35 to
commercially available, albeit expensive ($57.40/g), naphthoquinone 3.34.  After
aromatization of the intermediate with DDQ, a mixture (7.3:1) of 3.36 and 3.37
210
was obtained (Scheme 3.8).138  Isomer 3.37 was deprotected and used to
synthesize regioisomeric SS-228R to assist in proving the correct structure for the














3.36: R = Me
3.37: R = H
i) cycloaddition; ii) DDQ, 80% 3.36 11% 3.37
3.34 3.35
Isomer 3.36 was reduced with zinc borohydride and the intermediate
anthracene was oxidized with Jones reagent and the phenol methylated to provide
quinone 3.38 (Scheme 3.9).  A second cycloaddition gave the desired cycloadduct
as a mixture (1.7:1) of inseparable regioisomers 3.39 and 3.40.  Both of the
regioisomers were then carried on through the global deprotection to give SS-



















i) ZnBH4, DME; ii) chloranil, 65%; iii) MeI, Ag2O, CHCl3, 95%;
iv) TMSOCH=CHCH=CH2, CH2Cl2; v) Jones reagent, 29% 3.39, 17% 3.40 










Cameron later published a second synthesis of SS-228R that also
employed a cycloaddition to assemble the tetracyclic core.139  This synthesis
began with chloroanthraquinone 3.43, which can be made from commercially
available 1,8-dihydroxy-9,10-anthraquinone (3.42) (Scheme 3.10).140
Cycloaddition of anthraquinone 3.43 with diene 3.35 followed by aromatization
with DDQ gave 3.44 as the only regioisomer along with a small amount of
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deprotected 3.45.  Conversion of the chloro substituent to the required oxygen
functionality was then accomplished by treatment with TFA.  A
reduction/oxidation sequence was then performed to give the desired
dihydroxynaphthacenequinone.  The synthesis of SS-228R (3.33) was then























vi, vii, viii, ix
O
i) oleum, H3BO3, then H2O; ii) SOCl2, 86%; iii) Ac2O, pyr
iv) cycloaddition; v) DDQ, 71% 3.44, 26% 3.45; vi) TFA, 78%; 











Although there have been three total syntheses of SS-228R (3.33), the
primary goal of Cameron's was the proof of the structure of SS-228R.  The first of
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Cameron's syntheses of 3.33 began with an expensive starting material while the
second synthesis began with an advanced intermediate, which made both of these
syntheses rather synthetically uninteresting.  Tamura's synthesis of 3.33, however,
was a true exercise in synthetic chemistry, and he developed a synthetic strategy,
involving the regioselective cycloaddition of a phthalic anhydride that was later
used in Suzuki's total synthesis of galtamycinone.
3.4 PREVIOUS WORK IN THE MARTIN GROUP
Previous work in the Martin group directed toward the total synthesis of
3.1 featured a benzyne cycloaddition as the key step to assemble the tetracyclic
carbon frame (Scheme 3.11).  It was envisioned that galtamycinone could be
made from the cycloaddition of juglone 3.47 with an isobenzofuran 3.48, which
would be generated in situ by dehydration of a lactol.  Juglone 3.47 could be
made in either of two ways; the first involved a SN2' palladium-catalyzed addition
of vinyl iodide 3.49 to the bridged ether 3.50 followed by aromatization.  The
second method features a benzyne cycloaddition of sugar-furan 3.51 to
dimethoxybenzyne 3.52 followed by opening of the bridging ether and
215
aromatization.  Both of these strategies have been developed in the Martin group








































3.49 3.50 3.51 3.52
Initial studies actually focused on the natural product SS-228R (3.33) as a
model system.  It was anticipated that similar, if not identical conditions could be
used in the synthesis of the tetracyclic core of galtamycinone (3.1).  Accordingly,
methylanisole (3.53) was subjected to a Birch reduction to provide diene 3.54.142
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A cycloaddition was then performed whereby the diene was generated in situ
from 3.54 and subsequently reacted with dimethyl acetylenedicarboxylate
(Scheme 3.12).143  Reduction of both esters was then accomplished with Dibal-H
to form a diol that was oxidized with TPAP to provided a separable mixture








2) TPAP, NMO, 
4Å mol. sieves, CH2Cl2


















Studies toward SS-228R then continued with the [4+2] cycloaddition of
isobenzofuran generated from either lactol 3.56 or 3.57 with commercially
available juglone under acidic conditions to give a separable mixture of
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regioisomers 3.58 and 3.59 (Scheme 3.13).  One feature of the cycloaddition that
is notable is that lactol 3.56 reacted more rapidly and at lower temperatures than
lactol 3.57 to form cycloadducts 3.58 and 3.59 in higher yields and with greater
regioselectivity (1.3:1 compared to 1.1:1).  This difference in reactivity is likely to
be due to the ability of the electron rich methoxy group of lactol 3.56 to assist in
the loss of water through resonance stabilization.  Additionally, reactions of lactol
3.57 resulted in the isolation of small amounts of an inseparable mixture of exo-
regioisomers (5%).  Although speculative, it was thought that this difference in
product distribution may have been due to the fact that at higher temperatures the
reaction is readily reversible, and therefore subject to thermodynamic equilibrium.
In light of these results, it became apparent that lactol 3.56 was better suited for
the synthesis of both 3.33 and 3.1, and therefore a strategy for the selective










Et2O, 0 ºC, 6 h
TsOH (1 eq.)



































The synthesis of lactol 3.56 commenced with monobromination of
dimethylanisole to give 3.60 (Scheme 3.14).144  Hydrolysis of the bromide gave
known benzyl alcohol 3.61.145  Formylation of the intermdiate benzyl alcohol was
achieved by directed lithiation followed by reaction with DMF, according to the

















With a reliable route to lactol 3.56 in hand, studies toward the oxidation of
the cycloadduct 3.58 were performed.  It was initially anticipated that both the
oxidation and opening of the bridging ether could be accomplished
simultaneously under basic or acidic conditions to provide 3.62 (Scheme 3.15).
Unfortunately, under these conditions, dehydration occurred to give 3.63 as the
only product.  These results indicated that the oxidation/opening sequence would























Investigations then turned to a two-step protocol that began with the
oxidation of the B-ring of 3.58 to quinone 3.64.  Treatment of 3.58 with
manganese dioxide or BaMnO4 gave no reaction.  When 3.58 was treated with
ceric ammonium nitrate (CAN) only a complex mixture was isolated from the
reaction (Scheme 3.16).  The attempted oxidation of 3.58 with Fremy's salt gave
only dehydration product 3.63.  Reaction of 3.58 with
dichlorodicycanohydroquinone (DDQ) or chloranil gave no reaction at room
temperature, whereas at temperatures higher than 40 ºC, regioisomers 3.58 and
3.59 as well as exo isomers of 3.58 and 3.59 were recovered from the reaction.
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These results indicated that at elevated temperatures, the starting material 3.58
undergoes a retro [4+2] cycloaddition followed by recombining via [4+2]
cycloaddition.  This difficulty in the oxidation of cycloadduct 3.58 was thought to
be due to the increase in ring strain resulting from placing two additional sp2
centers into the tetracyclic system.  This hypothesis could be supported by the fact
that the B-ring prefers to exist in the dicarbonyl form rather than the
hydroquinone form as evidenced by the 13C spectra that contained peaks that













Since the oxidation of the B-ring of 3.58 prior to the opening of the
bridging ether in the C-ring was not successful, it was anticipated that reversal of
these steps would make the transformation of 3.58 to 3.62 possible.  To this end,
reaction of 3.58 with MeI resulted in C-alkylation to provide 3.66 rather than the
desired O-alkylation to give 3.65 (Scheme 3.17).  While the result of the reaction
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was not the desired product, it did reveal that electrophiles could be placed
adjacent to the carbonyl groups in 3.58.  Therefore, if an electrophile was installed
adjacent to the carbonyl that could also act as a good leaving group, it could



















It was anticipated that NCS would be an ideal candidate for the oxidation
of 3.58 since it is a source of electrophilic chloride, and this chloride could later
β-eliminate to provide quinone 3.64.  Thus, 3.58 was treated with NaH and NCS
to give small amounts of 3.64 but the major product of the reaction was ortho or
para chlorination of the A-ring as evidenced by 1H NMR and LRMS(Scheme
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3.18).  In an effort to limit the formation of the undesired product, the free phenol
was protected as the methyl ether.  Oxidation of this material under the same
























Once the oxidation of 3.58 had been completed to provide 3.67, the
bridging ether in the B-ring was opened regioselectively with TMSOTf to provide
3.32 (Scheme 3.19).  Because the data for 3.32 matched all of the spectral data
that was provided by Tamura in his synthesis of SS-228R (3.33), preparation of
















Efforts were then directed toward the total synthesis of galtamycinone.
The synthesis of the required sugar-juglone was accomplished using each of three
strategies.  Dr. John Bender completed the first of the three methods by applying
the O→C-glycoside rearrangement to 3.79 and the mixed methyl acetal of D-
olivose 3.75 (Scheme 3.20).  The requisite D-olivose was prepared according to
literature procedures beginning with either calcium-D-gluconate (3.68),147,148 or









































































Naphthol 3.79 was prepared in two steps from chlorodimethoxybenzene.
Cycloaddition of furan and chlorodimethoxybenzene provided 3.78 treatment
with acid then provided 3.79 (Scheme 3.21).  The O→C-glycoside rearrangement
of 3.79 and 3.75 was then accomplished in modest, though inconsistent yield to
















































Dr. Omar Lopez completed the second approach to the synthesis of the
required sugar-juglone utlilizing the SN2' opening of 3.78, that was prepared from
the cycloaddition of furan and chlorodimethoxybenzene, to incorporate the sugar
moiety.  Vinyl iodide 3.82 was prepared from D-olivose glucal 3.74 in two steps
followed by the palladium-catalyzed reaction of 3.82 with 3.78 gave adduct 3.83
229
as a mixture (1:1) of the diastereomeric cis-dihydronaphthol.152  Oxidation of 3.83
was then accomplished using DDQ to give naphthol 3.84.  Reduction of the glucal











































1) TIPSCl, imid., DMF
2) t-BuLi, ZnCl2, I2, THF
3.74
56%
David Kaelin completed the third and final route to the required sugar-
juglone using the cycloaddition of furan 3.88 with chlorodimethoxybenzene 3.77
(Scheme 3.23).  The required furan 3.88 was prepared in two steps from 3.86
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(Scheme 3.20).  The cycloaddition of 3.88 with chlorodimethoxybenzene 3.77
proceeded smoothly to provide an adduct that was treated with trifluoroacetic acid



































The key cycloaddition was then performed with sugar-juglone 3.81 that
had been prepared using the O C glycoside rearrangement route (Scheme 3.21),
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and isobenzofuran derived from lactol 3.56 to give a mixture of stereo- and
regioisomers 3.89 and 3.90 (Scheme 3.24).  This mixture of 3.89 and 3.90 was
then oxidized using NCS to give 3.91 and 3.92 as an inseparable mixture of
isomers.  Fortunately, it was found that after treatment of 3.91/3.92 with TMOTf,
the two regioisomers 3.93 and 3.94 were separable by column chromatography to












































3.89: R1 = H, R2 = OMe, R3 = Me, R4 = H
3.90: R1 = OMe, R2 = H, R3 = H, R4 = Me
R4
3.91: R1 = H, R2 = OMe, R3 = Me, R4 = H














Completion of the total synthesis of galtamycinone (3.1) required the
global deprotection of 3.93, but this task proved much more difficult than
anticipated.  A variety of conditions were explored for the deprotection of 3.93
including BBr3, NaI and TMSCl, and BI3, but only 3.94 was recovered from the
reaction (Scheme 3.25).  The deprotection of the D-ring methyl ether could not be


























A B C D
In light of these results, the choice of the protecting group on the D-ring
phenol was reconsidered.  It was thought that benzyl would be a better choice
than the methyl ether since it was already known that a benzyl group at this
235
position could be deprotected because it coincided with an intermediate in the
Suzuki synthesis of galtamycinone (3.2) (Scheme 3.5).125
3.5 STUDIES TOWARD THE SYNTHESIS OF GALTAMYCINONE
It was anticipated that the required benzyl lactol 3.98 could be prepared
analogously to the approach used to make methoxylactol 3.56 (Scheme 3.15).
Accordingly, Dr. Omar Lopez brominated acetoxydimethylphenol 3.95 (Scheme
3.26).  Hydrolysis of the bromide and the acetyl protecting group gave 3.96.
Selective benzyl protection yielded the desired benzyl protected phenol 3.97.
Unfortunately, attempts to formylate 3.97 under the conditions that were used for
the synthesis of lactol 3.56 were unsuccessful.  Use of n-BuLi in refluxing hexane
resulted in the isolation of a complex reaction mixture.  Reaction of 3.97 with n-
BuLi in THF at –78 ºC resulted in recovery of starting material.  At this point, Dr.
Omar Lopez concluded his studies toward the synthesis of galtamycinone (3.1).
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Scheme 3.26
OAc 1) NBS, (PhCO)2O2, CCl4
2) CaCO3, dioxane/H2O
















Although these preliminary attempts to synthesize lactol 3.98 were
unsuccessful, there were still options that could be explored for its synthesis.
Other protecting group options were also possible.  After considerable
experimentation, it was discovered that treatment of the alcohol 3.97 with n-BuLi
in toluene at –10 ºC and subsequent addition of DMF gave a mixture of starting
material and an unidentified product that rapidly decomposed upon exposure to
acidic conditions (such as dissolution in CDCl3 or CD2Cl2).  In light of these
results, it was important to verify that 3.97 was being deprotonated effectively
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(Scheme 3.27).  Deuterium incorporation studies were performed by treating 3.97
with n-BuLi in toluene at –10 ºC.  This experiment showed that there was 77%
deuterium incorporation on the aryl ring at a single position.  Furthermore, it was
shown that the aryl ring could be brominated at the desired position to provide
3.100 by metallation with n-BuLi in toluene at –10 ºC followed by addition of
dibromotetrafluoroethane.  Since it was established that alcohol 3.97 was
deprotonated effectively, and furthermore it was shown that electrophiles could be





















A solution of alcohol 3.97 in toluene was metallated with n-BuLi at –10
ºC followed by addition of DMF to produce the same results (by TLC) as those
that were obtained previously (Scheme 3.27).  Since it was known that the
product of the reaction was sensitive to acidic conditions, the product was
dissolved in benzene (C6D6) or methanol (CD3OD) instead of chloroform
(CDCl3) or dichloromethane (CD2Cl2).  The 1H NMR of the reaction of 3.97
showed a mixture (4:1) of the desired lactol 3.98 as well as an unidentified
aldehyde that was believed to be either 3.101 or 3.102.  Recrystallization of the
mixture provided an improved ratio of desired product 3.98 to aldehyde (12:1).
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At this point it was unknown whether the observed aldehyde corresponded to
3.101, which would arise from lithiation in the wrong position or 3.102, which
would result from of the equilibration between the lactol 3.98 and aldehyde 3.102.
In an effort to determine the nature of the unidentified aldehyde, several
experiments were performed.  An 1H NMR spectrum was taken of the
recrystallized mixture (12:1) in both benzene (C6D6) and methanol (CD3OD) to
see if the ratio of desired lactol 3.97 to aldehyde change over time as monitored
by the signal of the aryl methyl group.  It was anticipated that if the mixture was a
combination of 3.97 and 3.102 rather than the two alkylation regioisomers 3.98
and 3.101, the two isomers would equilibrate in solution and therefore, the ratio of
lactol 3.98 to aldehyde 3.102 would change.  Initially, the ratio of 3.97 to
aldehyde in the two solvents was identical (12:1).  After standing overnight in
solution the ratio of 3.97 to aldehyde had changed.  The solution in benzene
(C6D6) had gone from a 12:1 mixture to a 3:1 mixture of lactol 3.98 to aldehyde
3.102, whereas the solution in methanol (CD3OD) had equilibrated to a 10:1
mixture of lactol 3.98 to aldehyde 3.102.  This experiment indicated that
equilibration of 3.98 had occurred, and so the aldehyde contaminant must be
240
3.102.153  Concurrent with the studies of benzyl protecting group 3.97 were





















The synthesis of t-butyl lactol 3.106 commenced with the synthesis of the
t-butyl ether 3.104 from dimethylphenol 3.103.  Radical bromination of 3.104 and
hydrolysis of bromide provided the desired alcohol 3.105.  Treatment of the
alcohol 3.105 with n-BuLi and subsequent addition of DMF yielded the desired
lactol 3.106.  Unfortunately, this reaction could not be reproduced, and only
starting material 3.105 was recovered from the reaction, although the reason for
this was not clear.  Because formation of the lactol 3.106 was not reproducible,
the use of a t-butyl protecting group was impractical, and efforts toward the
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The cycloaddition of the isobenzofuran derived from lactol 3.98 with
juglone 3.81 gave an inseparable mixture of stereo- and regioisomers 3.107 and
3.108 (Scheme 3.29).  Optimal results with this cycloaddition were obtained if the
calcium chloride was flame-dried immediately before the reaction; otherwise
significantly lower yields (40%) were observed.  Additionally, all of the
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compounds including and subsequent to the preparation 3.107/3.108 should be























3.107: R1 = H, R2 = OBn, R3 = Me, R4 = H
3.108: R1 = OBn, R2 = H, R3 = H, R4 = Me
R4
Oxidation of the mixture of compounds 3.107 and 3.108 with NCS to
3.109 and 3.110 then proved to be rather problematic.  Initial attempts to effect
the oxidation using unpurified NCS resulted the isolation of an inseparable
mixture of quinones 3.109 and 3.110 as well as an inseparable mixture of another
undesired side product that were tentatively assigned as being 3.111 and 3.112
(Scheme 3.30).  The nature of the undesired side products 3.111/3.112 was
determined by 1H NMR where there were four singlets that correspond to the four
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phenolic peaks.  Additionally LRMS and HRMS gave a base peak at m/z 751 a





















3.107: R1 = H, R2 = OBn, R3 = Me, R4 = H
3.108: R1 = OBn, R2 = H, R3 = H, R4 = Me
R4
3.109: R1 = H, R2 = OBn, R3 = Me, R4 = H












3.111: R1 = H, R2 = OBn, R3 = Me, R4 = H
3.112: R1 = OBn, R2 = H, R3 = H, R4 = Me
OH
OH
At this point other options were examined to effect the requisite oxidation
of 3.107 and 3.108.  In an effort to conserve material, however, the cycloaddition
was performed on the isobenzofuran generated from lactol 3.98 and juglone 3.113
(Scheme 3.31).  An additional benefit to using 3.113 rather than 3.81 was the fact
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that without the sugar, the two regioisomers 3.114 and 3.115 were separable by






















It was hoped that the oxidation of 3.114 and opening of the oxabicycle
could be done in a one-pot procedure by subjecting the cycloadduct 3.114 to
Lewis acidic conditions under an atmosphere of oxygen.  Unfortunately, this
tactic resulted in the dehydration of 3.114 to give 3.118, the structure of which
was supported by LRMS when either TMSOTf or Sc(OTf)3 was used as the
catalyst (Scheme 3.32).
The tendency of 3.114 to dehydrate to 3.118 under Lewis acidic
conditions led to the return to a two-pot approach, and a number of conditions to
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effect the requisite oxidation of 3.114 to 3.116 were investigated (Scheme 3.32).
The use of NCS gave primarily 3.118, analogous to the oxidation of 3.107 and
3.108 with NCS.  Reaction of 3.114 with DDQ at room temperature gave only
starting material.  Higher temperatures could not be used because it was known
that the retro[4+2] could take place as shown by Dr. John Bender.  Cycloadduct
3.114 was also treated with chloranil, but again only starting material was
recovered.  The use of CAN at room temperature to oxidize 3.114 resulted in
decomposition of the starting material.  Dehydrogenation of cyclohexene and
cyclohexadiene systems using transition metal catalysts is known, but only
starting material was isolated when 3.114 heated with Pd/C in refluxing
diglyme.154  Silver-based oxidations are also known to convert hydroquinones to
quinones, but when Fetizon's reagent (Ag2CO3 on celite) was used,
155 only 3.114
was recovered.  Attempted oxidation of 3.114 with Fremy's salt (potassium
nitrosodisulfonate) also resulted in the recovery of starting material.156  In light of
Nicolaou's recent successes in using IBX (2-iodoxybenzoic acid) as a mild
oxidant to effect the stepwise, controlled oxidation of carbonyl compounds to
α,β-unsaturated ketones,157 this reagent was examined.  However, reaction of
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3.114 with IBX gave an unidentified mixture of compounds with no recovered
starting material or desired product.  After the investigation of many oxidative
conditions for the desired transformation, it was decided that the NCS oxidation

















Successful oxidation of 3.89 and 3.90 to 3.91 and 3.92 and 3.58 to 3.67
had been previously performed in the Martin group with commercially available
NCS that had not been purified.  Because the oxidation of 3.107 and 3.108 could
not be accomplished using the same NCS, it seemed reasonable to purify the
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NCS.  The NCS was first purified using published methods involving
recrystallization from either benzene or acetic acid.158  Treatment of 3.107 and
3.108 with NCS that had been recrystallized from benzene and stored in a
dessicator over Drierite resulted in the isolation of primarily 3.111 and 3.112
rather than quinones 3.109 and 3.110 (Scheme 3.33).  When the recrystallized
NCS (from benzene) was stored over P2O5 under vacuum, the oxidation of 3.107
and 3.108 was still problematic.  Use of NCS that had been recrystallized from
acetic acid followed by storage over P2O5 did not effect the oxidation of 3.107
and 3.108.
Recrystallization of the NCS from acetic acid could leave residual acid
that could interfere with the desired reaction, even after the recrystallized NCS
was dried under vacuum overnight.  Because of this, the following process was
developed for the purification of the NCS: (1) The NCS was recrystallized from
acetic acid; (2) The crystals were then dissolved in methylene chloride containing
solid potassium carbonate; (3) The solution was stirred vigorously to quench any
residual acid; (4) The solvent was removed to give acid free NCS that was stored
in a dessicator over Drierite and potassium carbonate.  Use of NCS thusly purified
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for the oxidation of 3.107 and 3.108 resulted in the isolation a mixture of
quinones 3.109 and 3.110, although there were still small amounts of 3.111 and
3.112 present as evidenced by LRMS and 1H NMR.  The exact ratio of 3.109 and
3.110 to 3.111 and 3.112 was difficult to determine since there was a rather
complex mixture of stereo- and regio- isomers of 3.109 and 3.110 and 3.111 and
3.112.  Furthermore, the oxidation of 3.107 and 3.108 was rather capricious so an





















3.107: R1 = H, R2 = OBn, R3 = Me, R4 = H
3.108: R1 = OBn, R2 = H, R3 = H, R4 = Me
R4
3.109: R1 = H, R2 = OBn, R3 = Me, R4 = H




With quinones 3.109 and 3.110 in hand, attention was turned to the
opening of the bridged oxabicycle.  Treatment of 3.107 and 3.108 with TMSOTf
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gave a mixture of regioisomers 3.118 and 3.119 that was inseparable by column
chromatography (Scheme 3.34).  Additionally, small amounts of unidentified
isomeric compounds were observed, however regioisomers 3.118 and 3.119 were
the major products as determined by the integration of the phenolic protons and
comparison to the spectral data provided by Suzuki.125  Although the
regioisomeric methyl ethers 3.93 and 3.94 were separable by column
chromatography, separation of benzyl ethers 3.118 and 3.119 was not possible
using only column chromatography.  HPLC separation of the four isomers using
two silica columns in series gave partial separation a mixture of 3.118 and 3.119
from the other two isomers.  Isolation of only 3.118 was not possible using either
flash chromatography or HPLC with silica columns.  Unfortunately, during the
process of HPLC there was a significant amount of decomposition of the four
isomers, although it is not clear at this time whether decomposition was due to the
silica columns used on the HPLC, exposure to light, or exposure to air.  The
suspected decomposition of compounds 3.118 and 3.119 was supported by the
fact that after collection of the desired compounds from HPLC, reinjection of the
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3.109: R1 = H, R2 = OBn, R3 = Me, R4 = H






In light of Suzuki's results in his studies toward galtamycinone, it was
anticipated that use of a halogenated juglone in the cycloaddition rather than
juglone 3.81 could result in the isolation of quinones 3.118 and 3.119 after
spontaneous dehydrohalogenation of the cycloadduct.  The requisite halogenated
juglone could be made in only one step from juglone 3.81 where juglone 3.81 was


















The cycloaddition of bromojuglone with the isobenzofuran derived from
lactol 3.98 was then accomplished, albeit in low yield, to give quinones 3.109 and
3.110 (Scheme 3.36).  The bridging ether was then treated with TMSOTf to give a
mixture of 3.118 and 3.119 that was inseparable by column chromatography.  The
two regioisomers 3.118 and 3.119 were separable with chiral HPLC using a
Chiralpak AD column.  The spectral data was identical to that reported by Suzuki,
and therefore constituted a formal synthesis of galtamycinone (3.1).125  The global
deprotection to provide galtamycinone (3.1) was attempted, however because of
lack of material, treatment of 3.118 with BBr3 to effect the global deprotection







































3.109: R1 = H, R2 = OBn, R3 = Me, R4 = H






In conclusion, the formal synthesis of galtamycinone (3.1) was completed
using both the SN2' and the sugar-furan methodologies that have been developed
in the Marting group as alternatives to the O C glycoside rearrangement.
Additionally, the viability of the isobenzofuran cycloaddition to assemble the
tetracyclic core was established, although the regioselectivity of this reaction was
rather disappointing.  Current efforts in the Martin group are focusing on the
development of methodologies to address the regioselectivity issue cycloaddition
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to assemble the tetracyclic core.  Additionally, efforts continue toward the
synthesis of other C-aryl glycoside natural products such as pluramycin and
vineomycinone to further demonstrate the utility of the methods developed thus
far.
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CHAPTER 4.  EXPERIMENTAL PROCEDURES.
General Procedures.  Unless otherwise noted, all starting materials were
obtained from commercial sources and used without further purification.  Melting
points are uncorrected.  Tetrahydrofuran (THF) was distilled from potassium
benzophenone ketyl immediately prior to use.  Methanol (MeOH) was distilled
from magnesium methoxide immediately prior to use.  Triethylamine (TEA), and
methylene chloride were distilled from calcium hydride immediately prior to use.
Reactions involving air or moisture sensitive reagents or intermediates were
performed under an inert atmosphere of nitrogen or argon in glassware that had
been flame dried.  IR spectra were recorded as noted on an FTIR instrument.  The
1H (250 MHz) and 13C (62.5 MHz) NMR spectra were determined as solutions as
indicated; chemical shifts are expressed in parts per million (δ units) downfield
from tetramethylsilane and referenced to the solvent.  Splitting patterns are
designated as s, singlet; d, doublet; t, triplet; q, quartet; m, multiplet; comp,















(2.53).  A suspension of erythronolactone (2.51) (5.90 g, 50.0 mmol) and
dibutyltin oxide (12.45 g, 50.0 mmol) in toluene (250 mL) was heated at reflux
for 6 h in an apparatus equipped with a Dean-Stark trap.  After cooling, the
solvent was removed under reduced pressure to give a tan solid that was
combined with CsF (14.43 g, 95.0 mmol) and dried under reduced pressure.  The
solids were suspended in DMF (150 mL), and KI (11.05 g, 66.5 mmol) and p-
MeOC6H4CH2Cl (10.17 mL, 75.0 mmol) were added.  The mixture was stirred
for 5 h at room temperature, EtOAc (350 mL) was added, and the mixture was
poured into H2O (300 mL).  The layers were separated, and the aqueous layer was
extracted with EtOAc (2 x 200 mL).  The combined organic layers were dried
(Na2SO4) and concentrated under reduced pressure to provide a yellow solid that
was purified by column chromatography eluting with hexanes/EtOAc (1:1-1:4) to
afford 8.49 g of a mixture (6:1) of regioisomers.  Recrystallization from hot
EtOAc provided 5.65 g (47%) of 2.53 as white needles: mp 100-103 °C; 1H NMR
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δ 7.35 (dd, J = 2.0, 6.6 Hz, 2 H), 7.32 (dd, J = 2.0, 6.6 Hz, 2 H), 4.96 (d, J = 11.6
Hz, 1 H), 4.76 (d, J = 11.6 Hz, 1 H), 4.33 - 4.19 (comp, 3 H), 4.14 (d, J = 4.8 Hz,
1 H), 3.81 (s, 3 H); 13C NMR δ 173.5, 159.9, 130.1, 128.1, 114.1, 73.7, 72.6,
71.3, 67.7, 55.3; IR (neat) 3462, 2958, 1781, 1612, 1514, 1465 cm-1; mass
spectrum (CI) m/z 238.0846 [C12H15O5 (M+1) requires 238.0841] (base), 161,
154, 149, 137..
NMR Assignments.  1H NMR δ 7.35 (dd, J = 2.0, 6.6 Hz, 2 H, C8-H),
7.32 (dd, J = 2.0, 6.6 Hz, 2 H, C9-H), 4.96 (d, J = 11.6 Hz, 1 H, C6-H), 4.76 (d, J
= 11.6 Hz, 1 H, C6-H), 4.33 - 4.19 (comp, 3 H, C4-H and C5-H), 4.14 (d, J = 4.8
Hz, 1 H, C3-H), 3.81 (s, 3 H, C11-H); 13C NMR δ 173.5 (C2), 159.9 (C10), 130.1




















2(3H)-furanone.  A solution of 2.53 (5.65 g, 23.7 mmol) in CH2Cl2 (85.0 mL)
containing imidazole (2.02 g, 29.6 mmol) and TBDPSCl (7.40 mL, 28.5 mmol)
was stirred for 5 h at room temperature.  The mixture was poured into a mixture
of EtOAc (200 mL) and H2O (100 mL).  The layers were separated, and the
aqueous layer was extracted with EtOAc (2 x 50 mL).  The combined organic
layers were dried (Na2SO4) and concentrated under reduced pressure, and the
residual oil was purified by flash chromatography eluting with hexanes/EtOAc
(9:1) to afford 9.88 g (87%) of diprotected lactone as a colorless oil; 1H NMR δ
7.73-7.62 (comp, 4 H), 7.47-7.23 (comp, 6 H), 7.17 (d J = 8.7 Hz, 2 H), 6.82 (d, J
= 8.7 Hz, 2 H), 4.67 (s, 2 H), 4.40 (ddd, J = 1.1, 3.0, 4.4 Hz, 1 H), 4.13 (dd, J =
1.1, 10.2 Hz, 1 H), 3.98 (dd, J = 3.0, 10.2 Hz, 1 H), 3.90 (d, J = 4.4 Hz, 1 H), 3.77
(s, 3 H), 1.07 (s, 9 H); 13C NMR δ 173.8, 159.4, 135.9, 135.6, 133.1, 132.5,
130.0, 129.9, 129.7, 128.6, 127.8, 127.6, 113.7, 74.0, 71.9, 71.5, 69.1, 55.1, 26.7,
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19.2; IR (neat) 2333, 2858, 1790, 1613, 1514, 1464, 1428 cm-1; mass spectrum
(CI) m/z 475.1932 [C28H32O5Si (M+1) requires 475.1941] (base), 257, 241.
NMR Assignments.  1H NMR δ .73-7.62 (comp, 4 H, Haro), 7.47 - 7.23
(comp, Haro, 6 H), 7.17 (d, J = 8.7 Hz, 2 H, C8-H), 6.82 (d, J = 8.7 Hz, 2 H, C9-
H), 4.67 (s, 2 H, C6-H), 4.40 (ddd, J = 1.1, 3.0, 4.4 Hz, 1 H, C4-H), 4.13 (dd, J =
1.1, 10.2 Hz, 1 H, C5-H), 3.98 (dd, J = 3.0, 10.2 Hz, 1 H, C5-H), 3.90 (d, J = 4.4
Hz, 1 H, C3-H), 3.77 (s, 3 H, C11-H), 1.07 (s, 9 H, C13-H); 13C NMR δ 173.8
(C2), 159.4 (C10), 135.9 (Caro), 135.6 (Caro), 133.1 (Caro), 132.5 (Caro), 130.0
(Caro), 129.9 (Caro), 129.7 (C8), 128.6 (C10), 127.8 (Caro), 127.6 (Caro), 113.7





















methoxybenzyoxy)butanoate (2.54).  A solution of Cs2CO3 (0.4 g, 1.0 mmol)
and the diprotected lactone from the preceeding experiment (9.88 g, 20.7 mmol)
in MeOH (70 mL) was stirred for 1 h at 0 °C.  Brine (200 mL) and CH2Cl2 (100
mL) were added, and the layers were separated.  The aqueous layer was extracted
with CH2Cl2 (2 x 50 mL).  The combined organic layers were dried (Na2SO4)
and concentrated under reduced pressure to give 10.84 g of a light yellow oil that
was purified by flash chromatography eluting with hexanes/EtOAc (4:1) to afford
10.01 g (95%) of 2.54 as a colorless oil; 1H NMR δ 7.65-7.62 (comp, 4 H), 7.44-
7.35 (comp, 6 H), 7.19 (d, J = 8.6 Hz, 2 H), 6.83 (d, J = 8.6 Hz, 2 H), 4.57 (d, J =
11.1 Hz, 1 H), 4.34 (d, J = 11.1 Hz, 1 H), 4.09 (d, J = 6.9 Hz, 1 H), 3.98-3.94 (m,
1 H), 3.80-3.77 (m, 2 H), 3.79 (s, 3 H), 3.74 (s, 3 H), 2.56 (d, J = 6.9 Hz, 1 H),
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1.05 (s, 9 H); 13C NMR δ 171.6, 159.4, 135.5, 133.0, 129.8, 129.8, 129.0, 127.8,
113.8, 78.3, 72.5, 72.3, 63.7, 55.2, 52.0, 26.8, 19.2; IR (neat) 3490, 2952, 2932,
2856, 1750, 1611, 1513, 1427 cm-1; mass spectrum (CI) m/z  507.2203
[C29H36O6Si (M+1) requires 507.2203] (base), 311, 251, 233.
NMR Assignments.  1H NMR δ 7.65 - 7.62 (comp, Haro, 4 H), 7.44 -
7.35 (comp, Haro, 6 H), 7.19 (d, J = 8.6 Hz, 2 H, C7-H), 6.83 (d, J = 8.6 Hz, 2 H,
C8-H), 4.57 (d, J = 11.1 Hz, 1 H, C5-H), 4.34 (d, J = 11.1 Hz, 1 H, C5-H), 4.09
(d, J = 6.9 Hz, 1 H, C2-H), 3.98 - 3.94 (m, 1 H, C3-H), 3.80 - 3.77 (m, 2 H, C4-
H), 3.79 (s, 3 H, C10-H), 3.74 (s, 3 H, C13-H), 2.56 (d, J = 6.9 Hz, 1 H, OH),
1.05 (s, 9 H, C12-H); 13C NMR δ 171.6 (C1), 159.4 (C6), 135.5 (Caro), 133.0
(Caro), 129.8 (Caro), 129.8 (Caro), 129.0 (Caro), 127.8 (Caro), 113.8 (C8), 78.30






























furoyloxy)-2-(4'-methoxybenzyloxy)butanoate (2.55).  A solution of 2.54
(10.01 g, 19.7 mmol), 2.23a (4.77 g, 21.6 mmol), DMAP (1.20 g, 9.8 mmol), and
DCC (4.87 g, 23.6 mmol) in CH2Cl2 (200 mL) was stirred at room temperature
for 12 h.  The mixture was filtered, and the filtrate was concentrated to give 16.4
g of a light tan oil that was purified by flash chromatography eluting with
hexanes/EtOAc (85:15) to afford 11.95 g (95%) of 2.55 as a colorless oil; 1H
NMR δ 7.64-7.60 (comp, 4 H), 7.42-7.21 (comp, 11 H), 7.11 (d, J = 3.4 Hz, 1 H),
6.79 (d, J = 8.7 Hz, 2 H), 6.65 (d, J = 3.4 Hz, 1 H), 5.45 (dt, J = 4.5, 9.9 Hz, 1 H),
4.71 (d, J = 11.5 Hz, 1 H), 4.46 (d, J = 11.5 Hz, 1 H), 4.38 (d, J = 5.4 Hz, 1 H),
3.99 (dd, J = 5.4, 11.1 Hz, 2 H), 3.93 (dd, J = 4.5, 11.1 Hz), 3.76 (s, 3 H), 3.66 (s,
3 H), 1.00 (s, 9 H); 13C NMR δ 170.2, 159.3, 156.6, 150.2, 146.4, 135.6, 135.5,
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135.4, 133.4, 132.9, 132.8, 129.7, 129.6, 129.6, 129.2, 128.8, 127.6, 127.5, 127.5,
119.6, 118.5, 113.7, 75.7, 74.4, 72.5, 61.3, 55.1, 52.0, 26.6, 19.0; IR (neat) 3070,
3012, 2931, 2856, 1731, 1612, 1577, 1513 cm-1; mass spectrum (CI) m/z
711.2459 [C40H43O8SSi (M+1) requires 711.2448] (base), 653, 302, 207.
NMR Assignments.  1H NMR δ 7.64 - 7.60 (comp, 4 H, Haro), 7.42 -
7.21 (comp, 13 H, Haro), 7.11 (d, J = 3.4 Hz, 1 H, C13-H), 6.79 (d, J = 8.7 Hz, 2
H, C8-H), 6.65 (d, J = 3.4 Hz, 1 H, C14-H), 5.45 (dt, J = 4.5, 9.9 Hz, 1 H, C3-H),
4.71 (d, J = 11.5 Hz, 1 H, C5-H), 4.46 (d, J = 11.5 Hz, 1 H, C5-H), 4.38 (d, J =
5.4 Hz, 1 H, C2-H), 3.99 (dd, J = 5.4, 11.1 Hz, 2 H), 3.93 (dd, J = 4.5, 11.1 Hz),
3.76 (s, 3 H, C18-H), 3.66 (s, 3 H, C10-H), 1.00 (s, 9 H, C17-H); 13C NMR δ
170.2 (C1), 159.3 (C9), 156.6 (C11), 150.2 (C12), 146.4 (C15), 135.6 (Caro),
135.5 (Caro), 135.4 (Caro), 133.4 (Caro), 132.9 (Caro), 132.8 (Caro), 129.7
(Caro), 129.6 (Caro), 129.6 (Caro), 129.2 (Caro), 128.8 (Caro), 127.6 (Caro),
127.5 (Caro), 127.5 (Caro), 119.6 (C13 or C14), 118.5 (C13 or C14), 113.7 (C8),
75.7 (C5), 74.4 (C3 or C4), 72.5 (C3 or C4), 61.3 (C2), 55.1 (C10), 52.0 (C18),




















furoyloxy)-2-hydroxybutanoate.  A solution of 2.55 (13.31 g, 18.7 mmol) and
DDQ (8.50 g, 37.4 mmol) in CH2Cl2/H2O (270 mL, 10:1) was stirred at 35 °C for
12 h.  The solvent was removed under reduced pressure, and the residue was
dissolved in Et2O (300 mL) and poured into saturated NaHCO3 (200 mL).  The
layers were separated, and the organic layer was washed with saturated NaHCO3
(5 x 100 mL).  The organic layer was then stirred vigorously with saturated
NaHSO3 solution (500 mL) until no p-methoxybenzaldehyde could be detected
by TLC.  The organic layer was dried (Na2SO4) and concentrated under reduced
pressure to give 9.86 g (89%) of alcohol as a yellow oil that was used in the next
reaction without further purification; 1H NMR δ 7.69-7.63 (comp, 4  H), 7.44-
7.22 (comp, 11 H), 7.17 (d, J = 3.5 Hz, 1 H), 6.63 (d, J = 3.5 Hz, 1 H), 5.43 (dt, J
= 3.7, 9.4 Hz, 1 H), 4.58 (dd, J = 3.7, 6.5 Hz, 1 H), 3.93 (dd, J = 1.4, 5.8 Hz, 2 H),
3.72 (s, 3 H), 3.37 (d, J = 6.5 Hz, 1 H), 1.03 (s, 9 H); 13C NMR δ 172.3, 157.0,
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150.5, 146.2, 135.4, 135.4, 133.3, 132.5, 129.7, 129.2, 127.7, 127.5, 119.9, 118.4,
74.8, 70.2, 61.5, 52.7, 26.7, 26.5, 19.0; IR (neat) 3489, 3070, 2953, 2856, 1736,
1566, 1463 cm-1; mass spectrum (CI) m/z  591.1883 [C32H35O7SSi (M+1)
requires 591.1873] (base), 513, 435, 302, 279.
NMR Assignments.  1H NMR δ 7.69 - 7.63 (comp, 4 H, Haro), 7.44 -
7.22 (comp, 11 H, Haro), 7.17 (d, J = 3.5 Hz, 1 H, C7-H), 6.63 (d, J = 3.5 Hz, 1
H, C8-H), 5.43 (dt, J = 3.7, 9.4 Hz, 1 H, C3-H), 4.58 (dd, J = 3.7, 6.5 Hz, 1 H,
C2-H), 3.93 (dd, J = 1.4, 5.8 Hz, 2 H, C4-H), 3.72 (s, 3 H,   C12-H), 3.37 (d, J =
6.5 Hz, 1 H, OH), 1.03 (s, 9 H, C11-H); 13C NMR δ 172.3 (C1), 157.0 (C5),
150.5 (C6), 146.2 (C9), 135.4 (Caro), 135.4 (Caro), 133.3 (Caro), 132.5 (Caro),
129.7 (Caro), 129.2 (Caro), 127.7 (Caro), 127.5 (Caro), 119.9 (C7 or C8), 118.4























1,7-dioxaspiro[4.4]non-3-ene-2,6-dione (2.67).  HF•pyridine (1.25 mL) was
added to a solution of 2.30 (0.569 g, 1.00 mmol) in THF (10 mL) at 0 °C, the
cooling bath was removed, and the solution was stirred for 1 h at room
temperature.  Solid NaHCO3 was added until CO2 evolution ceased.  The mixture
was filtered, and the filtrate was concentrated under reduced pressure to give a
light brown oil.  The crude diol was dissolved in CH2Cl2 (10 mL) containing 3 Å
molecular sieves, p-MeOC6H4CH2OMe  (0.300 g, 2.00 mmol), and DDQ (.028 g,
1.25 mmol), and the resulting mixture was stirred for 16 h t room temperature.
The reaction mixture was filtered through a Celite pad, and the filtrate was
washed with saturated NaHCO3 (10 mL).  The layers were separated, and the
aqueous wash was back extracted with CH2Cl2 (3 x 10 mL).  The combined
organic extracts were dried (Na2SO4) and concentrated, and the residual dark red
oil was purified by flash chromatography on silica gel eluting with
hexanes/EtOAc (7:3) to give 0.164 g (44%) of 2.67 as a white crystalline solid;
mp 150–151 °C; 1H NMR δ 7.55 (d, J = 5.8 Hz, 1 H), 7.36 (d, J = 8.7 Hz, 2 H),
6.91 (d, J = 8.7 Hz, 2 H), 6.43 (d, J = 5.8 Hz, 1 H), 5.51 (s, 1 H), 5.02 (t, J = 1.5
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Hz, 1 H), 4.61 (dd, J = 1.5, 13.9 Hz, 1 H), 4.38 (dd, J = 1.5, 13.9 Hz, 1 H), 3.85
(s, 3 H), 3.82 (s, 3 H); 13C NMR δ 168.9, 166.8, 165.1, 160.8, 149.3, 128.1,
127.5, 125.4, 113.9, 98.4, 88.5, 82.8, 72.4, 65.0, 55.4, 53.7; IR (neat) 3113, 2960,
2842, 1794, 1747 cm-1; mass spectrum (CI) m/z 377.0867 [C18H17O9 (M+1)
requires 377.0873], 377, 269, 234.
NMR Assignments.  1H NMR δ 7.55 (d, J = 5.8 Hz, 1 H, C2-H), 7.36 (d,
J = 8.7 Hz, 2 H, C11-H), 6.91 (d, J = 8.7 Hz, 2 H, C12-H), 6.43 (d, J = 5.8 Hz, 1
H, C3-H), 5.51 (s, 1 H, C10-H), 5.02 (t, J = 1.5 Hz, 1 H, C6-H), 4.61 (dd, J = 1.5,
13.9 Hz, 1 H, C8-Ha), 4.38 (dd, J = 1.5, 13.9 Hz, 1 H, C8-Hb), 3.85 (s, 3 H, C14-
H), 3.82 (s, 3 H, C16-H); 13C NMR δ 168.9 (C1, C5, or C15) 166.8 (C1, C5, or
C15), 165.1 (C1, C5, or C15), 160.8 (C3), 149.3 (C2) , 128.1 (Caro), 127.5
(Caro), 125.4 (Caro), 113.9 (Caro), 98.4 (C9), 88.5 (C4), 82.8 (C7) , 72.4 (C6),




























dione (2.71).  Me2PhSiCl (0.125 g, 0.123 mL, 0.733 mmol) was added to a
suspension of Li (0.022 g, 3.29 mmol) in THF (0.8 mL) at room temperature, and
the mixture was stirred for 3 h.  This solution of silyllithium reagent was then
added to a stirred solution of Me2Zn (2.0 M in toluene, 0.367 mL, 0.733 mmol) in
THF (2.2 mL) at 0 °C.  After stirring the mixture for 15 min, it was cooled to –78
°C, and a solution of 2.67 (0.092 g, 0.244 mmol) in THF (1.8 mL) was added
slowly.  The reaction was stirred for 5 min, warmed to –60 °C, and stirred for 10
min.  Saturated NH4Cl (5 mL) and 1 M HCl (2 mL) were added, and the layers
were separated.  The aqueous layer was extracted with CH2Cl2 (3 x 5 mL), and
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the combined organic layers were washed with brine (5 mL), dried (Na2SO4), and
concentrated.  The resulting in a yellow oil was purified by flash chromatography
on silica gel eluting with hexanes/EtOAc (4:1) to afford 0.076 g (61%) of 2.71 as
a white crystalline solid;  mp 154-155 ˚C; 1H NMR δ 7.41–7.26 (comp, 7 H), 6.95
(d, J = 8.8 Hz, 2 H), 5.51 (s, 1 H), 4.97 (dd, J = 1.2, 2.1 Hz, 1 H), 4.64 (dd, J = 1.2
Hz, 14.3 Hz, 1 H), 4.30 (dd, J = 2.1, 14.3 Hz, 1 H), 3.90 (s, 3 H), 3.80 (s, 3 H),
2.74–2.40 (comp, 3 H), 0.38 (s, 3 H), 0.24 (s, 3 H); 13C NMR δ 174.0, 171.0,
166.4, 160.5, 137.9, 133.7, 129.2, 127.8, 127.7, 113.6, 98.4, 89.2, 81.6, 77.1, 72.5,
65.4, 55.3, 53.6, 31.0, 22.7, -2.3, -3.7; IR (neat) 2959, 1799, 1744 cm-1; mass
spectrum (CI) m/z 513.1589 [C26H29O9Si (M+1) requires 513.1581] 513 (base),
435, 377, 269.
NMR Assignments.  1H NMR δ 7.41 – 7.26 (comp, 7 H, Haro), 6.95 (d, J
= 8.8 Hz, 2 H, C12-H), 5.51 (s, 1 H, C9-H), 4.97 (dd, J = 1.2, 2.1 Hz, 1 H, C6-H),
4.64 (dd, J = 1.2 Hz, 14.3 Hz, 1 H, C8-Ha), 4.30 (dd, J = 2.1, 14.3 Hz, 1 H, C8-
Hb), 3.90 (s, 3 H, C14-H), 3.80 (s, 3 H, C16-H), 2.74 – 2.40 (comp, 3 H, C2 and
C3-H), 0.38 (s, 3 H, C17-H), 0.24 (s, 3 H, C17-H); 13C NMR δ 174.0 (C1, C5, or
C11), 171.0 (C1, C5, or C11), 166.4 (C1, C5, or C11), 160.5 (Caro), 137.9 (Caro),
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133.7 (Caro), 129.2 (Caro), 127.8 (Caro), 127.7 (Caro), 113.6 (Caro), 98.4 (C9),
89.2 (C4), 81.6 (C7), 77.1 (C3), 72.5 (C6), 65.4 (C9), 55.3 (C14), 53.6 (C16),






















2(3H)-furanone.  Imidazole (0.316 mmol, 0.022 g) and TBDPSCl (0.316 mmol,
0.082 mL) were added to a solution of 2.73 (0.244 mmol, 0.058 g) in CH2Cl2
(2.0 mL) at 0 ºC.  The reaction was then warmed to rt by removing the cooling
bath.  After stirring for 12 h, H2O (5 mL) and EtOAc (5 mL) were added.  The
organic layer was then washed with brine (5 mL), dried (Na2SO4) and
concentrated under reduced pressure to give a clear colorless oil.  Purification by
flash chromatography (1.5 g silica) eluting with hexanes/EtOAc (70:30) afforded
89 mg (77%) of lactone as a clear colorless oil; 1H NMR δ 7.78 - 7.70 (comp, 4
H), 7.45 - 7.33 (comp, 6 H), 7.19 (d, J = 8.6 Hz, 2 H), 6.83 (d, J = 8.6 Hz, 2 H),
4.54 (d, J = 11.5 Hz, 1 H), 4.42 (d, J = 11.5 Hz, 1 H), 4.36 (d, J = 4.9 Hz, 1 H),
4.21 (d, J = 10.6 Hz, 1 H), 3.97 (dd, J = 3.1, 10.6 Hz, 1 H), 3.80 - 3.78 (m, 1 H),
3.80 (s, 3 H), 1.15 (s, 9 H); 13C NMR δ 173.8, 159.4, 136.0, 135.7, 133.5, 131.2,
130.1, 129.3, 127.8, 113.8, 75.1, 71.4, 71.0, 68.9, 55.3, 26.7, 19.3; IR (neat) 3499,
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3070, 3048, 2956, 2931, 2857, 1794, 1613 cm-1; mass spectrum (CI) m/z
475.1941[(M-1) requires 475.1941] 477 (base), 399, 279, 211.
NMR Assignments.  1H NMR δ 7.78 - 7.70 (comp, 4 H, Haro), 7.45 -
7.33 (comp, 6 H, Haro), 7.19 (d, J = 8.6 Hz, 2 H, C10-H), 6.83 (d, J = 8.6 Hz, 2
H, C11-H), 4.54 (d, J = 11.5 Hz, 1 H, C8-Ha), 4.42 (d, J = 11.5 Hz, 1 H, C8-Hb),
4.36 (d, J = 4.9 Hz, 1 H, C3-H), 4.21 (d, J = 10.6 Hz, 1 H, C5-Ha), 3.97 (dd, J =
3.1, 10.6 Hz, 1 H, C5-Hb), 3.80 - 3.78 (m, 1 H, C4-H), 3.80 (s, 3 H, C13-H), 1.15
(s, 9 H, C7-H); 13C NMR δ 173.8 (C2), 159.4 (C9), 136.0 (Caro), 135.7 (Caro),
133.5 (Caro), 131.2 (Caro), 130.1 (Caro), 129.3 (Caro), 127.8 (Caro), 113.8






















methoxybenzyoxy)butanoate (2.74).  Cs2CO3 (0.001 g, 0.003 mmol) was added
to a solution of lactone (0.032 g, 0.067 mmol) in MeOH (1.0 mL) at 0˚ C.  After
stirring for 1.5 h, brine (3.0 mL) and CH2Cl2 (3.0 mL) were added.  The aqueous
layer was extracted with CH2Cl2 (2 x 3.0 mL).  The combined organic layers
were dried (Na2SO4) and concentrated to give 0.084 g of a light yellow oil that
was purified by flash chromatography (1.0 g silica) eluting with hexanes/EtOAc
(1:9) to afford 0.021 g (62%) of 2.74 as a clear colorless oil; 1H NMR δ 7.68 -
7.64 (comp, 4 H), 7.44 - 7.40 (comp, 2 H), 7.37 - 7.33 (comp, 4 H), 7.19 (d, J =
8.6 Hz, 2 H), 6.85 (d, J = 8.6 Hz, 2 H), 4.59 (d, J = 11.2 Hz, 1 H), 4.44 (d, J =
11.2 Hz, 1 H), 4.40 (d, J = 3.4 Hz, 1 H), 3.81 - 3.73 (m, 3 H), 3.79 (s, 3 H), 3.39
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(s, 3 H), 1.11 (s, 9 H); 13C NMR δ 171.7, 159.3, 136.1, 136.0, 133.5, 133.2,
129.9, 129.5, 127.7, 127.5, 113.8, 81.1, 73.0, 72.2, 61.2, 55.3, 51.6, 26.9, 19.3; IR
(neat) 3568, 2951, 2857, 1751, 1611, 1513 cm-1; mass spectrum (CI) m/z
507.2201 [(M-1) requires 507.2203] 509 (base), 507, 431.
NMR Assignments.  1H NMR δ 7.68 - 7.64 (comp, 4 H, Haro), 7.44 -
7.40 (comp, 2 H, Haro), 7.37 - 7.33 (comp, 4 H, Haro), 7.19 (d, J = 8.6 Hz, 2 H,
C9-H), 6.85 (d, J = 8.6 Hz, 2 H, C10-H), 4.59 (d, J = 11.2 Hz, 1 H, C7-Ha), 4.44
(d, J = 11.2 Hz, 1 H, C7 -Hb), 4.40 (d, J = 3.4 Hz, 1 H, C2-H), 3.81 - 3.73 (m, 3
H, C3-H, C4-H), 3.79 (s, 3 H, C12-H), 3.39 (s, 3 H, C13-H), 1.11 (s, 9 H, C6-H);
13C NMR δ 171.7 (C1), 159.3 (C8), 136.1 (Caro), 136.0 (Caro), 133.5 (Caro),
133.2 (Caro), 129.9 (Caro), 129.5 (Caro), 127.7 (Caro), 127.5 (Caro), 113.8























 (2R, 4R )-(2-(4’methoxyphenyl)-[1,3]dioxolan-4-yl)-tert-
butyldiphenylsiloxy-acetic acid methyl ester.  A solution of 2.74 (2.94 g, 5.78
mmol) and DDQ (1.57 g, 6.94 mol) in CH2Cl2 (60 mL) containing 4Å molecular
sieves was stirred at rt for 1 h.  The reaction mixture was then filtered through
celite and the filtrate washed with saturated NaHCO3 (20 mL).  The layers were
separated and the aqueous layer was extracted with CH2Cl2 (3 x 20 mL).  The
combined organic layers were dried (Na2SO4) and concentrated to give a brown
oil that was purified by flash chromatography (60 g silica) eluting with
EtOAc/Hex (10:90) to provide 1.63 g (56%) of the acetal as a clear, colorless oil;
IR (neat) 2859, 2360, 1743 cm-1; mass spectrum (CI) m/z 507.2198 [(M+1)
























methoxybenzyloxy)butanoate (2.75).  A solution of TFA (1.23 g, 0.832 mL,
10.80 mmol) in CH3CN (6 mL) at –30 ºC was added via cannula to a solution of
the acetal (0.547 g, 1.08 mmol) and NaCNBH3 (0.339 g, 5.40 mmol) in MeCN
(9.0 mL) at –30 ºC. After stirring for 30 min, saturated NaHCO3 (5 mL) was
added and the layers were separated.  The aqueous layer was then extracted with
CH2Cl2  (3 x 5 mL) and the combined organic layers were dried (Na2SO4) and
concentrated to give a clear colorless oil that was purified by flash
chromatography (7 g silica) eluting with EtOAc/Hex (30:70) to provide 0.523 g
(95%) of 2.75 as a clear, colorless oil; 1H NMR δ 7.65-7.62 (comp, 4 H), 7.44-
7.25 (comp, 6 H), 7.20 (d, J = 8.6 Hz, 2 H), 6.86 (d, J = 8.6 Hz, 2 H), 4.43 (d, J =
11.3 Hz, 1 H), 4.37 (d, J = 11.3 Hz, 1 H), 4.31 (d, J = 5.7 Hz, 1  H), 4.07-3.86 (m,
1 H), 3.80 (s, 3 H), 3.59 (d, J = 4.9 Hz, 2 H), 3.37 (s, 3 H), 1.08 (s, 9 H); 13C
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NMR δ 171.3, 159.1, 135.8, 135.7, 129.8, 139.3, 127.5, 127.4, 113.6, 73.5, 72.9,
72.3, 69.4, 55.1, 51.3, 26.8, 19.3; IR (neat) 3537, 2949, 2858, 1749 cm-1; mass
spectrum (FAB) m/z 507.2210 [(M+) requires 507.2202] 507 (base), 431, 403,
323, 311, 279.
NMR Assignment:  1H NMR δ 7.65-7.62 (comp, 4 H, Haro), 7.44-7.25
(comp, 6 H, Haro), 7.20 (d, J = 8.6 Hz, 2 H, Haro), 6.86 (d, J = 8.6 Hz, 2 H,
Haro), 4.43 (d, J = 11.3 Hz, 1 H, C5-Ha), 4.37 (d, J = 11.3 Hz, 1 H, C5-Hb), 4.31
(d, J = 5.7 Hz, 1 H, C2-H), 4.07-3.86 (m, 1 H, C3-H), 3.80 (s, 3 H, C10-H), 3.59
(d, J = 4.9 Hz, 2 H, C4-H), 3.37 (s, 3 H, C117-H), 1.08 (s, 9 H, C12-H); 13C
NMR δ 171.3 (C1), 159.1 (Caro), 135.8 (Caro), 135.7 (Caro), 129.8 (Caro), 139.3
(Caro), 127.5 (Caro), 127.4 (Caro), 113.6 (Caro), 73.5 (C4), 72.9 (C3), 72.3 (C5),






























3-(5-phenylthio-2-furoyloxy)butanoate (2.76).  Furoic acid 2.23a (1.13 mmol,
0.249 g), DMAP (0.515 mmol, 0.063 g), and DCC (1.23 mmol, 0.254) were
added sequentially to a solution of 2.75 (1.03 mmol, 0.523 g) in CH2Cl2 (10 mL)
at 0 ºC.  The reaction was then stirred at rt for 4.5 h and then filtered and
concentrated to give a light brown oil that was purified by flash chromatography
(10 g silica) eluting with EtOAc/Hex (30:70) to provide 0.664 g (91%) of 2.76 as
a clear, colorless oil; 1H NMR δ 7.64-7.57 (comp, 4 H), 7.38-7.15 (comp, 8 H),
6.99 (d, J = 3.4 Hz, 1 H), 6.84 (d, J = 8.7 Hz, 2 H), 6.63 (d, J = 3.4 Hz, 1 H),
5.55-5.47 (m, 1 H), 4.54 (d, J = 3.3 Hz, 1 H), 4.44 (d, J = 4.7, 2 H), 3.85-3.76 (m,
1 H), 3.78 (s, 3 H), 3.36 (s, 3 H), 1.07 (s, 9 H); 13C NMR δ 170.1, 159.1, 156.8,
150.1, 146.4, 135.9, 135.8, 132.5, 132.4, 129.7, 129.2, 127.4, 127.3, 119.7, 118.5,
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113.6, 74.1, 72.7, 72.2, 66.8, 55.1, 54.5, 26.7, 19.4; IR(neat) 2951, 2858, 2361,
1732 cm-1; mass spectrum (FAB) m/z 711.2440 [(M+1) requires 711.2448] 711
(base) 513, 427, 366.
NMR Assigments:  1H NMR δ 7.64-7.57 (comp, 4 H, Haro), 7.38-7.15
(comp, 8 H, Haro), 6.99 (d, J = 3.4 Hz, 1 H, C20-H), 6.84 (d, J = 8.7 Hz, 2 H,
Haro), 6.63 (d, J = 3.4 Hz, 1 H, C19-H), 5.55-5.47 (m, 1 H, C3-H), 4.54 (d, J =
3.3 Hz, 1 H, C4-H), 4.44 (d, J = 4.7, 2 H, C5-H), 3.85-3.76 (m, 1 H, C2-H), 3.78
(s, 3 H, C10-H), 3.36 (s, 3 H, C26-H), 1.07 (s, 9 H, C12-H); 13C NMR δ 170.1
(C1), 159.1 (C6), 156.8 (C17, C18, or C21), 150.1 (C17, C18, or C21), 146.4
(C17, C18, or C21), 135.9 (Caro), 135.8 (Caro), 132.5 (Caro), 132.4 (Caro), 129.7
(Caro), 129.2 (Caro), 127.4 (Caro), 127.3 (Caro), 119.7 (C19 or C20), 118.5 (C19
or C20), 113.6 (Caro), 74.1 (C4), 72.7 (C3), 72.2 (C5), 66.8 (C2), 55.1 (C10),


















(2.82).  A t-BuLi solution (1.55M in hexanes, 2.58 mL, 4.00 mmol) was added to
a solution of 2.76 (0.365 g, 2.00 mmol) in Et2O (10 mL) at –78 ºC.  After
warming to 0 ºC and stirring for 1 h, the solution was warmed to rt for 10 min and
then recooled to –78 ºC.  A solution of 2.77 in Et2O was added slowly and then
the reaction was stirred at 0 ºC for 2.5 h.  Saturated NH4Cl (5mL) was added, and
the layers were separated.  The aqueous layer was extracted with Et2O (2 x 5 mL)
and the combined organic layers were dried (Na2SO4) and concentrated to give a
bright yellow oil that was purified by flash chromatography (10 g silica) eluting
with EtOAc/Hex (5:95 – 10:90) to provide 0.102 g (33%) of 2.82 as a yellow oil;
1H NMR (500 MHz) δ 7.36-7.33 (comp, 1 H), 7.31-7.24 (comp, 5 H), 7.20-7.12
(comp, 4 H), 5.16 (s, 0.5 H), 5.13 (s, 0.5 H), 5.01 (s, 0.5 H), 5.01 (s, 0.5 H), 3.93
(d, J = 4.6 Hz, 0.5 H), 3.90 (d, J = 7.2 Hz, 0.5 H), 3.16-2.98 (comp, 3 H), 2.72
(dd, J = 6.6, 13.4 Hz, 1 H), 2.53-2.23 (comp, 2 H), 1.92-1.85 (comp, 1 H), 0.83
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(d, J = 6.8 Hz, 1.5 H), 0.74 (d, J = 6.6 Hz, 1.5 H); IR (neat) 3448, 3061, 3025,
2925 cm-1; mass spectrum (FAB) m/z 312.1547 [(M+) requires 312.1548] 313
(base), 295.
NMR Assignments.  1H NMR (500 MHz) δ 7.36-7.33 (comp, 1 H, Haro),
7.31-7.24 (comp, 5 H, Haro), 7.20-7.12 (comp, 4 H, Haro), 5.16 (s, 0.5 H, C16-Ha
(anti)), 5.13 (s, 0.5 H, C16-Ha (syn)), 5.01 (s, 0.5 H, C1-Hb (anti)), 5.01 (s, 0.5 H,
C1-Hb(syn)), 3.93 (d, J = 4.6 Hz, 0.5 H, C3-H (anti)), 3.90 (d, J = 7.2 Hz, 0.5 H,
C3-H (syn)), 3.16-2.98 (comp, 3 H, C11-H, C5-Hb), 2.72 (dd, J = 6.6, 13.4 Hz, 1
H, C5-Ha), 2.53-2.23 (comp, 2 H, C10-H), 1.92-1.85 (comp, 1 H, C4-H), 0.83 (d,
J = 6.8 Hz, 1.5 H, C16-H (anti), 0.74 (d, J = 6.6 Hz, 1.5 H, C16-H (syn)).  Note:
The NMR assignments of syn and anti are based on the assignments of compound
2.83.  These assignments were based on the crystal structure obtained from a





















(3S, 4R)- 4-methyl-5-phenyl-2-(2-phenylsulfonyl-ethyl)- pent-1-en-3-
ol.  A solution of 2.82 (0.049 g, 0.157 mmol), (PhSe)2 (0.052 g, 0.165 mmol) and
30% H2O2 (0.106 mL) in 15% CH2Cl2/Et2O (0.820 mL) was stirred for 2 h.
Saturated NaHCO3 (5 mL) and CH2Cl2 (5 mL) were added and the organic layer
and the layers were separated.  The organic layer was then washed with 5%
NaHSO3 (5 mL) and brine (5 mL), dried (Na2SO4) and concentrated to give a
light yellow oil that was purified by flash chromatography (1 g silica) eluting with
EtOAc/Hex (30:70) to provide 0.035 g (65%) of the sulfone as a clear, colorless
oil; 1H NMR (500 MHz) δ 7.95-7.88 (comp, 2 H), 7.69-7.65 (comp, 1 H), 7.60-
7.56 (comp, 2 H), 7.28-7.25 (comp, 1 H), 7.21-7.17 (comp, 1 H), 7.14-7.09
(comp, 3 H), 5.12 (s, 0.5 H), 5.08 (s, 0.5 H), 4.90 (d, J = 0.6 Hz, 0.5 H), 4.89 (d, J
= 0.8 Hz, 0.5 H), 3.87-3.86 (comp, 1 H), 3.39-3.12 (comp, 2 H), 3.01 (dd, J = 3.6,
13.5 Hz, 0.5 H), 2.66 (dd, J = 6.6, 13.5 Hz, 0.5 H), 2.61-2.26 (comp, 3 H), 1.88-
1.80 (comp, 1 H), 0.82 (d, J = 6.6 Hz, 1.5 H), 0.69 (d, J = 6.6 Hz, 1.5 H); IR(neat)
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3511, 3063, 3025, 2926 cm-1; mass spectrum (FAB) m/z 345.1522 [(M+1)
requires 345.1524] 345 (base), 327.
NMR Assignments.  1H NMR (500 MHz) δ 7.95-7.88 (comp, 2 H, Haro),
7.69-7.65 (comp, 1 H, Haro), 7.60-7.56 (comp, 2 H, Haro), 7.28-7.25 (comp, 1 H,
Haro), 7.21-7.17 (comp, 1 H, Haro), 7.14-7.09 (comp, 3 H, Haro), 5.12 (s, 0.5 H,
C1-Ha (anti)), 5.08 (s, 0.5 H, C1-Ha (syn)), 4.90 (d, J = 0.6 Hz, 0.5 H, C1-Hb
(anti)), 4.89 (d, J = 0.8 Hz, 0.5 H, C1-Hb (syn)), 3.87-3.86 (comp, 1 H, C3-H),
3.39-3.12 (comp, 2 H, C11-H), 3.01 (dd, J = 3.6, 13.5 Hz, 0.5 H, C5-H), 2.66 (dd,
J = 6.6, 13.5 Hz, 0.5 H, C5-H), 2.61-2.26 (comp, 3 H, C10-H, C5-H), 1.88-1.80
(comp, 1 H, C4-H), 0.82 (d, J = 6.6 Hz, 1.5 H, C16-H (anti)), 0.69 (d, J = 6.6 Hz,
1.5 H, C16-H (syn)).  Note:  The NMR assignments of syn and anti are based on
the assignments of compound 2.83.  These assignments were based on the crystal




























pent-1-ene (2.83).  A solution of NaHMDS (1.0 M in THF, 0.026 mL, 0.026
mmol) and BnBr (0.007 mL, 0.061 mmol) were added to a solution of the alcohol
(0.020 mmol, 0.007 g) in THF (0.1 mL) and DMF (0.05 mL).  After stirring for 6
h, H2O (2 mL) and CH2Cl2 (5 mL) were added and the layers were separated.
The organic layer was washed with 2 mL each of saturated NaHCO3 and brine,
dried (Na2SO4), and concentrated to give a yellow oil that was purified by flash
chromatography (1 g silica) eluting with EtOAc/Hex (20:80) to provide 0.005 g
(55%) of 2.83 as a white solid.  Recrystallization (EtOAc/Hex) provided a 4.5:1
ratio of diastereomers.  After recrystallizing once more (EtOAc/Hex) a 14:1
mixture of diastereomers was obtained.  The mother liquor was found to contain a
2:1 mixture of diastereomers enriched in the other isomer; IR(neat) 2924, 1449
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cm-1; mass spectrum (FAB) m/z 435.1992 [(M+1) requires 435.1993] 435 (base),
417, 327.
The 14:1 mixture was submitted for X-ray crystallography and the results
showed the anti diastereomer.  Since this sample was not pure, it cannot be
concluded that the X-ray structure represents the major diastereomer, however,
tentatively all assignments were based on that assumption.
anti diastereomer (2.84):  1H NMR (500 MHz) δ 7.91-7.89 (comp, 2 H),
7.69-7.65 (m, 1 H),  7.59-7.55 (comp, 2 H), 7.34-7.15 (comp, 8 H), 6.99-6.97
(comp, 2 H), 5.10 (s, 1 H), 5.01 (d, J = 1.0 Hz, 1 H), 4.43 (d, J = 11.8 Hz, 1 H),
4.17 (d, J = 11.8 Hz, 1 H), 3.44 (d, J = 6.4 Hz, 1 H), 3.28 (ddd, J = 4.7, 12.0, 16.8
Hz, 1 H), 3.16 (ddd, J = 4.7, 12.1, 16.8 Hz, 1 H), 2.58 (dd, J = 5.6, 13.5 Hz, 1 H),
2.47 (ddd, J = 4.7, 12.1, 15.8 Hz, 1 H), 2.35 (ddd, J = 4.7, 12.0, 15.8 Hz, 1 H),
2.23 (dd, J = 9.0, 13.5 Hz, 1 H), 1.88-1.79 (m, 1 H), 0.85 (d, J = 6.6 Hz, 3 H).
NMR Assignments.  1H NMR (500 MHz) δ 7.91-7.89 (comp, 2 H, Haro),
7.69-7.65 (m, 1 H, Haro),  7.59-7.55 (comp, 2 H, Haro), 7.34-7.15 (comp, 8 H,
Haro), 6.99-6.97 (comp, 2 H, Haro), 5.10 (s, 1 H, C1-Ha), 5.01 (d, J = 1.0 Hz, 1
H, C1-Hb), 4.43 (d, J = 11.8 Hz, 1 H, C16-Ha), 4.17 (d, J = 11.8 Hz, 1 H, C16-
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Hb), 3.44 (d, J = 6.4 Hz, 1 H, C3-H), 3.28 (ddd, J = 4.7, 12.0, 16.8 Hz, 1 H, C11-
Ha), 3.16 (ddd, J = 4.7, 12.1, 16.8 Hz, 1 H, C11-Hb), 2.58 (dd, J = 5.6, 13.5 Hz, 1
H, C5-Ha), 2.47 (ddd, J = 4.7, 12.1, 15.8 Hz, 1 H, C10-Ha), 2.35 (ddd, J = 4.7,
12.0, 15.8 Hz, 1 H, C10-Hb), 2.23 (dd, J = 9.0, 13.5 Hz, 1 H, C5-Hb), 1.88-1.79
(m, 1 H, C4-H), 0.85 (d, J = 6.6 Hz, 3 H, C21-H).
syn diastereomer (2.85):  Note:  the peaks for the syn diastereomer were
obtained by subtracting the protons known to belong to the trans isomer whenever
possible.  1H NMR (500 MHz) δ 7.91-7.88 (comp, 4 H), 7.68-7.63 (comp, 2 H),
7.59-7.53 (comp, 4 H), 7.34-7.14 (comp, 16 H), 7.10-7.08 (comp, 2 H), 6.99-6.97
(comp, 2 H), 5.03 (s, 1 H), 5.00 (d, J = 1.0 Hz, 1 H), 4.42 (d, J = 11.8 Hz, 1 H),
4.22 (d, J = 11.8 Hz, 1 H), 3.41 (d, J = 8.8 Hz, 1 H), 3.34 (ddd, J = 4.8, 11.9, 16.9
Hz, 1 H), 3.23 (ddd, J = 5.0, 12.0, 16.9, 1 H), 2.61-2.31 (comp, 6 H), 2.18 (dd, J =
7.6, 11.3 Hz, 1 H), 2.04-1.81 (comp, 2 H), 0.60 (d, J = 6.8 Hz, 3 H).
NMR Assignments.  1H NMR (500 MHz) δ 7.91-7.88 (comp, 4 H, Haro),
7.68-7.63 (comp, 2 H, Haro), 7.59-7.53 (comp, 4 H, Haro), 7.34-7.14 (comp, 16
H, Haro), 7.10-7.08 (comp, 2 H, Haro), 6.99-6.97 (comp, 2 H, Haro), 5.03 (s, 1 H,
C21-Ha), 5.00 (d, J = 1.0 Hz, 1 H, C21-Hb), 4.42 (d, J = 11.8 Hz, 1 H, C16-Ha),
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4.22 (d, J = 11.8 Hz, 1 H, C16-Hb), 3.41 (d, J = 8.8 Hz, 1 H, C3-H), 3.34 (ddd, J
= 4.8, 11.9, 16.9 Hz, 1 H, C11-Ha), 3.23 (ddd, J = 5.0, 12.0, 16.9, 1 H, C11-Hb),
2.61-2.31 (comp, 6 H, C10-H, C5-Ha), 2.18 (dd, J = 7.6, 11.3 Hz, 1 H, C5-Hb),

























1,7-dioxaspiro[4.4]non-2,6-dione (2.88). 10% Pt/C (0.013 g, 5 mol%) was added
to a solution of 2.67 (0.100 g, 0.27 mmol) in EtOAc (5.0 mL) under an
atmosphere of H2.  After stirring for 14 h, the suspension was filtered through
celite and concentrated under reduced pressure to give 0.101 g (100%) of 2.88 as
a clear, colorless oil;  1H NMR δ 7.30 (d, J = 8.7 Hz, 1 H), 6.86 (d, 8.7 Hz, 1 H),
5.48 (s, 1H), 4.88 (t, J = 1.5 Hz, 1 H), 4.53 (dd, J = 1.5, 13.7 Hz, 1 H), 4.32 (dd, J
= 1.5, 13.7 Hz, 1 H), 3.88 (s, 3 H), 3.77 (s, 3 H), 2.87 - 2.45 (comp, 4 H); 13C
NMR δ 173.8, 170.7, 165.9, 160.5, 128.2, 127.3, 113.6, 97.9, 85.7, 80.2, 72.2,
64.9, 55.2, 53.5, 26.6, 21.1; IR (neat) 2959, 1802, 1745, 1615, 1517 cm-1; mass
spectrum (CI) m/z 379.1030 [(M+1) requires 379.1029] 379 (base).
NMR Assignments.   1H NMR δ 7.30 (d, J = 8.7 Hz, 1 H, C11-H), 6.86
(d, 8.7 Hz, 1 H, C12-H), 5.48 (s, 1H, C9-H), 4.88 (t, J = 1.5 Hz, 1 H, C6-H), 4.53
288
(dd, J = 1.5, 13.7 Hz, 1 H, C8-Ha), 4.32 (dd, J = 1.5, 13.7 Hz, 1 H, C8-Hb), 3.88
(s, 3 H, C14-H), 3.77 (s, 3 H, C16-H), 2.87 - 2.45 (comp, 4 H, C1-H and C2-H);
13C NMR δ 173.8 (C1, C5, or C15), 170.7 (C1, C5, or C15), 165.9 (C1, C5, or
C15), 160.5 (Caro), 128.2 (Caro), 127.3 (Caro), 113.6 (Caro), 97.9 (C9), 85.7
(C4), 80.2 (C7), 72.2 (C3), 64.9 (C9), 55.2 (C14), 53.5 (C16), 26.6 (C2 or C3),





























2-furoyloxy)-2-(4'-methoxybenzyloxy)butanoate (2.91).  Furoic acid 2.23a
(0.680 g, 2.27 mmol), DMAP (0.126 g, 1.03 mmol), and DCC (0.512 g, 2.48
mmol) were added sequentially to a solution of alcohol 2.90 (1.05 g, 2.06 mmol)
in CH2Cl2 (21 mL).  After stirring for 1 d, the reaction was filtered and the filtrate
was then concentrated under reduced pressure to give 2.05 g of a light tan oil that
was purified by flash chromatography (20 g silica) eluting with hexanes/EtOAc
(80:20) to afford 1.53  (94%) of 2.91 as a clear, colorless oil; 1H NMR δ  7.64 -
7.60 (comp, 4 H), 7.42 - 7.21 (comp, 13 H), 6.79 (d, J = 8.6 Hz, 2 H), 6.60 (s, 1
H), 5.46 (dt, J = 5.2, 10.1 Hz, 1 H), 4.72 (d, J = 11.5 Hz, 1 H), 4.46 (d, J = 11.5
Hz, 1 H), 4.41 (d, J = 5.2 Hz, 1 H), 3.99 - 3.92 (m, 2 H), 3.76 (s, 3 H), 3.67 (s, 3
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H), 1.00 (s, 9 H); 13C NMR δ 170.1, 159.3, 156.0, 151.2, 142.6, 135.5, 135.4,
132.9, 132.7, 131.7, 129.6, 129.5, 129.4, 128.8, 128.2, 127.5, 127.5, 121.1, 113.6,
109.6, 75.5, 74.8, 72.6, 61.2, 55.1, 52.0, 26.6, 19.0; IR (neat) 2935, 2858, 1727,
1612, 1560, 1513 cm-1; mass spectrum (CI) m/z 789.1556 [(M+1) requires
789.1553] 791, 790, 789 (base), 657, 655, 329, 327.
NMR Assignments.  1H NMR δ  7.64 - 7.60 (comp, 4 H, Haro), 7.42 -
7.21 (comp, 13 H, Haro), 6.79 (d, J = 8.6 Hz, 2 H, C8-H), 6.60 (s, 1 H, C14-H),
5.46 (dt, J = 5.2, 10.1 Hz, 1 H, C3-H), 4.72 (d, J = 11.5 Hz, 1 H, C5-Ha), 4.46 (d,
J = 11.5 Hz, 1 H, C5-Hb), 4.41 (d, J = 5.2 Hz, 1 H, C2-H), 3.99 - 3.92 (m, 2 H,
C4-H), 3.76 (s, 3 H, C18-H), 3.67 (s, 3 H, C10-H), 1.00 (s, 9 H, C17-H); 13C
NMR δ 170.1 (C1), 159.3 (C6), 156.0 (C11), 151.2 (C12), 142.6 (C15), 135.5
(Caro), 135.4 (Caro), 132.9 (Caro), 132.7 (Caro), 131.7 (Caro), 129.6 (Caro),
129.5 (Caro), 129.4 (Caro), 128.8 (Caro), 128.2 (Caro), 127.5 (Caro), 127.5
(Caro), 121.1 (C13 or C14), 113.6 (C13 or C14), 109.6 (C8), 75.5 (C5), 74.8 (C3






















2-furoyloxy)-2-hydroxybutanoate.  A solution of 2.91 (1.53 g, 1.94 mmol) and
DDQ (0.880 g, 3.87 mmol) in CH2Cl2/H2O (10:1, 28.6 mL was stirred for 1 d.
The solution was then concentrated under reduced pressure, redissolved in Et2O
(25 mL) and poured into saturated NaHCO3 (30 mL).  The organic layer was then
washed with saturated NaHCO3 (5 x 25 mL) and subsequently stirred vigorously
with a saturated NaHSO3 solution (50 mL) until there was no remaining PMB
aldehyde as monitored by TLC.  The organic layer was then dried (Na2SO4) and
concentrated under reduced pressure to give 1.22 g (94%) of the alcohol as a light
yellow oil which was used in the next reaction without further purification;  1H
NMR δ 7.65 - 7.61 (comp, 5 H), 7.37 - 7.26 (comp, 10 H), 6.55 (s, 1 H), 5.45 (dt,
J = 3.7, 5.8 Hz, 1 H), 4.58 (d, J = 3.7 Hz, 1 H), 3.93 (d, J = 5.8 Hz, 2 H), 3.69 (s,
3 H), 1.00 (s, 9 H); 13C NMR δ 172.1, 156.5, 151.6, 142.4, 135.5, 135.4, 132.5,
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130.9, 129.7, 129.4, 128.2, 127.6, 121.0, 109.9, 75.3, 70.0, 61.5, 52.7, 26.5, 19.0;
IR (neat) 3503, 3133, 3069, 2935, 2858, 1730, 1560, 1468 cm-1; mass spectrum
(CI) m/z 669.0960 [(M+1) requires 669.0978] 671, 669 (base), 593, 591, 507,
505, 329, 327.
NMR Assignments.  1H NMR δ 7.65 - 7.61 (comp, 5 H, Haro), 7.37 -
7.26 (comp, 10 H, Haro), 6.55 (s, 1 H, C8-H), 5.45 (dt, J = 3.7, 5.8 Hz, 1 H, C3-
H), 4.58 (d, J = 3.7 Hz, 1 H, C2-H), 3.93 (d, J = 5.8 Hz, 2 H, C4-H), 3.69 (s, 3 H,
C12-H), 1.00 (s, 9 H, C11-H); 13C NMR δ 172.1 (C1), 156.5 (C5), 151.6 (C6),
142.4 (C9), 135.5 (Caro), 135.4 (Caro), 132.5 (Caro), 130.9 (Caro), 129.7 (Caro),
129.4 (Caro), 128.2 (Caro), 127.6 (Caro), 121.0 (Caro), 109.9 (C8), 75.3 (C3),





















furoyloxy)-2-oxobutanoate (2.92).  Dess-Martin periodinane (1.16 g, 2.73
mmol) was added to a solution of the alcohol (1.22 g, 1.82 mmol) in CH2Cl2
(18.5 mL) at 0 ºC.  After stirring for 5 min, H2O saturated CH2Cl2 (46 mL) was
added dropwise.  After 1.5 h, the reaction mixture was concentrated under
reduced pressure, redissolved in Et2O and poured into saturated NaHCO3/10%
NaHSO3 (1:1; 50 mL).  The organic layer was washed with saturated NaHCO3,
dried (Na2SO4), and concentrated under reduced pressure to give 0.868 g (71%)
of 2.92 as a light yellow oil which was used in the next reaction without further
purificaton; 1H NMR δ 7.67 - 7.58 (comp, 5 H), 7.41 - 7.27 (comp, 10 H), 6.59 (s,
1 H), 5.98 (dd, J = 3.4, 4.6 Hz, 1 H), 4.40 (dd, J = 4.6, 11.3 Hz, 1 H), 4.09 (dd, J
= 3.4, 11.3 Hz, 1 H), 3.85 (s, 3 H), 0.97 (s, 9 H); 13C NMR δ 186.8, 159.9, 156.1,
152.1, 141.9, 135.5, 135.3, 132.4, 132.0, 131.0, 129.8, 129.5, 128.4, 127.7, 121.1,
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110.9, 77.2, 62.9, 53.0, 26.4, 19.1; IR (neat) 3134, 3068, 2935, 2858, 1731, 1561
cm-1; mass spectrum (CI) m/z 667.0816 [(M+1) requires 667.0821] 669, 667
(base), 507, 505, 382, 380, 329, 327.
NMR Assignments.  1H NMR δ 7.67 - 7.58 (comp, 5 H, Haro), 7.41 -
7.27 (comp, 10 H, Haro), 6.59 (s, 1 H, C8-H), 5.98 (dd, J = 3.4, 4.6 Hz, 1 H, C3-
H), 4.40 (dd, J = 4.6, 11.3 Hz, 1 H, C4-Ha), 4.09 (dd, J = 3.4, 11.3 Hz, 1 H, C4-
Hb), 3.85 (s, 3 H, C12-H), 0.97 (s, 9 H, C11-H); 13C NMR δ 186.8 (C2), 159.9
(C5), 156.1 (C6), 152.1 (C9), 141.9 (Caro), 135.5 (Caro), 135.3 (Caro), 132.4
(Caro), 132.0 (Caro), 131.0 (Caro), 129.8 (Caro), 129.5 (Caro), 128.4 (Caro),

















(3-Benzyloxy-2-bromo-5-methylphenyl)methanol (3.100).  A solution
of n-BuLi in hexanes (1.61 M, 0.758 mL, 1.22 mmol) was added to a solution of
3.97 (0.114 g, 0.500 mmol) in toluene (1.6 mL) at –10 ºC, and the reaction was
then warmed to –5 ºC.  After 6 h, dibromotetrafluoroethane (0.122 mL, 1.02
mmol) was added, and the reaction was allowed to warm to rt.  After stirring for
10 h, saturated NH4Cl was added, and the aqueous layer was extracted with Et2O
(3 x 5 mL) and the combined organic layers were dried (MgSO4) and
concentrated under reduced pressure.  The residual oil was purified by flash
chromatography (4 g silica) eluting with EtOAc/hexanes (15:85) to afford 3.100
as a white crystalline solid: m.p; 96 – 98 ºC; 1H NMR δ 7.48 – 7.22 (comp, 5 H),
6.90 (s, 1 H), 6.70 (s, 1 H), 5.10 (s, 2 H), 4.70 (s, 2 H), 2.28 (s, 3 H), 2.00 (s, 1 H);
13C NMR δ 154.8, 140.9, 138.3, 136.6, 128.5, 127.9, 126.9, 122.0, 113.8, 109.3,
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70.9, 65.3, 21.4; IR (neat) 2914, 2867, 1588, 1454 cm-1; mass spectrum (CI) m/z
306.0262 [(M+) requires 306.0255] 309 307, 291 (base), 289, 279, 277, 211, 209.
NMR Assignments: 1H NMR δ 7.48 – 7.22 (comp, 5 H, Haro), 6.90 (s, 1
H, C6-H), 6.70 (s, 1 H, C4-H), 5.10 (s, 2 H, C9-H), 4.70 (s, 2 H, C7-H), 2.28 (s, 3
H, C13-H), 2.00 (s, 1 H, OH); 13C NMR δ 154.8 (Caro), 140.9 (Caro), 138.3
(Caro), 136.6 (Caro), 128.5 (Caro), 127.9 (Caro), 126.9 (Caro), 122.0 (Caro),



































7-Benzyloxy-5-methyl-1,3-dihydro-isobenzofuran-1-ol (3.98) and 2-
benxyloxy-6-hydroxymethyl-4-methylbenzaldehyde (3.102).  A solution of n-
BuLi in hexanes (1.07M, 4.33 mL, 4.63 mmol) was added slowly to a solution of
3.97 (0.423 g, 1.85 mmol) at –10 ºC to give a viscous yellow solution.  The
reaction was warmed to –5 ºC and stirred for 4 h.  The reaction was then cooled to
–78 ºC and DMF (0.716 g, 9.25 mmol).  After 15 min, the cold bath was removed
and brine (10 mL) was added.  After warming to rt, the aqueous layer was
extracted with CH2Cl2 (2 x 15 mL) and dried (MgSO4) and the combined organic
layers were concentrated under reduced pressure to give a yellow oil that was
filtered through a plug of silica eluting with EtOAc/Hex (20:80) to give 0.456 g
(96%) of a white solid as a mixture (4:1) of 3.98 and 3.102.  Recrystallization
from EtOAc/Hex gave 0.287 g (60%) of a mixture (12:1) of 3.98 and 3.102 as a
white crystalline solid: m.p. 100 – 102 ºC.
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3.98: 1H NMR δ 7.32 – 7.31 (comp, 2 H), 7.18 – 7.06 (comp, 3 H), 6.65
(dd, J = 2.1, 7.0 Hz, 1 H), 6.39 (s, 1 H), 6.24 (s, 1 H), 5.05 (dd, J = 2.1, 12.7 Hz, 1
H), 4.76 (s, 2 H), 4.72 (d, J = 12.7 Hz, 1 H), 2.67 (d, J = 7.0 Hz), 2.08 (s, 3 H);
13C NMR δ 154.7, 142.9, 141.0, 137.6, 126.0, 114.1, 112.3, 100.7, 71.9, 69.9,
21.6; IR (neat) 3386, 2921, 2866, 1602, 1497, 1453 cm-1; mass spectrum (CI) m/z
257.1185 [(M+1) requires 257.1178] 257, 239 (base), 229, 211, 149, 125, 113.
NMR Assignments for 3.98: 1H NMR δ 7.32 – 7.31 (comp, 2 H, Haro),
7.18 – 7.06 (comp, 3 H, Haro), 6.65 (dd, J = 2.1, 7.0 Hz, 1 H, C1-H), 6.39 (s, 1 H,
C4-H), 6.24 (s, 1 H, C6-H), 5.05 (dd, J = 2.1, 12.7 Hz, 1 H, C2-Ha), 4.76 (s, 2 H,
C9-H), 4.72 (d, J = 12.7 Hz, 1 H, C2-Hb), 2.67 (d, J = 7.0 Hz, OH), 2.08 (s, 3 H,
C14-H); 13C NMR δ 154.7 (Caro), 142.9 (Caro), 141.0 (Caro), 137.6 (Caro),
126.0 (Caro), 114.1 (C6), 112.3 (C4), 100.7 (C1), 71.9 (C2), 69.9 (C9), 21.6
(C14).
3.102: 1H NMR δ 10.68 (d, J = 0.6 Hz, 1 H), 7.32 – 7.31 (comp, 2 H),
7.18 – 7.06 (comp, 3 H), 6.62 (d, J = 0.6 Hz, 1 H), 6.3 (s, 1 H), 4.78, (d, J = 7.4
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Hz, 2 H), 4.50 (s, 2 H), 3.88 (t, J = 7.4 Hz, 1 H), 1.91 (s, 3 H); 13C NMR δ 192.0,
163.1, 146.7, 145.4, 136.5, 123.3, 112.8, 70.6, 64.8, 21.9.
NMR Assignments for 3.102: 1H NMR δ 10.68 (d, J = 0.6 Hz, 1 H, C1-
H), 7.32 – 7.31 (comp, 2 H, Haro), 7.18 – 7.06 (comp, 3 H, Haro), 6.62 (d, J = 0.6
Hz, 1 H, C4-H), 6.3 (s, 1 H, C6-H), 4.78, (d, J = 7.4 Hz, 2 H, C2-H), 4.50 (s, 2 H,
C9-H), 3.88 (t, J = 7.4 Hz, 1 H, OH), 1.91 (s, 3 H, C14-H); 13C NMR δ 192.0
(C1), 163.1 (Caro), 146.7 (Caro), 145.4 (Caro), 136.5 (Caro), 123.3 (C4), 112.8












(3-t-Butoxy-5-methylphenyl) methanol (3.105).  CaCO3 (4.00 g, 40.0
mmol) was added to a solution of the bromide (2.05 g, 8.00 mmol) in dioxane (16
mL) and H2O (16 mL).  After heating at reflux for 24 h, the reaction mixture was
concentrated under reduced pressure and acidified with 3 M HCl (1 mL).  The
aqueous layer was extracted with CH2Cl2 (2 x 20 mL) and dried (MgSO4) and the
combined organic layers were concentrated under reduced pressure.  The residual
yellow oil was purified by flash chromatography (10 g silica) eluting with
EtOAc/hexanes (10:90) to afford 0.724 (48%) of 3.105 as a yellow oil; 1H NMR
δ 6.86 (s, 1 H), 6.74 (s, 1 H), 6.70 (s, 1 H), 4.56 (d, J = 3.5 Hz, 2 H), 2.27 (s, 3 H),
1.92 (br s, 1 H), 1.30, (s, 9 H); 13C NMR δ 155.4, 141.4, 138.8, 123.8, 122.5,
119,4, 78.2, 65.1, 28.8, 21.2; IR (neat) 3390, 2978, 2932, 2872, 1596 cm-1; mass
spectrum (CI) m/z 194.1300 [(M+) requires 194.1307] 195, 194, 193, 179, 178,
177 (base), 140, 139, 138, 137, 121.
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NMR Assignments: 1H NMR δ 6.86 (s, 1 H, C2-H), 6.74 (s, 1 H, C6-H),
6.70 (s, 1 H, C4-H), 4.56 (d, J = 3.5 Hz, 2 H, C7-H), 2.27 (s, 3 H, C10-H), 1.92
(br s, 1 H, OH), 1.30, (s, 9 H, C9-H); 13C NMR δ 155.4 (C3), 141.4 (C5), 138.8



















Method A.  CaCl2 (0.05 g, 0.45 mmol) and p-TsOH (0.006 g, 0.03 mmol) were
added to a solution of lactol 3.98 (0.046 g, 0.180 mmol) and juglone 3.81 (0.075
g, 0.150 mmol) in Et2O (8.4 mL) at 0 ºC and the mixture was allowed to stand in
the refrigerator at 4 ºC for 12 h.  The mixture was filtered and the filtrate was
concentrated under reduced pressure.  The residual dark oil was purified by flash
chromatography (5 g silica) eluting with Et2O/CH2Cl2 (0:100 →5:95) to afford
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0.062 g of 3.107 and 3.108 as a yellow oil that was used without further
purification.
NaH (0.009 g, 0.217 mmol) was added to a solution of 3.107 and 3.108
(0.032 g, 0.043 mmol) in THF (2.40 mL) at 0 ºC.  After stirring for 10 min, NCS
(0.011 g, 0.086 mmol) was added to the reaction.  After 20 min the cold bath was
removed, and the reaction was allowed to warm to rt.  The mixture was stirred at
rt for 4 h, whereupon saturated NaHCO3 (5 mL) was added and the aqueous layer
was extracted with CH2Cl2 (2 x 5 mL) and the combined organic layers were
dried (MgSO4) and concentrated under reduced pressure.  The residual dark
yellow oil was purified by flash chromatography to afford 0.015 g (47%) of 3.109
and 3.110 as a yellow oil that was used directly in the next step.
A solution of TMSOTf (0.020 mL, 0.110 mmol) in CH2Cl2 (0.5 mL) was
added via cannula to a solution of 3.109 and 3.110 (0.016 g, 0.022 mmol) in
CH2Cl2 (1.5 mL) at –78 ºC.  After 20 min, the cold bath was removed and the
reaction was allowed to warm to rt.  The mixtue was stirred at rt for 1 h, and brine
(2 mL) was added and stirring was continued for 10 min.  The aqueous layer was
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extracted with CH2Cl2 (3 x 5 mL) and the combined organic layers were dried
(MgSO4) and concentrated under reduced pressure.  The residual red oil was
purified by flash chromatography (1 g silica) eluting with EtOAc/hexanes (30:70)
to afford 0.009 g (56%) of a mixture of 3.118, 3.119, 3.120 and 3.121 as a red
amorphous solid.  HPLC separation using two silica gel columns in sequence was
performed eluting with EtOAc/Hex (5:95) to afford a mixture of 3.118 and 3.119.
Method B.  CaCl2 (0.021 g, 0.19 mmol) and p-TsOH (0.001 g, 0.006
mmol) were added to a solution of lactol 3.98 (0.020 g, 0.077 mmol) and
bromojuglone 3.120 (0.037 g, 0.064 mmol) in THF (1.7 mL) at 0 ºC, and the
mixture was allowed to stand in the refrigerator at 4 ºC for 12 h.  Saturated
NaHCO3 (5 mL) was then added to the reaction and the aqueous layer was
extracted with Et2O (3 x 5 mL) and the combined organic layers were dried
(MgSO4) and concentrated under reduced pressure.  The residual yellow oil was
purified by flash chromatography (5 g silica) eluting with EtOAc/Hex (15/85) to
afford 0.011 g of 3.109 and 3.110 as a yellow oil that was used without further
purification.
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A solution of TMSOTf (0.014 mL, 0.075 mmol) in CH2Cl2 (0.4 mL) was
added via cannula to a solution of 3.109 and 3.110 (0.011 g, 0.015 mmol) in
CH2Cl2 (1.3 mL) at –78 ºC.  After 10 min, the cold bath was removed and the
reaction was allowed to warm to rt.  The mixture was stirred at rt for 1h,
whereupon brine (5 mL) was added and the aqueous layer was extracted with
CH2Cl2 (3 x 5 mL) and the combined organic layers were dried (MgSO4) and
concentrated under reduced pressure.  The residual dark red oil was purified by
flash chromatography (2 g silica) eluting with EtOAc/Hex (15:85) to afford 0.004
g (36%) of a mixture of 3.118 and 3.119 as a red, amorphous solid.  Further
purification was accomplished using HPLC with a Chiralpak AD column eluting
with i-PrOH/Hex (1:9) to afford 0.001 g of 3.118 as a red amorphous solid where
the spectral data was identical to that reported by Suzuki, with the exception of
the t at 3.24 ppm that was identified as a dd by Suzuki; 1H NMR (500 MHz) δ
14.35 (s, 1 H), 8.73 (s, 1 H), 8.24 (d, J = 8.2 Hz), 7.96 (d, J = 8.2 Hz), 7.88 (s, 1
H), 7.52 – 7.55 (m, 2 H), 7.25 – 7.47 (m, 13 H), 6.97 (s, 1 H), 5.29 (s, 2 H), 5.02
(d, J = 11.0 Hz, 1 H), 4.85 (dd, J = 1.8, 11.7 Hz, 1 H), 4.73 (d, J = 11.0 Hz, 1 H),
4.72 (d, J = 11.7 Hz, 1 H), 4.64 (d, J = 11.7 Hz, 1 H), 3.93 (s, 3 H), 3.86 (ddd, J =
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5.1, 9.0, 11.3 Hz, 1 H), 3.59 (dq, J = 6.1, 9.4 Hz, 1 H), 3.24 (t, 9.0 Hz, 1 H), 2.57
(ddd, J = 1.8, 5.0, 12.8 Hz, 1 H), 2.54 (s, 3 H), 1.55 (m, 1 H), 1.41 (d, J = 6.1 Hz,
3 H); 13C NMR (125 MHz) δ 187.5, 181.8, 162.4, 157.7, 156.2, 143.9, 140.1,
138.7, 138.5, 136.3, 135.3, 132.2, 128.8, 128.6, 128.4, 128.4, 128.2, 128.0, 127.7,
127.7, 127.6, 126.8, 126.6, 123.5, 116.3, 116.1, 113.0, 109.7, 83.9, 80.9, 75.9,









naphthoquinone (3.120).  A solution of Br2 (0.009 mL, 0.179 mmol) in CHCl3
(3.4 mL) was added slowly to a solution of juglone 3.81 (0.081 g, 0.162 mmol) in
CHCl3 (1.7 mL) at 0 ºC.  After stirring for 20 min, the reaction mixture was
concentrated, and 10% aqueous AcOH (0.1 mL) was added.  The resulting
solution was concentrated, and EtOH (5 mL) added, and the solution was then
heated at reflux for 30 min.  The reaction was cooled to rt, and H2O (5 mL) and
CH2Cl2 (5 mL) were added.  The aqueous layer was extracted with CH2Cl2 (3 x 5
mL), and the combined organic layers were dried (MgSO4) and concentrated
under reduced pressure.  The residual yellow oil was purified by flash
chromatography (6 g silica) eluting with EtOAc/Hex (15:85) to afford 0.057 g
(61%) of 3.120 as a yellow oil; 1H NMR (500 MHz) δ 8.01 (d, J = 7.9 Hz, 1 H),
7.91 (dd, J = 0.6, 7.9 Hz, 1 H), 7.40 (s, 1 H), 7.27 – 7.35 (m, 9 H), 5.0 (d, J = 11.4
Hz, 1 H), 4.79 (dd, J = 1.8, 11.2 Hz, 1 H), 4.71 (d, J = 9.8 Hz, 1 H), 4.70 (d, J =
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9.8 Hz), 4.62 (d, J = 11.4 Hz, 1 H), 3.86 (s, 3 H), 3.82 (ddd, J = 5.1, 9.0, 11.4 Hz,
1 H), 3.56 (dq, J = 6.0, 9.4 Hz, 1 H), 3.21 (t, J = 8.8 Hz, 1 H), 2.50 (ddd, J = 1.8,
4.8, 12.6 Hz, 1 H), 1.50 (m, 1 H), 1.39 (d, J = 6.0 Hz, 3 H); 13C (125 MHz)
δ 181.5, 177.7, 157.0, 144.4, 141.8, 138.5, 138, 3, 138.0, 132.5, 132.0, 128.4,
128.4, 128.0, 127.7, 127.7, 127.6, 124.7, 123.2, 83.7, 80.7, 75.9, 75.3, 71.5, 71.4,
62.4, 41.1, 41.0, 38.1, 18.6, 15.2; mass spectrum (CI) m/z 578.1296 [(M+1)
requires 578.1304] 579, 578, 577 (base), 487, 485, 399, 397, 379.
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APPENDIX. X-RAY CRYSTALLOGRAPHY DATA
Table A1.  Crystal data and structure refinement for 2.67.





Space groupP1 (No. 1)
Unit cell dimensions a = 9.759(2) Å   alpha = 108.39(2)°.
b = 10.026(3) Å   beta = 97.06(2)°.
c = 10.776(2) Å   gamma = 113.17(2)°.
Volume, Z 882.2(4) A^3,  2
Density (calculated) 1.417 Mg/m^3
Absorption coefficient 0.116 mm^-1
F(000) 392
Crystal size 0.80 x 0.60 x 0.34 mm
Theta range for data collection 2.08 to 26.21 deg.
Limiting indices -1<=h<=11, -11<=k<=10, -13<=l<=13
Reflections collected 3967
Independent reflections 3967 [R(int) = 0.0000]
Refinement method Full-matrix least-squares on F^2
Data / restraints / parameters 3966 / 3 / 488
Goodness-of-fit on F^2 1.026
Final R indices [I>2sigma(I)] R1 = 0.0379, wR2 = 0.0953
R indices (all data) R1 = 0.0428, wR2 = 0.0994
Absolute structure parameter 0.5(9)
Extinction coefficient 6.8(4)x10-5
Largest diff. peak and hole 0.295 and -0.272 e.A^-3
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Table A2.  Atomic coordinates ( x 10^4) and equivalent isotropic
displacement parameters (A^2 x 10^3) for 2.67.  U(eq) is defined as one third of
the trace of the orthogonalized Uij tensor.
x y z U(eq)
O1 1904(2) 4886(2) 6144(2) 36(1)
C2 2884(4) 4524(3) 6960(3) 41(1)
O3 3842(3) 4081(2) 6230(2) 44(1)
C4 4886(4) 5363(4) 5986(3) 46(1)
C5 4023(4) 5919(4) 5184(3) 41(1)
O6 3195(3) 4688(3) 3812(2) 49(1)
C7 1770(5) 4552(4) 3380(3) 49(1)
C8 1544(4) 5791(3) 4479(3) 38(1)
O9 1968(3) 7143(3) 4136(2) 44(1)
C10 702(4) 7428(4) 3958(3) 44(1)
C11 -563(4) 6255(4) 4207(3) 43(1)
C12 -90(4) 5316(3) 4520(3) 40(1)
C13 2730(4) 6132(3) 5747(3) 37(1)
C14 1824(4) 3202(3) 7257(3) 40(1)
C15 1045(5) 1672(4) 6276(3) 50(1)
C16 26(5) 467(4) 6543(3) 53(1)
C17 -248(4) 769(4) 7811(3) 45(1)
C18 508(4) 2282(4) 8799(3) 48(1)
C19 1534(4) 3480(4) 8509(3) 45(1)
O20 -1263(4) -526(3) 7975(2) 60(1)
C21 -1663(6) -257(5) 9219(4) 65(1)
O22 881(4) 3603(4) 2303(2) 75(1)
O23 777(3) 8482(3) 3634(3) 58(1)
C24 3345(4) 7764(3) 6892(3) 39(1)
O25 4683(3) 8676(3) 7357(3) 70(1)
O26 2214(3) 8016(2) 7284(2) 48(1)
C27 2679(5) 9535(4) 8382(3) 55(1)
O1' 5911(2) 1731(2) 2249(2) 36(1)
C2' 5231(4) 2728(3) 2139(3) 38(1)
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O3' 3627(3) 1843(3) 1524(2) 46(1)
C4' 2884(4) 1068(4) 2331(4) 51(1)
C5' 3519(4) -15(4) 2532(3) 45(1)
O6' 3133(3) -1281(2) 1205(2) 54(1)
C7' 4335(5) -1566(4) 1055(3) 54(1)
C8' 5658(4) -581(4) 2384(3) 41(1)
O9' 5404(2) -1559(2) 3144(2) 42(1)
C10' 6677(4) -1816(4) 3379(3) 45(1)
C11' 7823(4) -906(5) 2830(4) 55(1)
C12' 7254(4) -190(4) 2264(3) 48(1)
C13' 5297(3) 802(3) 2993(3) 36(1)
C14' 5968(4) 3557(3) 1278(3) 38(1)
C15' 5271(4) 4302(4) 748(3) 52(1)
C16' 5934(5) 5113(5) -21(4) 58(1)
C17' 7304(4) 5181(4) -281(3) 48(1)
C18' 8012(4) 4447(4) 237(3) 49(1)
C19' 7333(4) 3646(4) 1013(3) 44(1)
O20' 7839(4) 5985(3) -1071(3) 66(1)
C21' 9240(6) 6106(6) -1384(5) 79(1)
O22' 4328(5) -2487(3) 32(3) 85(1)
O23' 6706(3) -2648(3) 3959(2) 54(1)
C24' 6008(4) 1759(4) 4532(3) 42(1)
O25' 7067(4) 3019(4) 5015(3) 102(1)
O26' 5225(4) 1089(3) 5224(3) 81(1)
C27' 5831(8) 1904(5) 6691(4) 96(2)
312



































































































































































































































































Table A4.   Anisotropic displacement parameters (A^2 x 10^3) for 2.67.
The anisotropic displacement factor exponent takes the form:
 -2 pi^2 [ h^2 a*^2 U11 + ... + 2 h k a* b* U12 ]
U11 U22 U33 U23 U13 U12
O1 39(1) 34(1) 37(1) 16(1) 14(1) 18(1)
C2 44(2) 40(2) 34(1) 10(1) 6(1) 21(1)
O3 46(1) 43(1) 48(1) 16(1) 14(1) 26(1)
C4 37(2) 44(2) 52(2) 12(1) 14(1) 18(2)
C5 43(2) 38(1) 45(2) 14(1) 20(1) 20(1)
O6 57(1) 58(1) 39(1) 13(1) 20(1) 36(1)
C7 62(2) 56(2) 39(2) 18(1) 16(2) 36(2)
C8 43(2) 37(1) 37(1) 15(1) 14(1) 20(1)
O9 45(1) 51(1) 54(1) 32(1) 25(1) 28(1)
C10 47(2) 48(2) 46(2) 22(1) 19(1) 27(2)
C11 36(2) 45(2) 44(2) 17(1) 12(1) 16(1)
C12 38(2) 35(1) 39(1) 12(1) 10(1) 12(1)
C13 39(2) 33(1) 39(1) 14(1) 15(1) 16(1)
C14 47(2) 38(1) 34(1) 12(1) 6(1) 22(1)
C15 69(2) 43(2) 32(1) 14(1) 14(2) 22(2)
C16 71(2) 38(2) 40(2) 10(1) 15(2) 19(2)
C17 57(2) 42(2) 42(2) 19(1) 14(1) 26(2)
C18 61(2) 50(2) 35(1) 15(1) 17(1) 29(2)
C19 54(2) 37(1) 37(1) 8(1) 10(1) 21(2)
O20 78(2) 49(1) 54(1) 24(1) 31(1) 24(1)
C21 78(3) 59(2) 58(2) 27(2) 31(2) 26(2)
O22 90(2) 92(2) 36(1) 0(1) 1(1) 60(2)
O23 54(2) 61(1) 85(2) 45(1) 32(1) 35(1)
C24 48(2) 32(1) 40(1) 13(1) 16(1) 21(1)
O25 44(2) 41(1) 91(2) -1(1) 17(1) 10(1)
O26 47(1) 44(1) 45(1) 4(1) 14(1) 24(1)
C27 66(2) 45(2) 49(2) 6(1) 19(2) 31(2)
O1' 38(1) 41(1) 35(1) 16(1) 13(1) 21(1)
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C2' 40(2) 37(1) 35(1) 6(1) 8(1) 22(1)
O3' 37(1) 47(1) 50(1) 13(1) 8(1) 22(1)
C4' 36(2) 48(2) 64(2) 17(2) 13(2) 20(2)
C5' 34(2) 42(2) 48(2) 13(1) 9(1) 13(1)
O6' 47(1) 36(1) 56(1) 3(1) -7(1) 15(1)
C7' 66(2) 42(2) 48(2) 11(1) 0(2) 30(2)
C8' 42(2) 44(2) 40(2) 18(1) 12(1) 22(2)
O9' 38(1) 44(1) 50(1) 24(1) 15(1) 20(1)
C10' 43(2) 53(2) 44(2) 21(1) 14(1) 24(2)
C11' 48(2) 75(2) 64(2) 41(2) 27(2) 35(2)
C12' 55(2) 61(2) 50(2) 33(2) 30(2) 35(2)
C13' 31(2) 38(1) 36(1) 13(1) 8(1) 13(1)
C14' 44(2) 35(1) 30(1) 6(1) 6(1) 21(1)
C15' 56(2) 59(2) 56(2) 24(2) 16(2) 39(2)
C16' 71(2) 61(2) 60(2) 32(2) 17(2) 43(2)
C17' 63(2) 39(2) 38(2) 16(1) 7(2) 22(2)
C18' 48(2) 54(2) 50(2) 24(2) 15(2) 26(2)
C19' 50(2) 45(2) 42(2) 22(1) 10(1) 27(2)
O20' 76(2) 62(2) 67(2) 41(1) 19(1) 28(2)
C21' 64(3) 82(3) 87(3) 54(3) 19(2) 14(2)
O22' 121(3) 71(2) 49(1) -9(1) -10(2) 67(2)
O23' 55(2) 69(2) 61(1) 43(1) 24(1) 36(1)
C24' 41(2) 40(2) 38(1) 16(1) 13(1) 12(2)
O25' 77(2) 98(2) 40(1) 17(1) 4(1) -33(2)
O26' 100(2) 54(1) 44(1) 13(1) 27(2) -3(2)
C27' 151(5) 68(2) 41(2) 20(2) 37(3) 22(3)
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Table A5.   Hydrogen coordinates ( x 10^4) and isotropic displacement
parameters (A^2 x 10^3) for 2.67.
x y z U(eq)
H2 3512(4) 5428(3) 7796(3) 49
H4A 5531(4) 5039(4) 5490(3) 56
H4B 5548(4) 6220(4) 6841(3) 56
H5 4730(4) 6880(4) 5140(3) 50
H11 -1587(4) 6168(4) 4141(3) 51
H12 -706(4) 4452(3) 4739(3) 48
H15 1226(5) 1444(4) 5395(3) 60
H16 -508(5) -590(4) 5851(3) 64
H18 332(4) 2508(4) 9683(3) 57
H19 2059(4) 4536(4) 9202(3) 54
H21A -2379(6) -1242(5) 9219(4) 97
H21B -738(6) 225(5) 9960(4) 97
H21C -2134(6) 436(5) 9325(4) 97
H27A 1775(5) 9605(4) 8591(3) 82
H27B 3345(5) 9638(4) 9177(3) 82
H27C 3228(5) 10368(4) 8102(3) 82
H2' 5429(4) 3495(3) 3030(3) 46
H4'A 1787(4) 467(4) 1889(4) 61
H4'B 3038(4) 1846(4) 3201(4) 61
H5' 3102(4) -442(4) 3160(3) 54
H11' 8835(4) -849(5) 2882(4) 66
H12' 7787(4) 472(4) 1825(3) 58
H15' 4310(4) 4249(4) 913(3) 62
H16' 5435(5) 5624(5) -379(4) 69
H18' 8970(4) 4495(4) 68(3) 58
H19' 7830(4) 3133(4) 1369(3) 52
H21D 9474(6) 6698(6) -1943(5) 119
H21E 10069(6) 6636(6) -553(5) 119
H21F 9127(6) 5066(6) -1864(5) 119
H27D 5175(8) 1304(5) 7115(4) 144
319
H27E 6863(8) 2030(5) 6970(4) 144
H27F 5860(8) 2926(5) 6961(4) 144
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Figure A1.  View of molecule 1 of 2.67 showing the atom labeling
scheme.  Thermal ellipsoids are scaled to the 50% probability level.  Most
hydrogen atoms have been omitted for clarity.
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Figure A2.  View of molecule 2 of 2.67 showing the atom labeling scheme.
Thermal ellipsoids are scaled to the 50% probability level.  Most hydrogen atoms
have been omitted for clarity.
322
Figure A3.  Fit by least squares of selected atoms from molecule 1
(dashed lines) to the equivalent atoms of molecule 2 (solid lines) of 2.67
illustrating the conformational differences between the two crystallographically
independent molecules.  The atoms of molecule 2 used in the fit are labeled.
323
Figure A4.  Unit cell packing diagram for 2.67.  The view direction is
approximately down the a axis.  Molecules 2 are shown in wireframe form.  There
are many close C-H…O contacts.  A complete listing of these contacts is found in
Table 6.
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Table A6.  Crystal data and structure refinement for 2.71.






Unit cell dimensions a = 8.744(3)    alpha = 90_.
b = 16.503(4)     beta = 90_.
c = 17.372(4)    gamma = 90_.
Volume, Z 2506.8(12) A^3,  4
Density (calculated) 1.36 Mg/m^3
Absorption coefficient 0.15 mm^-1
F(000 1080
Crystal size .17 x .28 x .64 mm
Theta range for data
collection
2.3 to 27.5 deg.
Limiting indices -11<=h<=11, 0<=k<=21,
0<=l<=22
Reflections collected 6125
Independent reflections 5755 [R(int) = 0.040]
Refinement method Full-matrix least-squares on F^2
Data / restraints / parameters 5754 / 0 / 326
Goodness-of-fit on F^2 1.074
Final R indices [I>2sigma(I)] R1 = 0.070, wR2 = 0.110
R indices (all data) R1 = 0.138, wR2 = 0.132
Absolute structure parameter -0.2(2)
Extinction coefficient 4.5(6)x10-6
Largest diff. peak and hole 0.27 and -0.22 e.A^-3
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Table A7.  Atomic coordinates ( x 10^4) and equivalent isotropic
displacement parameters (A^2 x 10^3) for 2.71.  U(eq) is defined as one third of
the trace of the orthogonalized Uij tensor.
x y z U(eq)
O1 7837(3) 1899(2) 9350(2) 43(1)
C2 7210(6) 1185(3) 9136(2) 42(1)
C3 8455(5) 545(3) 9053(2) 34(1)
C4 9904(5) 1055(3) 9002(2) 33(1)
O5 10069(3) 1252(2) 8214(2) 32(1)
C6 11048(5) 1932(3) 8091(2) 35(1)
O7 10366(4) 2627(2) 8392(2) 41(1)
C8 10282(6) 2565(3) 9211(3) 47(1)
C9 9489(5) 1819(3) 9473(3) 40(1)
O10 5859(4) 1105(2) 9068(2) 61(1)
O11 8459(3) 134(2) 9785(2) 43(1)
C12 7831(7) -623(3) 9702(3) 55(2)
C13 7360(7) -745(3) 8881(2) 58(2)
C14 8207(5) -109(3) 8439(2) 42(1)
O15 7715(6) -1049(2) 10245(2) 83(1)
Si16 7530(1) 120(1) 7418(1) 29(1)
C17 6854(5) 1166(2) 7256(2) 36(1)
C18 9155(5) -116(3) 6768(3) 45(1)
C19 5896(5) -599(2) 7228(2) 30(1)
C20 4449(4) -449(2) 7521(3) 36(1)
C21 3241(5) -966(3) 7401(3) 44(1)
C22 3454(6) -1655(3) 6976(3) 44(1)
C23 4875(6) -1833(3) 6684(3) 47(1)
C24 6096(5) -1310(3) 6808(2) 39(1)
C25 11321(6) 579(3) 9274(3) 40(1)
O26 11905(4) 73(2) 8896(2) 67(1)
O27 11765(3) 809(2) 9964(2) 48(1)
C28 13028(5) 343(3) 10284(3) 60(2)
C29 11327(5) 1995(3) 7247(2) 34(1)
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C30 12603(6) 1636(3) 6951(3) 48(1)
C31 12863(5) 1601(3) 6172(3) 49(1)
C32 11819(6) 1931(3) 5677(3) 44(1)
C33 10530(6) 2322(3) 5957(3) 45(1)
C34 10299(5) 2349(3) 6747(3) 42(1)
O35 12146(4) 1841(2) 4912(2) 62(1)
C36 11032(7) 2104(4) 4374(3) 73(2)
327




































































































































































































Table A9.   Anisotropic displacement parameters (A^2 x 10^3) for 2.71.
The anisotropic displacement factor exponent takes the form:
-2 pi^2 [ h^2 a*^2 U11 + ... + 2 h k a* b* U12 ]
U11 U22 U33 U23 U13 U12
O1 43(2) 43(2) 42(2) -1(2) 3(2) 10(2)
C2 49(3) 48(3) 30(2) 10(2) 1(2) 1(3)
C3 43(3) 37(2) 24(2) 9(2) 1(2) 2(2)
C4 36(3) 35(2) 28(2) -1(2) -2(2) 1(2)
O5 43(2) 31(2) 22(2) 0(1) 1(1) -7(2)
C6 27(2) 38(3) 39(3) 0(2) -5(2) -6(2)
O7 48(2) 32(2) 42(2) -5(2) 0(2) -5(2)
C8 63(4) 40(3) 39(3) -9(2) 0(3) -3(3)
C9 45(3) 44(3) 30(3) -5(2) -4(2) 3(2)
O10 35(2) 82(3) 65(2) 19(2) 6(2) 2(2)
O11 56(2) 46(2) 26(2) 9(2) -1(1) -3(2)
C12 91(4) 36(3) 37(3) 7(2) 8(3) 9(3)
C13 98(4) 39(3) 38(3) 4(2) 4(3) -3(3)
C14 54(3) 35(2) 37(2) 4(2) -5(2) -3(2)
O15 159(4) 55(2) 36(2) 19(2) 9(3) -4(3)
Si16 27(1) 31(1) 29(1) 0(1) 1(1) 1(1)
C17 34(2) 36(2) 37(3) 5(2) -4(2) -2(2)
C18 35(3) 54(3) 47(3) -6(3) 12(2) 2(2)
C19 32(2) 30(2) 28(2) 5(2) -5(2) -3(2)
C20 33(2) 32(2) 43(3) -4(2) -2(2) 3(2)
C21 29(2) 50(3) 53(3) 3(3) -1(2) -6(2)
C22 45(3) 43(3) 43(3) 5(2) -8(2) -16(2)
C23 63(4) 35(3) 42(3) -5(2) -1(3) -6(3)
C24 39(3) 40(3) 37(3) -2(2) 2(2) 3(2)
C25 43(3) 45(3) 31(3) -2(2) 1(2) -2(2)
O26 70(3) 75(3) 55(2) -17(2) -12(2) 33(2)
O27 48(2) 58(2) 39(2) -4(2) -17(2) 9(2)
C28 46(3) 79(4) 54(3) 19(3) -17(3) 1(3)
C29 36(3) 32(2) 34(3) -1(2) 1(2) -5(2)
331
C30 37(3) 62(3) 46(3) 4(2) -3(3) 3(3)
C31 41(3) 59(3) 48(3) -1(3) 10(2) 3(2)
C32 53(3) 41(3) 37(3) 3(2) 4(2) -12(3)
C33 47(3) 49(3) 40(3) 11(2) -4(2) -6(3)
C34 33(3) 49(3) 44(3) 7(2) 5(2) -3(2)
O35 84(3) 64(2) 38(2) -1(2) 15(2) -4(2)
C36 101(5) 80(4) 37(3) 1(3) -6(3) -21(4)
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Table A10.   Hydrogen coordinates ( x 10^4) and isotropic displacement
parameters (A^2 x 10^3) for 2.71.
x y z U(eq)
H6 12003(5) 1838(3) 8350(2) 41
H8A 9741(6) 3029(3) 9404(3) 57
H8B 11303(6) 2580(3) 9416(3) 57
H9 9688(5) 1725(3) 10009(3) 47
H13A 6283(7) -642(3) 8830(2) 70
H13B 7578(7) -1286(3) 8708(2) 70
H14 9199(5) -348(3) 8370(2) 50
H17A 6517(5) 1231(2) 6734(2) 53
H17B 6015(5) 1269(2) 7600(2) 53
H17C 7668(5) 1541(2) 7361(2) 53
H18A 8879(5) -6(3) 6243(3) 68
H18B 10023(5) 210(3) 6908(3) 68
H18C 9410(5) -679(3) 6822(3) 68
H20 4306(4) 23(2) 7836(3) 43
H21 2237(5) -835(3) 7589(3) 53
H22 2618(6) -2020(3) 6880(3) 53
H23 5032(6) -2328(3) 6405(3) 56
H24 7092(5) -1438(3) 6607(2) 46
H28A 13265(5) 547(3) 10788(3) 89
H28B 12747(5) -218(3) 10321(3) 89
H28C 13908(5) 397(3) 9957(3) 89
H30 13346(6) 1407(3) 7296(3) 58
H31 13741(5) 1328(3) 5964(3) 59
H33 9814(6) 2565(3) 5607(3) 54
H34 9411(5) 2610(3) 6957(3) 50
H36A 11393(7) 2002(4) 3861(3) 109
H36B 10096(7) 1812(4) 4458(3) 109
H36C 10849(7) 2675(4) 4437(3) 109
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Figure A5.  View of 2.71 showing the atom labeling scheme.  The thermal
ellipsoids are scaled to the 30% probability level.  The hydrogen atoms have been
scaled to an arbitrary size.  Most hydrogen atoms have been omitted for clarity.
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Figure A6.  Unit cell packing diagram for 2.71.  The view direction is
approximately down the c axis.
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Table A11.  Crystal data and structure refinement for 2.84.






Unit cell dimensions a = 5.6380(7) Å      alpha = 90°.
b = 15.1560(10) Å    beta = 96.908(5)°.
c = 13.8310(11) Å    gamma = 90°.
Volume, Z 1173.3(2) A^3,  2
Density (calculated) 1.230 Mg/m^3
Absorption coefficient 0.163 mm^-1
F(000) 464
Crystal size 0.25 x 0.06 x 0.04 mm
Theta range for data collection 2.97 to 27.53 deg.
Limiting indices -7<=h<=7, -19<=k<=16, -17<=l<=17
Reflections collected 4793
Independent reflections 4793 [R(int) = 0.0000]
Refinement method Full-matrix least-squares on F^2
Data / restraints / parameters 4793 / 1 / 401
Goodness-of-fit on F^2 1.11
Final R indices [I>2sigma(I)] R1 = 0.0608, wR2 = 0.1263
R indices (all data) R1 = 0.1029, wR2 = 0.1546
Absolute structure parameter 0.13(11)
Largest diff. peak and hole 0.231 and -0.264 e.A^-3
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Table A12.  Atomic coordinates ( x 10^4) and equivalent isotropic
displacement parameters (A^2 x 10^3) for 2.84.    U(eq) is defined as one third of
the trace of the orthogonalized Uij tensor.
x y z U(eq)
C1 -1681(8) 440(3) 2303(3) 46(1)
C2 -1888(10) -140(3) 3077(4) 53(1)
C3 -133(9) -173(3) 3853(4) 47(1)
C4 1811(10) 380(3) 3882(3) 48(1)
C5 1993(9) 971(3) 3124(3) 43(1)
C6 232(8) 1003(3) 2321(3) 39(1)
C7 427(9) 1671(3) 1517(3) 43(1)
C8 2621(8) 1566(3) 983(3) 36(1)
C9 2553(11) 702(3) 418(4) 46(1)
C10 2899(8) 2356(2) 314(3) 33(1)
C11 3019(8) 3239(2) 844(3) 32(1)
C12 1516(10) 3875(3) 550(3) 46(1)
C13 5041(9) 3318(3) 1669(3) 37(1)
C14 5041(8) 4180(3) 2224(3) 35(1)
S15 7264(2) 4230(1) 3246(1) 36(1)
O16 7003(7) 5060(2) 3732(2) 50(1)
O17 9539(6) 4024(2) 2926(2) 48(1)
C18 6525(8) 3381(2) 4032(3) 33(1)
C19 4632(9) 3498(3) 4568(3) 44(1)
C20 4096(10) 2828(3) 5195(3) 51(1)
C21 5450(10) 2073(3) 5281(3) 48(1)
C22 7295(11) 1954(3) 4747(3) 50(1)
C23 7849(10) 2612(3) 4113(3) 43(1)
O24 5005(6) 2212(2) -140(2) 36(1)
C25 5242(10) 2808(3) -916(3) 42(1)
C26 6969(8) 2445(3) -1556(3) 37(1)
C27 8138(10) 3006(3) -2125(3) 46(1)
C28 9732(11) 2681(3) -2726(4) 55(1)
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C29 10187(10) 1783(3) -2774(3) 47(1)
C30 9022(10) 1220(3) -2206(3) 47(1)
C31 7394(9) 1543(3) -1606(3) 45(1)
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Table A14.  Anisotropic displacement parameters (A^2 x 10^3) for 2.84.
The anisotropic displacement factor exponent takes the form:
    -2 pi^2 [ h^2 a*^2 U11 + ... + 2 h k a* b* U12 ]
U11 U22 U33 U23 U13 U12
C1 33(3) 41(3) 62(3) -2(2) -1(2) 2(2)
C2 41(3) 36(3) 84(4) 5(2) 14(3) 1(2)
C3 53(3) 37(3) 54(3) 3(2) 14(2) 0(2)
C4 50(3) 50(3) 44(2) 5(2) 5(2) 3(2)
C5 36(3) 46(3) 47(2) 2(2) 4(2) -9(2)
C6 33(3) 33(2) 51(2) 1(2) 5(2) 5(2)
C7 42(3) 37(3) 47(2) 6(2) 1(2) 10(2)
C8 35(3) 35(2) 36(2) -1(2) -6(2) 5(2)
C9 55(4) 36(2) 45(3) -4(2) -5(2) 1(2)
C10 35(3) 33(2) 31(2) -3(2) -1(2) 6(2)
C11 29(2) 35(2) 30(2) -2(2) 2(2) 5(2)
C12 52(3) 37(2) 46(3) -2(2) -4(2) 11(2)
C13 38(3) 32(2) 39(2) -5(2) 0(2) 4(2)
C14 37(2) 30(2) 38(2) -1(2) 5(2) 1(2)
S15 36(1) 38(1) 35(1) -3(1) 6(1) -8(1)
O16 69(3) 35(2) 47(2) -12(1) 8(2) -14(1)
O17 34(2) 66(2) 43(2) 2(1) 6(1) -10(2)
C18 32(3) 38(2) 29(2) -2(2) 0(2) -6(2)
C19 43(3) 51(3) 39(2) 5(2) 14(2) 2(2)
C20 49(3) 62(3) 44(3) 7(2) 15(2) -8(3)
C21 58(4) 43(3) 42(2) 8(2) 2(2) -11(2)
C22 62(4) 40(3) 46(2) 0(2) 0(2) 5(2)
C23 40(3) 50(3) 39(2) -2(2) 9(2) -1(2)
O24 39(2) 37(2) 31(1) -1(1) 3(1) 7(1)
C25 42(3) 39(2) 46(3) 3(2) 5(2) 6(2)
C26 37(3) 38(2) 32(2) -1(2) -3(2) 1(2)
C27 61(3) 36(3) 41(2) 1(2) 10(2) 2(2)
C28 73(4) 44(3) 51(3) 6(2) 24(3) -1(3)
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C29 54(3) 43(3) 47(3) -2(2) 14(2) 4(2)
C30 60(3) 32(2) 50(3) -4(2) 17(2) 1(2)
C31 51(3) 35(2) 51(3) -4(2) 12(2) -2(2)
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Table A15.   Hydrogen coordinates ( x 10^4) and isotropic displacement
parameters (A^2 x 10^3) for 2.84.
x y z U(eq)
H1 -2841(79) 382(26) 1704(28) 33(10)
H2 -3303(118) -572(40) 3060(38) 82(18)
H3 -304(114) -551(40) 4395(41) 89(20)
H4 3125(89) 335(28) 4456(30) 42(11)
H5 3416(99) 1368(32) 3237(33) 56(13)
H7A -1069(115) 1672(35) 863(40) 80(17)
H7B 266(95) 2197(36) 1698(34) 55(15)
H8 4030(85) 1542(27) 1344(30) 33(10)
H9A 1072(98) 706(30) -99(33) 51(13)
H9B 4008(120) 631(36) 65(39) 66(17)
H9C 2485(92) 198(33) 765(33) 48(13)
H10 1371(67) 2361(21) -213(23) 21(9)
H12A 235(94) 3782(28) -3(33) 46(12)
H12B 1514(82) 4424(30) 860(30) 39(12)
H13A 6651(108) 3272(32) 1321(34) 60(15)
H13B 4757(100) 2877(35) 2063(36) 59(15)
H14A 3638(85) 4251(31) 2482(28) 38(11)
H14B 5440(83) 4737(30) 1807(30) 43(12)
H19 3549(110) 3962(35) 4500(35) 67(17)
H20 2830(105) 2878(32) 5580(35) 59(16)
H21 5064(107) 1636(40) 5624(39) 74(18)
H22 8372(131) 1499(46) 4834(44) 93(21)
H23 9007(89) 2575(28) 3826(29) 31(12)
H25A 3920(88) 2900(26) -1217(29) 29(11)
H25B 5809(121) 3461(41) -531(41) 86(19)
H27 7888(87) 3645(33) -2091(31) 42(12)
H28 10684(123) 3105(44) -3134(45) 90(20)
H29 11144(115) 1582(38) -3330(43) 82(18)
H30 9339(95) 534(35) -2143(31) 58(14)
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H31 6665(129) 1112(43) -1033(45) 97(19)
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Figure A7.  View of 2.84 showing the atom labeling scheme.  Thermal
ellipsoids are scaled to the 50% probability level.  Hydrogen atoms shown are
drawn to an arbitrary scale.
346
Figure A8.  Unit cell packing diagram for 2.84.  The view is
approximately down the a axis.
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